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Introduction 
 
1. Magnetic nanoparticles 
The use of nanoparticles (NPs) in biomedicine has attracted much attention in the 
past decades, for their remarkable potential in the resolution of many long-standing 
problems.1 NPs, thanks to their large surface area, can be loaded with huge amounts 
of small molecules, and therefore can act as efficient carriers of drugs or 
functionalized imaging agents toward their target, preventing their rapid clearance. 
Magnetic NPs, have shown promising results in different fields, in particular in the 
biomedical one, thanks to their useful magnetic properties, as contrast agent, drug 
carriers and therapeutic agents, especially in cancer therapy. The most used magnetic 
NPs are based on magnetic iron oxides: magnetite and maghemite (see Fig. 1). These 
materials are known for their high biocompatibility and lack of toxicity.2 
 
 
Magnetite (Fe3O4) differs from most other iron oxides in that it contains both 
divalent and trivalent iron ions. Fe3O4 has a cubic inverse spinel structure that consists 
of a cubic close packed array of oxide ions, where all of the Fe2+ ions occupy half of 
the octahedral sites and the Fe3+ are split evenly across the remaining octahedral sites 
and the tetrahedral sites. In stoichiometric magnetite Fe2+:Fe3+ = 1:2, and the divalent 
Figure 1. Crystal structure of magnetite (right) and maghemite (left) (Fe
2+
in black, Fe
3+
 
in green and O
2−
in red).
2
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irons may be partly or fully replaced by other divalent ions (Co, Mn, Zn, etc). 
Moreover, magnetite shows the highest magnetization out of the different iron 
oxides, with a bulk magnetic saturation of up to 92 emu/g. 
Maghemite (γ-Fe2O3) adopts a cubic structure, in which oxygen anions give rise to a 
cubic close-packed array while ferric ions are distributed over tetrahedral sites (eight 
Fe ions per unit cell) and octahedral sites (the remaining Fe ions and vacancies). 
Therefore, the maghemite can be considered as fully oxidized magnetite. 
During the last decades many different methods have been developed for the 
synthesis of iron oxide NPs.3 During my work I used mainly two of these different 
methods: co-precipitation from ferrous and ferric salts and thermal decomposition of 
organometallic precursors (see Paragraphs 1.1 and 1.2). 
 
1.1 Co-precipitation 
Coprecipitation from a Fe2+/Fe3+ solution was one of the first methods used, first 
discovered by Massart in 1981.4 Iron oxide NPs are produced mixing ferric and ferrous 
ions in a basic solution (the most commonly used bases are ammonia and sodium 
hydroxide, at pH= 8-14), at room or elevated temperature, as in the following 
equation:  
Fe2+ + Fe3+ + 8 OH−  →  Fe3O4↓ + 4H2O 
Usually the reaction is conducted under inert atmosphere, to prevent unwanted 
oxidation. The size, shape, and composition of an obtained product is highly 
dependent on the reaction parameters (e.g. iron precursor, molar ratio of Fe2+ and 
Fe3+, pH, reaction temperature, and reaction medium). The addition of chelating 
organic compounds (such as carboxylates like citric acid) or polymers (such as 
dextran) can help control the size of the NPs. This method is simple, low cost, green 
and able to easily produce gram-scale material with almost quantitative yields: for 
these reasons, it has been the most widely adopted method for the industrial 
synthesis of iron oxide NPs. However, due to the fast particle formation rate, it lacks 
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precise size control and, due to the low reaction temperature, it produces NPs of low 
crystallinity and magnetic properties. 
 
1.2 Thermal decomposition 
Highly crystalline and monodisperse iron oxide NPs, with diverse sizes and shapes 
can be synthesized via thermal decomposition or organometallic precursor (iron 
acetylacetonate, iron oleate, iron pentacarbonyl) in the presence of surfactants (for 
example oleic acid and oleylamine) in high boiling organic solvents (such as 1-
octadecene or dibenzylether). The most common organic compounds are oleic acid 
and oleyamine, which have a C18 tail with a cis-double-bond in the middle of the 
chain, forming a kink. Such kinks have been postulated as being necessary for 
effective stabilization, which can be a reasonable explanation for why stearic acid 
cannot stabilize IONPs (without double-bond in its C18 tail).5 
For example, Hyeon et al. used a thermal decomposition approach for the large-
scale synthesis of monodisperse iron oxide NPs by using iron oleate as a precursor. 
Nontoxic and cheap iron(III) chloride and sodium oleate were used to generate an 
iron oleate complex, which was then decomposed at temperatures between 240 °C 
and 320 °C in different organic solvents (e.g., 1 hexadecene, octylether, 1-octadecene, 
1-eicosene, or trioctylamine) to produce iron oxide NPs.6 Numerous studies have 
indicated that the iron(III) oleate is a critical reaction intermediate for preparing iron 
oxide NPs with a narrow size distribution in thermal decomposition.7 
Many synthetic parameters (concentration of surfactants, reaction temperatures, 
reaction time, precursor to surfactant ratio, solvents and heating rate) govern the 
final properties of the synthesized NPs. However, while the resulting hydrophobic 
SPIONs usually show high magnetic properties, they also show good dispersibility only 
in organic solvents (such as hexane, toluene or chloroform) because of the 
hydrophobic oleate coating and require further functionalization to be applied in 
biomedical applications. 
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2. Surface functionalization 
An unavoidable problem associated with magnetic IONPs in the size range is their 
intrinsic instability over long periods, which manifests in two main ways: (1) loss of 
dispersibility, where small NPs tend to aggregate and form larger particles in order to 
reduce the surface energy; and (2) loss of magnetism, where bare IONPs are easily 
oxidized in air due to their high chemical activity. Therefore, it is crucial to develop a 
proper protection strategy to chemically stabilize bare IONPs against damage during 
or after the subsequent application, yielding well-dispersed individual NPs in 
biological fluids for various in vitro and in vivo purposes, thereby increasing the blood 
circulation half-life. This last point is especially challenging for NPs produced via the 
thermal decomposition method, which are usually coated with hydrophobic oleic 
acid. Moreover, the organic material layer can endow the magnetic NPs with more 
functionality, providing functional terminal groups for further engineering or 
modification, such as further coating by other inorganic or organic materials, the 
encapsulation or attachment of therapeutic agents, targeting agents, and permeation 
enhancers. 
2.1 Silica 
Silica coating not only prevents direct contact between a biological medium and 
inner active materials but also overcomes undesirable side reactions and improves 
dispersibility and stability because of its excellent intrinsic physical/chemical stability. 
Moreover, it provides a useful way to further functionalize the NPs surface thanks to 
the well-known silica chemistry and the use of different commercial alcoxysilanes. 
The Stöber synthesis and reverse microemulsion methods are two of the most 
conventional routes for fabricating iron oxide@SiO2 composite NPs. 
The Stöber process is a synthetic process employed for the generation of 
monodisperse SiO2 particles. Tetratethyl ortho silicate (TEOS) is typically added to an 
excess of water containing a low molar-mass alcohol (such as ethanol), and ammonia 
under constant stirring. The resulting SiO2 particles have diameters spanning from 50 
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nm to 2000 nm, depending on the type of silicate ester used, the type of alcohol used, 
the pH, and the volume ratios. This method can be used to coat iron oxide NP seeds 
with silica, creating a core/shell structure. The silica shell thickness can be controlled 
by varying the reaction parameters. 
The microemulsion method allows better control of the size of composite NPs and 
the thickness of the silica layer compared to the classical Stöber process. Previously 
prepared iron oxide seeds were typically coated with silica within the microemulsion 
droplets. This method also prevents the formation of core-free or multicore NPs.8 
Unfortunately the reaction parameters that are suitable for Fe3O4 NPs with a certain 
size are not definitely applicable to those with other sizes, and a match of the number 
of Fe3O4 NPs with the aqueous domain is essential in order to reach the desired goal. 
2.2 Small molecules 
A common way to displace hydrophilic ligands is a ligand exchange procedure. It 
involves the addition of an excess of ligand to the NP solution, resulting in the 
displacement of the original ligand on the surface of NPs, thus changing the polarity 
from hydrophobic to hydrophilic. The main advantages of small-molecule coated NPs 
are the retention of a small hydrodynamic radius without loss of the original magnetic 
properties. Different functional groups such as carboxylic acid (as in citric acid9 or 
dimercaptosuccinic acid, DMSA10) and catechol (as in nitrodopamine or in Tiron, 
disodium 4,5-dihydroxy-1,3-benzenedisulfonate)11 have been used to produce a 
strong covalent interaction between ligand molecules and iron oxide surface. This 
ligand exchange can also be achieved using surfactant molecules, such as 
tetramethylammonium hydroxide, which is able to form an electrically charged 
double layer on the NP surface, preventing agglomeration.12 Other surfactants such as 
CTAB (cetyltrimethylammonium bromide) were also used to impart water solubility to 
NPs exploiting their ability to intercalate with the apolar tails of the oleate coating 
layer. 
Nitrosonium tetrafluoroborate (NOBF4) can also be used to replace the original 
organic ligands attached to the NPs’ surface, stabilizing the NPs in various polar and 
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hydrophilic media for years, without aggregation or precipitation. Significantly the 
hydrophilic NPs obtained by NOBF4 treatment can readily undergo secondary surface 
modification due to the weak binding affinity of BF4
− anions to the surface of NPs, 
allowing fully reversible phase transfer of NPs between hydrophobic and hydrophilic 
media.13  
Although a wide variety of ligand layers can be fabricated through the ligand-
exchange reaction, this route suffers from several limitations, including incomplete 
replacements and reduced stability in water after the reaction. 
2.3 Polymers 
Compared with small molecules and surfactants, polymer functionalization not 
only provides multifunctional groups and more colloid stability, but also plays a 
significant role regarding its biological fate (i.e., pharmacokinetics and 
biodistribution). For many applications in biomedicine, a polymer coating on MIONs is 
thus preferred over basic functionalization with small organic compounds, because of 
the increases in repulsive forces, able to balance the magnetic interaction and the van 
der Waals attractive forces between iron oxide NPs and the improvement in blood 
circulation time, stability, and biocompatibility in biomedical applications. 
However, it is worth noting that, in some cases, the presence of polymer or 
copolymer layers may negatively influence the magnetic properties of the IONPs. 
Thus, great caution has to be exercised during the selection of polymeric materials for 
the stabilization of magnetic colloids. 
 7 
 
3. Enhanced permeability and retention effect 
Solid tumors must stimulate the production of blood vessels in order sustain their 
quick growth. To achieve this, they release different growth factors that stimulate 
angiogenesis. The newly formed tumor vessels are usually abnormal in form and 
architecture. presenting wide fenestrations. Furthermore, tumor tissues usually lack 
effective lymphatic drainage. All of these factors lead to preferential accumulation of 
nanometric drugs into tumor tissue. This effect was first observed by Maeda et al.14  
 
 
Figure 2. Schematic representation of EPR effect.
15
 
For this effect to take place, the NPs diameters must be in the range 10-100 nm, 
since smaller particles would escape from the circulatory system through renal 
clearance, whereas larger ones will be recognized by reticulo-endothelial system 
(RES), sequestered and mainly delivered to the liver. This effect can be further 
enhanced if the surface is functionalized with molecules or polymers able to make the 
NPs stealth to the RES, prolonging their circulation time. Historically, this was mainly 
achieved via coating the NP surface with biocompatible polymers such as poly-
ethylene glycol (PEG). Some researches, however, highlights how the PEGylating 
process also shows significant drawbacks: studies performed on PEGylated liposomes 
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demonstrates that it apparently hinders tumor cellular uptake and endo/lysosome 
escape, causing a consequent lower efficiency in drug administration.16 In fact, an in 
vivo comparison between a PEGylated and non-PEGylated liposomal formulation of 
doxorubicin shows that “there was no difference in toxicity and therapeutic effect for 
liposomal doxorubicin with or without PEGylation”.16a Moreover, it has been 
demonstrated that PEG moieties can in fact be immunogenic, inducing the production 
of PEG antibodies: an immune response was observed when PEGylated liposomes 
where repeatedly administered  to an animal was performed. This considerably 
worsened the liposome circulation time, increasing at the same time hepatic and 
splenic accumulation for the subsequent administrations. This accelerated blood 
clearance (ABC) phenomenon is observed even after days from the first injection, due 
to the presence of anti-PEG immunoglobulins and heavily affects the therapeutic 
efficacy of the liposome.16c 
For these reasons, the use of a non-PEG based coating agent could be beneficial 
for an effective NP application, see Chapter 6 for further discussion. 
 
4. Superparamagnetism 
Ferro- and ferrimagnetic NPs smaller than a certain size are known to possess an 
unusual magnetization behavior, known as superparamagnetism. In this state single 
NPs act as single domain magnets, in which magnetization randomly flips thanks to 
the environment thermal energy, thus averaging to zero. However, when an external 
magnetic field is applied, the NPs magnetic moment aligns themselves with the 
applied field, showing a magnetization that can be as intense as the one of the bulk 
magnetic material. This magnetization is immediately lost at the removal of the 
external field. In this particular case the ferromagnetic material behaves similarly to a 
paramagnet, but with much higher magnetic susceptibility. When the temperature is 
lowered below a certain threshold, called blocking temperature, the 
superparamagnetic behavior is lost, reverting back to the normal ferromagnetic 
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behavior. This property is fundamental to avoid aggregation and precipitation of the 
NPs inside of the human body under the effect of external magnetic fields. 
The superparamagnetic behavior of the NPs can be seen by their magnetic 
hysteresis curve, lacking both remanence and coercivity (see Fig. 3). 
 
Figure 3 Magnetic hysteresis loop for ferromagnetic (black) and superparamagnetic (blue) material. 
 
5. Magnetic Resonance Imaging (MRI)  
Magnetic resonance imaging is a non-invasive medical imaging technique that, 
using nuclear magnetic resonance (NMR), reconstructs a contrast image starting from 
atoms magnetic relaxation information. The main atom of interest is hydrogen, being 
a major component of both water and fat, which are the two major components of 
our body. It has the advantage of providing high spatial and temporal resolution with 
excellent soft tissue contrast. Unfortunately, NMR major limitation is an intrinsically 
low sensitivity. 
When under the effect of an external uniform magnetic field, proton nuclear spin 
magnetic moments tend to align themselves with the field in either parallel or 
antiparallel way, starting a precessing motion. Due to the influence of the mangetic 
field, the parallel state will have a lower energy of the antiparallel state, thus being 
slightly more populated. For this reason, a macroscopic positive magnetization along 
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the field axis will take place. At the same time no transversal magnetization is 
present, due to the phase displacement between the precessing magnetic moments 
around the magnetic field axis. The frequency of the precession depends on the atom 
type and magnetic field intensity, and it is called “Larmor frequency”. Resonant 
absorption can take place when protons are subjected to a secondary perpendicular 
magnetic field, oscillating at the appropriate Larmor frequency, exciting part of them 
to the antiparallel spin state. This will bring on two different phenomena: first of all a 
decrease in the longitudinal magnetization and, due to an induced phase coherence 
between the spins, a concomitant increase in the transversal magnetization. 
When the secondary magnetic field is turned off the nucleus spin will once again 
relax to its equilibrium/fundamental state, with the nuclear spins parallel to the 
external field. This relaxation triggers two different macroscopic effects, each 
following an exponential law: the recovery of longitudinal magnetization and the loss 
of transversal magnetization. The time constant after which longitudinal 
magnetization has recovered to 63% of its total value is called T1 (spin-lattice 
relaxation time). Similarly, the time constant after which transversal magnetization 
has lost 63% of its value is called T2 (spin-spin relaxation time). Both these time 
constants are heavily affected not only by the atom nature but also by the 
surrounding environment. For this reason, different tissues have different relaxation 
times. These differences in relaxation times are one of the different parameters that 
can then be used to create MRI images: by applying the proper acquisition 
parameters an MRI scan can be influenced more by the tissues T1 or T2, producing T1- 
or T2 weighted images. 
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Figure 4. Example of T1- and T2 weighted MRI scans.
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5.1 MRI contrast agents 
Exogenous agents can be also used to further enhance contrast in MRI imaging, 
modifying the relaxation times of the surrounding protons. The ability of a contrast 
agent in modifying the relaxation time is expressed by its relaxivity, the variation in 
relaxation speed of the tissues nuclei after introduction of the contrast agent, 
normalized by its concentration:  
(𝑟𝑖 =
1/𝑇𝑖 𝑚𝑒𝑎𝑠 − 1/𝑇𝑖 𝑑𝑖𝑎
𝐶
; 𝑖 = 1,2) 
 
where C is the contrast agent concentration, (1/Ti)meas is the measured relaxation time 
and  (1/Ti)dia  is the tissue or solvent original relaxation time. 
The r2/r1 ratio is an indicator of the contrast agent properties and is used to 
differentiate between T1 and T2 agents. T1 agents shorten the longitudinal relaxation 
time, thus giving a local positive contrast (i.e. brighter images) in T1 weighted images. 
T2 agents, instead, shorten the transversal relaxation time, giving a local negative 
contrast (i.e. darker images) in T2 weighted images. 
Typical T1 contrast agents are lanthanide-(Gd, Dy, Tb) or transition metal (Mn) 
based chelates, thanks to these elements paramagnetic properties deriving from the 
magnetic moment of unpaired electrons. 
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The most common T2 contrast agents are superparamagnetic iron oxide 
nanoparticles (SPIONs) that generate local magnetic field anisotropy in the tissue 
thanks to their own magnetic field, thus affecting T2 relaxation time. The contrast 
effect of MNPs are generally dependent on (Ms*V)2 and d-6 where Ms is the 
saturation magnetization, V is the NP volume and d is the distance measured from 
protons to magnetic surface. 18 
 
6. Magnetic Hyperthermia 
Cancer cells are considered as more susceptible to heat than normal cells due to 
their higher rate of metabolism.19 Moreover, on a tissue level, tumors possess a 
disorganized vascular system and their ability to dissipate heat stress is decreased. For 
these reasons, hyperthermia could be used as a therapeutic technique. Magnetic 
hyperthermia is an experimental therapeutic technique in which magnetic NPs are 
used to achieve localized cell death through an increase in temperature. When 
magnetic NPs are subjected to an external alternating magnetic field they undergo a 
magnetization cycle that provokes a loss of energy into the surrounding cells in the 
form of heat. This is done by two different mechanisms: Neel relaxation and Brownian 
relaxation. In Brownian relaxation the NPs physically rotate in order to maintain 
alignment with the external magnetic field. On the other hand, in the Neel relaxation 
mechanism the magnetic dipole of the NP reorientate without external rotation. This 
two mechanism are affected by both the size of the NPs and the physical properties of 
the surrounding media. The NP heating power is expressed as Specific Absorption 
Rate (SAR) and it is usually expressed in watts per gram of NPs. Usually the targeted 
temperature is between 41 and 47°C, which causes cell death through apoptosis. It 
was demonstrated using a micro-tumor-like environment that magnetic hyperthermia 
requires approximately 6 °C lower target temperature to produce the same cell death 
effect compared to other exogenous hyperthermia treatments.20 This increase in 
temperature cannot only directly harm the tumor cells but can also improve blood 
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flow and oxygenation in the targeted area, thus improving the effectiveness of 
complementary treatment methods such as chemio- and radiotherapy. For this 
reason hyperthermia is best used in combination with other cancer treatments.21  
More detailed discussion about magnetic hyperthermia can be found in Chapter 3. 
 
 
7. Dynamic Light Scattering (DLS) 
Dynamic Light Scattering (DLS) is a non-invasive technique that is widely used to 
determine the size and surface properties of different particles dispersions, such as 
polymers, proteins and NPs. It is based on the phenomenon of light scattering. 
Different objects have different scattering properties depending on the relationship 
between their size and the incident light wavelength. Depending on this ratio two 
differents scattering regimes can take place: for spherical objects with diameters less 
than 1/10th of light wavelength the scattering follows Rayleigh theory, for which the 
scattering distribution is isotropic and the scattering intensity is proportional to d6 
where d is the particle diameter. Most DLS instruments use and He-Ne laser at λ = 633 
nm, so this is true for NPs up to about 60 nm. 
Figure 5. Schematic representation of the major mechanisms for heat dissipation (left) 
and cartoon of an experimental apparatus (right). 
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For bigger particles the Rayleigh theory is no longer valid, and their scattering 
changes from being isotropic to a distortion in the forward scattering direction, 
following Mie theory. 
When the size of the particles becomes equivalent to or greater than the 
wavelength of the laser, the scattering becomes a complex function with maxima and 
minima with respect to angle. Using Mie theory, it is still possible to recover size 
information even in this last eventuality. 
The DLS instrument actually measures the diffusion coefficient of the target object 
that correlates to its hydrodynamic size through the Stokes-Einstein equation: 
𝑑𝐻 =
𝑘𝑇
3𝜋𝜂𝐷
 
 
where dH is the hydrodynamic diameter, k the Boltzmann’s constant, T the absolute 
temperature, η the medium viscosity and D the diffusion coefficient. It is important to 
underline that what is measured is the hydrodynamic diameter of the measured 
object that is the diameter of a sphere having the same diffusion coefficient. This 
does not include only the NP core, but also any surface-bound molecule and the 
surrounding solvation shell. 
Basically a DLS instrument shines a laser on the target suspension, whose 
scattered light is then recorded at a certain angle. The most common setups are the 
90° and 173°. Even if the light source is monochromatic and coherent there will still 
be fluctuations in the scattered light intensity due to the particle motion in the 
suspension: smaller particles will move faster, and thus will generate faster 
fluctuations while bigger particles will generate slower fluctuations (see Fig. 6). 
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Figure 6. Intensity fluctuations for small and large particles.
22
 
The time dependency of these fluctuations is then extracted using an 
autocorrelation function (see Fig. 7). 
 
Figure 7. Time-dependent intensity fluctuations and correlation function. The intensity of scatterd light 
will change during the measurement time from t=0 (red) to t=1 (blue) and t= 2 (green). The correlation 
in the intensity signal will decay exponentially from its starting value of 1 at t=0 to 0 at t=∞.22 
The correlation function contains the diffusion coefficient information required to 
be entered into the Stokes-Einstein equation. These diffusion coefficients are 
obtained by fitting the correlation function with a suitable algorithm. 
The primary result obtained by a DLS measurement is an intensity size distribution, 
i.e. a plot of scattered light intensity vs particles size. Due to the dependence of the 
scattered light intensity on the particle radius (I α d6) this distribution is highly 
sensitive to the presence of large particles that can easily shadow smaller 
populations, even if present only as a minority. From this distribution both volume 
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(equivalent to the mass or weight distribution) and number distributions can be 
obtained, provided the particles absorbtion and refractive index (usually assumed to 
be the same as the bulk material) are known. It is generally advised to use the volume 
and/or number distribution only for estimating the relative amount of material in 
different peaks and not as a size measurement (see Fig. 8). 
 
A second useful information that can be obtained via DLS analysis is the NP ζ–
potential. When an object is exposed to a fluid its surface will be coated by an 
electrical double layer of ions. The ideal plane between the two layers is called Stern 
layer. The external plane that surrounds the second layer is called slipping plane, and 
it ideally separates the solvent fraction that moves jointly with the NPs from the other 
mobile solvent. The ζ–potential is the electric potential at this plane, and is widely 
used as an indicator of the stability of a NP dispersion: particles with high ζ–potential 
will repel each other, avoiding flocculation and precipitation. Usually a ζ–potential > 
±30 mV is required to achieve stable dispersion over time. 
Figure 8. Intensity (top), volume (middle) and number (bottom) size 
distributions for a mixture of 60 nm and 220 nm latex NPs. 
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ζ–potential measurements are based on the principle of electrophoresis: the NP 
suspension is first subjected to an external magnetic field. The particles will then start 
moving toward one of the electrodes (depending on their charge sign) with a speed 
that is dependent on their ζ–potential. The Henry equation correlates the ζ–potential 
with the electrophoretic mobility (the ratio between particle velocity and electric field 
strength): 
 
𝑈𝐸 =
2𝜀𝜁𝑓(𝑘𝑎)
3𝜂
 
 
where UE is the electrophoretic mobility,  the dielectric constant of the medium, η 
the viscosity, ζ the ζ–potential and f(ka) is Henry’s function, a function of the ratio of 
particle radius to double layer thickness (ka). Henry’s function is usually approximated 
to 1.5 in polar media. 
The electrophoretic mobility is measured using the Doppler effect: the DLS laser is 
passed through the sample undergoing electrophoresis and the shift in the frequency 
of its scattered light, caused by the moving particles, is measured. This frequency shift 
is directly proportional to the particle velocity and allows the determination of the 
electrophoretic mobility. 
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Aim of the work 
 
The aim of this Ph.D thesis is the development of new nanometric compounds that 
could find possible theranostic applications in the field of nanomedicine. To this end 
different multimodal agents, based on magnetic iron oxide nanoparticles or 
poly(amidoamine)s were synthesized and characterized.  
To this aim we first synthesized a new luminescent metallopolymer for 
photodynamic therapy (PDT), based on an amphoteric and biocompatible 
poly(amidoamine) (PhenISA) to which an organometallic Ir complex was conjugated. 
This polymer was able to self-assemble into nanoparticles while the Ir complex could, 
upon light absorption, give rise to triplet metal to ligand charge transfer excited states 
that can both radiatively decay providing optical luminescence or react with 3O2, 
producing cytotoxic reactive oxygen species, allowing for both imaging and PDT 
applications. These properties were tested by cell uptake assays and prelaminar 
cytotoxicity studies. Poly(amidoamine)s functionalized with different metal complexes 
(namely Ru and Pt) were also investigated (Chapter 1).  
We then prepared a new magneto-optical probe and sensitizer for photodynamic 
therapy. This bimodal probe was constituted by a magnetic iron oxide core and a silica 
shell grafted with a luminescent Re complex, acting as both optical emitter and PDT 
sensitizer. The silica shell was also coated by a poly(ethyleneglycol) layer to reduce 
the toxicity and improve the colloidal stability of the nanoprobe. The nanocomposite 
photophysical properties were then tested, and the cellular uptake and light-activated 
cytotoxicity were subsequently investigated on HeLa cells (Chapter 2).  
As a next work we presented a new strategy to bind peptide nucleic acids (PNAs) 
onto the surface of iron oxide nanoparticles, that could find future application in 
combining the nanoparticle magnetic properties with the PNA specific targeting 
ability. Two different synthetic pathways were investigated, and an extensive 
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magnetic characterization was performed to check for any influence of the 
conjugation strategy on the nanoparticles initial magnetic properties (Chapter 3).  
During my abroad period in EMPA St. Gallen (CH) I worked on the possible 
application of magnetic nanoparticles for blood purification applications. We first 
developed a proof of concept study on the theranostic potential of magnetic blood 
purification applied to sepsis. Bacterial removal could not only directly improve the 
condition of sepsis-ill patients but also help in decreasing the time needed for 
effective diagnosis and treatment. To this end we used commercial magnetic 
nanoparticles functionalized with newly developed human IgG1 monoclonal antibody 
against poly-N-acetylglucosamine (PNAG), a key component of the bacterial cell wall. 
We investigated both the nanoparticles magnetic separation efficiency and 
degradation properties, as well as their biocompatibility and bacteria removal 
capability (Chapter 4).  
We then synthesized hydrophobic iron oxide and iron carbide nanoparticles that 
were subjected to an emulsion electrospinning procedure to synthetize magnetic 
nanoclusters. Their properties were then tested along with those of some commercial 
magnetic nanoparticles, for magnetic blood purification applications, checking 
biocompatibility, degradability in model buffers and separation efficiency to find the 
best candidate for future applications (Chapter 5).  
Finally we synthesized and characterized a new nanoparticle stabilizer based on a 
catechol functionalized amphoteric poly(amidoamine), and developed its conjugation 
reaction to iron oxide nanoparticles. The covering of the hydrophobic nanoparticles  
was achieved by both a one-step and a two-step reaction. A second polymer, 
endowed with fluorescent properties, was also prepared and employed (Chapter 6). 
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Chapter 1: Luminescent Poly(amidoamine)–
Metal Complexes as New Singlet-Oxygen 
Sensitizers for Photodynamic Therapy 
 
D. Maggioni, M. Galli, L. D’Alfonso, D. Inverso, M. V. Dozzi, L. Sironi, M. Iannacone, M. 
Collini, P. Ferruti, E. Ranucci and G. D’Alfonso, Inorg. Chem., 2015, 54, 544–553. 
 
1. Introduction 
Photodynamic therapy (PDT)1 is a clinical practice that has received an increasing 
attention as alternative method for the treatment of several cancer types2 (such as 
skin,3 bladder,4 esophagus,4 lung,5 and head and neck6 affecting types) as well as a 
new method for killing pathogens in localized infections7 since it is minimally invasive. 
In PDT a photosensitizer (PS), is first promoted to an excited triplet state upon 
interaction with visible or NIR light. This triplet state (3PS*) can produce toxic reactive 
oxygen species (ROS), such as singlet oxygen (1O2) or free radicals, by two different 
pathways. 3PS* can react with molecules to generate intermediate free radicals that 
in turn generate ROS (type I photochemistry), or alternatively, it can interact with 
molecular O2, which in its ground triplet state can produce “in situ” cytotoxic singlet 
oxygen (1O2) through an energy transfer process (eq 1, type II photochemistry). 
   3Ps* +3O2       PS + 
1O2 (1) 
This type II photochemistry is the most relevant mechanism of PDT in cells, 
because most PSs are effective 1O2 producers. The reactive oxygen species generated 
are capable of causing irreversible damage if generated inside cells, particularly inside 
specific subcellular organelles (mitochondria, Golgi apparatus, etc.) where the PSs can 
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localize and accumulate. Indeed, singlet oxygen has a radius of destruction measured 
in nanometers (10–60 nm, its lifetime being in the range of 10–320 ns), and 
photodynamic damage will then occur only very close to the intracellular location of 
the PS.8 Although dependent on many factors, only one of which is the subcellular 
location of the PS, PDT treatment can cause cell death by apoptotic or necrotic 
pathways, in dependence of many factors, including the subcellular location of the PS. 
Apoptosis is programed cell death that does not cause inflammation in vivo, whereas 
necrosis is a pathological cell death in which cellular content leaks out, potentially 
causing lethal damage in nearby cells and inflammation in vivo. In many cases, PDT 
has been found to be highly efficient at inducing apoptosis as a result of a complex 
cascade of events.9 This feature is very important because it implies that doses lower 
than those necessary for producing necrosis may still be effective at killing 
cells.10 Furthermore, efficient induction of apoptosis by PDT implies that PDT may be 
able to bypass mechanisms that make cells resistant to apoptosis in response to 
chemotherapeutic drugs and ionizing radiation.10  
PDT would therefore be able to selectively kill diseased cells, reducing collateral 
effects on healthy tissues, provided that selective delivery of the PS to the target 
could be assured. Porphyrins,1a,11 phthalocyanines,1a fullerene derivatives,12 and 
organic dyes, like methylene blue13 or rose bengal,14 are valid PSs, as are some 
organometallic complexes.1 Among them, cyclometalated iridium complexes have 
attracted much attention15-17 on the basis of many favorable properties: high 
quantum yields of triplet formation (even higher than 0.9 in deaerated 
solutions),18 long lifetimes of the excited triplet state (typically in the microsecond 
range, which is long enough to enable quenching reactions with 3O2 before 
spontaneous decay), and triplet energy high enough to allow for the energy transfer 
process (eq 1). Moreover, it has been shown that they are usually resistant to attack 
by singlet oxygen.16  
However, several disadvantages hinder biomedical applications of these 
complexes. Their solubility in water is generally very low. Moreover, the circulating 
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time of small molecules in biological fluids is generally too short to allow significant 
accumulation of a molecular sensitizer proximal to the target for in vivo applications. 
The loading of complexes on suitable nanometric carriers can be exploited to 
improve their solubility in aqueous media, increase their plasma residence time, and 
reduce their toxicity.1b,19 Actually, stealth NPs (i.e., NPs covered by macromolecules 
that make them invisible to the reticuloendothelial system) can benefit from a 
prolonged circulating time and effectively accumulate in solid tumors, owing to the so 
called enhanced permeability and retention (EPR) effect.20  
Linear amphoteric polyamidoamines (PAAs)21 have well established properties of 
water solubility, biocompatibility, biodegradability, and stealth-like 
behavior.22 Moreover, they tend to aggregate in water solutions in the form of small 
NPs with hydrodynamic diameters in the range of 5–20 nm.23,24 They are therefore 
very attractive as carriers for molecular complexes. In a previous work, a PAA 
copolymer (PhenISA, Chart 1) was synthesized bearing phenanthroline (phen) 
pendants,24 which are strong chelating ligands toward a variety of transition-metal 
fragments. The phen ligand pendants involved ∼6% repeating units, whereas the 
large majority of the units were those of the ISA23 polymer.25  
 
Chart 1 Structure of the PhenISA copolymer. 
PhenISA was able to bind Re(CO)3
+ and Ru(phen)2
2+ fragments, affording 
luminescent polymer complexes that were internalized by HEK-293 cells.24 These 
results prompted us to investigate the binding of PhenISA to different metal 
fragments fragments to obtain a luminescent triplet emitter useful for both optical 
imaging and producing 1O2 for PDT purposes. 
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2. Results and discussion 
2.1 Model Complex [Ir(ppy)2(bap)]
+ (1M) (ppy = 2-phenylpyridyl, bap = 4-(butyl-4-
amino)-1,10-phenanthroline) 
The related [Ir(ppy)2(phen)]
+ complex was previously prepared by reacting 
dinuclear precursor [Ir(ppy)2Cl]2 with phen at high temperature in ethylene glycol.
26 In 
the polymer complex reported here, phen ligands are appended to the polymer chain 
by butylamino substituents in the 4-position of phenanthrolines (bap ligand, whose 
synthesis has been reported elsewhere).24,27 It was therefore necessary to synthesize 
the [Ir(ppy)2(bap)]
+ complex (1M) to have a reliable molecular model of the designed 
polymer complex. A previously published protocol was followed with some 
modifications (Scheme 1). The precursor [Ir(ppy)2Cl]2 was treated with 2 equiv of bap 
ligand in a mixed solvent (THF/H2O 1:1) under mild heating (70 °C). A clear yellow 
solution formed upon heating, and the orange photoluminescence of the Ir complex 
progressively overcame the blue fluorescence of free phen.  
Scheme 1. Synthesis of complex 1M. 
Reaction progress was monitored by 1H NMR spectroscopy. All resonances were 
attributed by two-dimensional 1H–1H and 1H–13C NMR experiments (Figs 1 and 2). 
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Figure 1. 
1
H NMR spectrum of compound 1M (H2O/D2O, 300 K, 9.4 T). 
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Figure 2. 
1
H COSY (top) and. 
1
H-
13
C HSQC (bottom) NMR experiment on complex 1M (D2O, 300 K, 9.4 
T). 
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In contrast to the [Ir(ppy)2(phen)]
+ complex, 1M (as a chloride salt) is moderately 
soluble in water due to the presence of a protonated amino group on the phen ligand 
(pKa = 10.2, as determined by potentiometric titration on the bap ligand). Solubility 
was high enough to perform photophysical characterization in water solution, as well 
as the biological tests described in section 2.5. However, through dynamic light 
scattering (DLS) and NMR data, a minor fraction of the compound was found to be 
present in the form of nanoaggregates, as discussed below. 
The UV–vis absorption spectrum (Fig. 3) of 1M shows strong spin-allowed ligand-
centered (1LC) bands in the range of 200–300 nm and broad weaker absorptions at 
longer wavelengths (peaks are recognizable at approximately 378 and 417 nm; their 
position did not change significantly upon varying the solvent, attributable to singlet 
metal-to-ligand charge transfer (1MLCT) transitions, which is in agreement with 
literature data for similar complexes.15,26,28  
 
Figure 3. UV-Vis absorption (left) and emission (right, λex = 400 nm) spectra of complex 1M, at room 
temperature in different solvents. 
Upon excitation at 400 nm, complex 1M exhibits yellow-orange photoluminescence 
at wavelengths that are strongly sensitive to the nature of the solvent (see Table 1 ). A 
blue shift is observed upon decreasing solvent polarity,29which is typical of excited 
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states that are more polar than their ground states (such as CT states) because they 
are preferentially stabilized by polar solvents, provided that the excited state lifetime 
is longer than the solvent reorganization time.32,33 The sharp drop in the lifetimes (τ) 
and photoluminescence quantum yields (PLQYs, ϕ) in the presence of oxygen, 
observed in CH2Cl2 or CH3CN solution (Table 1), indicates that emission occurs from an 
excited state with a substantially triplet nature. This agrees with literature data that 
attributed the emission from [Ir(ppy)2(phen)]
+ complexes (phen indicating different 
phenanthroline-based ligands) as arising from 3MLCT states involving the π* orbitals 
of phen ligands as the acceptor orbitals.26,28,34  
In water, 1M photoluminescence is centered at 604 nm, a position that did not 
change in the pH range of 3.2–7.2. The behavior in the presence of oxygen did not fit 
with the typical behavior of triplet emitters observed in organic solvents. Lifetimes 
and PLQYs were only modestly affected by the presence of oxygen (Table 1). 
Moreover, in aerated conditions, the PLQYs were higher in water than in acetonitrile, 
contrary to what would be expected from the polarity trend. A possible explanation 
was provided by DLS analysis of the water solution 
(∼2 × 10–5 M), which showed the presence of NPs with hydrodynamic diameters of 
∼200 nm. This suggested that 1M was not completely dissolved but was present, at 
least in part, in the form of nanosized aggregates. Such aggregates cannot account for 
the entirety of 1M present in solution because colloids are NMR silent (or give very 
broad, hardly detectable resonances),35 whereas sharp 1H NMR signals were observed 
for samples of 1M in water (e.g. Fig. 1). It has been shown (see Exp. part) that the NMR 
silent fraction of 1M in water corresponds to ∼25% of the total sample. Such a fraction 
of aggregated 1M, even if minor, could dominate the emission features because the 
complexes inside the NPs are expected to be more brilliant, being protected from the 
deactivating actions of oxygen and the polar solvent.36 Therefore, the wavelength, 
lifetime, and PLQYs of the emission measured in water should be primarily attributed 
to the aggregates, with little contribution from the free molecules. Interestingly, in 
water, a double exponential model was necessary to describe the lifetime decays 
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(Table 1) to achieve a function of merit (χ2) comparable to that obtained for the 
organic solvents. The main component (longer and less sensitive to oxygen) is 
ascribable to the species inside the NPs, whereas the minor component (shorter and 
strongly affected by oxygen) is attributable to free molecules. 
Table 1. Photoluminescence Data for Molecular Complex 1M in Aerated or Deaerated Solutions in 
Different Solvents and for Polymer Complex 1P in an Aerated Water Solution.
a
 
Compound
 
Solvent
 
λem(nm)
 
τ (ns)
 
ϕ
 
1M
 
CH2Cl2 (areated) 574
 
153
 
0.052
 
1M
 
CH2Cl2 (deareated)
 
574
 
1123
 
0.35
 
1M
 
CH3CN (areated)
 
591
 
56
 
0.017
 
1M
 
CH3CN (deareated)
 
591
 
858
 
0.30
 
1M
 
H2O (areated)
 
604
 
116 (98%) 
2 (2%)
 
0.033
 
1M
 
H2O (deareated)
 
604
 
134 (95%) 
64 (5%)
 
0.038
 
1P
 
H2O (areated)
 
604
 
212
 
0.061
 
a
 Room temperature, λex = 400 nm; kr and knr indicate the radiative and nonradiative decay constants 
of the excited states, respectively. 
b
 Computed on the most significant lifetime component 
 
2.2 Preparation and Characterization of the 1P Complex. 
Synthesis of the PhenISA copolymer (Chart 1) has been previously reported.24The 
majority of it is derived from a Michael addition reaction between piperazine and 
bis(acrylamido)acetic acid (BAC), whereas a minority piece (∼6%) arises from the 
analogous reaction between BAC and the primary amine bap. DLS measurements 
indicated that this copolymer self-assembled in aqueous media, giving rise to the 
formation of roughly spherical nanoaggregates with a hydrodynamic diameter of ∼20 
nm.  
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Scheme 2. Synthesis of the polymer complex 1P. 
Complexation of Ir to PhenISA was performed by a route similar to that used for 
preparing molecular complex 1M (Scheme 2), but in a THF/H2O mixed solvent 
containing double the amount of water with respect to the synthesis of 1M because of 
the low solubility of PhenISA in non-aqueous media. On the other hand, the presence 
of THF was necessary because starting reagent [Ir(ppy)2Cl]2 is insoluble in water. The 
reaction temperature was lower (50 °C) than that used for the synthesis of 1M to 
avoid thermal degradation of the polymer. After 6.5 h, the mixture was concentrated 
under reduced pressure to remove most of the THF and dialyzed against water for 
four days to remove unreacted metal fragments and lower molecular weight polymer 
fractions, if present. 
The content of Ir bound to the polymer was measured by ICP-AES analysis. The 
results (2.45% w/w) indicated that the majority (88.3%) of the phenanthroline 
pendants had reacted with Ir(ppy)2fragments. 
Binding of the metal centers did not hamper the tendency of PhenISA to self-
aggregate. A DLS measurement, performed on a sample of dialyzed and lyophilized 1P, 
showed a size distribution centered at ∼30 nm (Fig. 4), which is slightly larger than 
that of PhenISA alone. 
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Figure 4. DLS size distribution by numbers of a sample of 1P in water solution. 
Another interesting feature of the organization of the polymer coils in solution was 
revealed by the 1H NMR spectrum of the purified polymer complex 1P in D2O solution. 
In these conditions, the aromatic resonances of the ppy and phen ligands were 
particularly broad, and their integrated intensities did not reflect the true percentage 
of the minority component (see the bottom spectrum of Fig. 5, in which the aromatic 
signals are almost undetectable).  
 
Figure 5. 
1
H NMR spectra of 1P in 500 µL of H2O/D2O 4:1 (a) and after addition of increasing 
amounts of THF-d8: (b) 100 µL, (c) 200 µL (300 K, 9.4 T). 
THF THF 
H2O 
residue 
signal 
1.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.0 ppm
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Progressive addition of THF-d8 to the NMR tube led to the recovery of the aromatic 
resonances at their correct intensities. This suggests that, in water, the complexes, in 
which the metal is surrounded by a lipophilic cage formed by the three large aromatic 
ligands, tend to segregate within the polymer to avoid contact with the water. Upon 
the less polar THF solvent being added, segregation was relieved, and exposure to the 
mixed solvent made the Ir(ppy)2(bap) pendants more mobile and consequently 
their 1H signals more visible. 
The UV–vis absorption spectrum of 1P was superimposable on that of molecular 
complex 1M, except for the very intense absorption at ∼200 nm due to the amide 
groups of the polymer (gray trace in Fig. 6). 
 
 
Figure 6. UV–vis absorption (left) and photoluminescence (right) spectra of 1M (black traces) 
and 1P (gray traces) in water at room temperature with λex = 400 nm. 
The photoluminescence spectrum instead showed some significant differences 
with respect to that of 1M. The emission maximum was blue-shifted by 9 nm (250 cm
–
1), and a longer lifetime (212 ns) and higher quantum yield (0.061) were found (see 
Table 1). These findings agree with the idea that, in water, the pendant Ir complexes 
are segregated into polymer pockets in which they experience less polar surroundings 
(thus giving a blue-shifted emission) and a more rigid environment than in solution. 
Moreover, the emitting Ir centers are very diluted along the polymer chains 
of 1P because the units bearing the phen pendants are a very minor component of the 
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copolymer. This prevents self-quenching and annihilation effects, which are often 
encountered for emission from the triplet state of transition-metal complexes in 
solids or in films at high dopant concentrations37 and might also occur in the 
nanoaggregates formed by 1M in water. In fact, the best emitting features are often 
observed in systems where a rigid environment (rigidochromic effect)38 is joined to a 
low dopant concentration.39 
 
2.3 Photochemical Stability of 1P 
Photochemical stability tests were carried out to determine the robustness of both 
the iridium complex and the PAA chain under prolonged irradiation in the presence of 
O2. This is a key prerequisite for using the polymer complex as a 
photosensitizer. 1P was dissolved in water/methanol (85:15), and the solution was 
saturated with oxygen by bubbling O2 for 10 min. The solution was then exposed to 
visible light (150 W xenon lamp, 390 nm cutoff filter), and UV–vis absorption spectra 
were recorded every 30 min for 4 h (Fig. 7). Superposition of the absorption spectra 
recorded at different times revealed high photostability of the compound. The same 
test was repeated for complex 1M with analogous results. 
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Figure 7. UV-vis absorption spectra at different irradiation times of a water/methanol (85/15) 
solution of 1P (4.1×10
-5
 M relative to the Ir content), presaturated with O2. 
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2.4 Photoreaction of 1P and 1M with 1,5-Dihydroxynaphthalene as a Reporter 
of 1O2 Formation 
To test the capability of 1M and 1P to act as sensitizers for 
1O2 generation, 
photochemical reactions were performed in solutions presaturated with O2, 
employing 1,5-dihydroxynaphthalene (DHN) as the 1O2 reporter. Indeed, it is known 
that DHN promptly and quantitatively reacts with 1O2 to give 5-hydroxy-1,4-
naphthalenedione (juglone, Scheme 3).15,40  
 
Scheme 3. Photochemical reaction used to monitor 
1
O2 formation. 
Reaction progress was monitored by UV–vis absorption spectroscopy following the 
decrease in the DHN band at 297 nm and the concomitant increase of the large 
juglone band centered at 427 nm (Fig. 8). This reaction occurred without the 
formation of long-lived intermediates or byproducts as indicated by the two isosbestic 
points at 280 and 330 nm observed in the spectra recorded during the course of the 
irradiation. Negligible juglone formation was observed in the absence of the Ir 
sensitizers, even after 70 min of irradiation of O2-saturated solutions.  
 
Figure 8. UV–vis absorption spectra recorded at different times of irradiation (λ > 390 nm, xenon 
lamp) on solutions containing (a) complex 1M (4.1 × 10
–5
 M) or (b) complex 1P (3.6 × 10
–5
 mol/L of Ir) 
and DHN (3.7 × 10
–4
 M) in 3 mL of H2O/MeOH (85:15) bubbled with O2 for 10 min. 
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Fig. 9 shows the first-order semilogarithmic plots for reaction 2, sensitized by 
either 1M or 1P. In the case of 1M, the values of ln(At/A0) decreased linearly over time 
from the beginning up to ∼50 min of irradiation, in agreement with pseudo-first-
order kinetics, with rate r = kobs[DHN] (slope = kobs = 5.1 × 10
–3 min–1). At longer times, 
progressive deviation from linearity was observed, possibly related to the fact that 
juglone absorbs at the same wavelengths as the Ir sensitizer. The rate of juglone 
formation compares well with that observed for the same reaction sensitized by the 
[Ir(ppy)2(phen)]
+ complex in an acetonitrile/2-PrOH solution (kobs = 6 × 10
–3 min–1).40 
 
                                                (2) 
 
 
Figure 9. Photooxidation of DHN in the presence of sensitizers 1M and 1P (data up to 50 min 
have been plotted corresponding to the linearity time interval). At and A0 represent the 
absorbance measured at 297 nm (the maximum of the DHN absorption band) at time t and 
time 0, respectively. The absorbance of the Ir sensitizer at this wavelength was subtracted. 
 
On the contrary, an induction period was observed for 1P, followed by a linear 
decrease with a smaller slope (kobs = 2.1 × 10
–3 min–1). The induction time suggests 
that at the beginning the polymer itself competed with DHN for consuming 1O2, most 
likely by reaction with the alkene groups41 constituting the terminals of the PAA 
 37 
 
chains (obtained by Michael addition reactions). Therefore, reaction 2 likely could 
only start when these terminal groups had been saturated. The lower rate relative 
to 1M is probably attributable to the fact that quenching of excited triplet sensitizers 
by 3O2 (reaction 1) requires the interaction of the two species, and the mobility of the 
Ir complexes in 1P is drastically reduced with respect to that of 1M because of their 
binding to the polymer. Furthermore, the photophysical and NMR data suggest that 
the polymer adopts conformations that favor segregation of the complexes to reduce 
its interaction with water. Therefore, the time necessary for the generated 1O2 to 
diffuse in the solution and encounter the DHN probe must also be considered. 
Working at short times, the reaction kinetics can be considered pseudo-first 
ordered. The rate equation, in these conditions, is the following. 
 
The kinetic constant (kobs) can easily be estimated by using the logarithmic form of 
the rate equation, and corresponds to the negative slope of a plot of ln(At/A0) versus 
time.  
In order to evaluate the quantum yields of singlet oxygen generation φΔ, the 
following formula must be taken into account:  
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where νi is the initial rate of reaction between DHN and 
1O2, I indicates the 
photons absorbed by the sensitizer and the apex std indicates the corresponding 
values for the standard.  
It must be noticed that, since polychromatic light source (and not a 
monochromatic one) was used, the estimation of the intensity I must be made by 
numerical integration of Ilamp(λ)x(1-10
A(λ)) where Ilamp(λ) is the intensity of the incident 
light at different wavelengths, and A(λ) is the absorbance value at a certain 
wavelength of the sensitizer.  
Table 2 reports the φΔ values estimated by this method resulting a similar value for 
both 1M and 1p. By this comparison, it is clear that the complex continues to generate 
singlet oxygen when stimulated by the proper light source even when conjugated to 
PhenISA. 
 
 
 
 
2.5 PDT Treatment of Cells 
Before testing the capability of the Ir complexes to induce cell death 
by 1O2 generation, we investigated their cellular uptake. The efficiency of 
photosensitizer incorporation into the cells can significantly affect the capability of 
the sensitizer to induce cell death.14 Therefore, HeLa cells were incubated with 
compounds 1M and 1P at 37 °C under a 5% CO2 atmosphere (see Experimental Section) 
for differing amounts of time. Images of the incubated cells were then acquired by 
two-photon excitation (TPE) microscopy at 840 nm, where both complexes showed 
the highest two-photon absorption. TPE allows for less cellular damage and deeper 
Table 2 Estimated 
1
O2 quantum yields φΔ of the studied compounds in water.  
 ΦΔ ν (×10
-6
) I 
Methylene Blue 0,50 2.124 1.39907 
1M  0.38 1.887 1.56863 
1p 0.25 0.777 1.040229 
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light penetration in vivo because typical laser wavelengths lie in the 700–900 nm 
range corresponding to the window in which both the tissue chromophores and water 
absorb more weakly. 
Previous studies had shown that cellular internalization of the Ru–PhenISA 
complex required several hours.24 Uptake of Ir–PhenISA complex 1P was therefore 
checked after 12 h of incubation. However, uptake of molecular complexes is usually 
faster;42 therefore, internalization of 1M was monitored after 2 h of incubation. 
Figure 10 shows that both molecular complex 1M (upper panels) and polymer 
complex 1P (lower panels) are able to penetrate the cellular membrane and that both 
tend to be located in the perinuclear region. This is in line with literature data 
concerning related bis(cyclometalated) Ir complexes, in which localization in 
subcellular organelles, such as the Golgi apparatus, endoplasmic reticulum, 
lysosomes, and mitochondria, was suggested.17b,d,e,43  
These preliminary experiments therefore indicated that 1P is an efficient cell 
staining agent endowed with TPE imaging capability that is well tolerated by cells. 
Indeed, cells still appeared viable after the long incubation time, which was further 
confirmed by quantification of dead cells on non-irradiated samples as described 
below. 
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Figure 10. TPE microscopy images (superposition of the blue and red channels) of HeLa cells 
incubated for 2 h with 26 μM 1M (upper panels) or for 12 h with 22 μM 1P (lower panels) and 
counterstained with Hoechst to visualize the nuclei in the blue channel. The red color is due to the Ir 
complexes. Left panels: 157 × 157 μm
2
; right panels: enhanced to 79 × 79 μm
2
. 
For PDT tests, HeLa cells were incubated with 1M or 1P as described above for the 
cellular uptake assays. Subsequently, multiwell plates were irradiated for 5 min with a 
Xe lamp and then maintained at 37 °C under a 5% CO2 atmosphere (see Experimental 
Section). The same treatment was applied to control cells (without sensitizer) to 
check for adverse effects of exposure to the Xe lamp. Cell viability was evaluated by 
flow cytometry analysis performed 4 and 6 h after irradiation along with 
nonirradiated samples (Fig. 11) using annexin V and 7-aminoactinomycin D (7AAD) 
staining to denote apoptotic and necrotic cells, respectively. 
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Figure 11. Fluorescence-activated-cell-sorting (FACS) plot showing the annexin V and 7AAD 
analysis of control cells (top panels) and of cells incubated with 1M (middle panels) or 1P (bottom 
panels), at indicated time point after Xe exposure. On each plot the fluorescence intensity of the 
Allophycocyanin conjugated annexin V (y axis) and of 7AAD (x axis) are indicated. Numbers 
show the percentage of cells within each quadrant. Plots are representative of 3 independent 
experiments. 
 
Cells incubated with either 1M or 1P underwent apoptosis upon irradiation (Fig. 12). 
The fraction of apoptotic cells for 1M was higher than that for 1P, which is in line with 
the kinetics of 1O2 generation measured in the photo-oxidation of DHN. However, an 
increased number of necrotic events with respect to the untreated cells were 
observed in the cells treated with 1M. 
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Figure 12. Percentages of dead cells resulting from apoptotic or necrotic events upon PDT 
treatments (6 h after being irradiated for 5 min) in control samples and samples sensitized 
by 1M or 1P.  
Next, to investigate dark toxicity (i.e., toxicity in the absence of irradiation), HeLa 
cells were incubated with either 1M or 1P, and the number of viable (living cells 
recovered after treatment) and dead cells was measured. As shown in Figure 13, cells 
treated with 1M had a significantly higher number of dead cells and a significant 
reduction in cell viability relative to both untreated and 1P-treated cells.  
Therefore, taken together, these results indicate that treatment with free 
complex 1M has a significant cytotoxic effect even without exposure to the Xe lamp. 
Cells incubated with 1P showed much less cytotoxicity (both in the dark and upon 
Figure 9. Cell viability tests showing the percentage of living cells (referred to the control, 
right panel) and the percentage of dead cells (left panel) for 1M and 1P. The asterisks indicate 
the statistical significance of the observed differences (p value > 0.000.1) . 
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irradiation). Interestingly, binding of the sensitizer to poly(amidoamine) inhibited 
necrosis upon irradiation while preserving its ability to induce apoptosis. 
2.6 Ruthenium based photosensitizers 
These positive results led us to investigate other metal complex-PAA conjugates 
for PDT applications. Our first focus was based the tris(1,10-phenanthroline) 
ruthenium(II), shown in Chart 2.  
 
Chart 2. Tris(1,10-phenanthroline) ruthenium(II) (left) and Ru(phen)2(BAP)(right). 
Tris(1,10-phenanthroline) ruthenium(II) is commercially available and its 
photophysical properties, as well as its reactivity towards oxygen, have been deeply 
studied before.44 Nonetheless, the compound studied in this thesis has not been 
purchased and it is slightly different from the commercial product, in that it carries an 
extra amino-functionalised pendant on one of the aromatic rings, as shown in Scheme 
4. The presence of this pendant can be used in order to conjugate the ruthenium 
complex to different polyamidoamine polymers. 
 
Scheme 4. Synthesis scheme of Ru(phen)2 (BAP). 
At the beginning of the reaction, the system was a cloudy, brick red suspension 
and did not exhibit luminescence under a 366 nm UV lamp. After heating at 55°C, the 
suspension quickly homogenised and it started showing orange luminescence under 
H2O 
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the 366 nm UV lamp, sign of the formation of Ru(phen)2(BAP). Unreacted 
Ru(phen)2(OTf)2 was precipitated by centrifugation of the basified solution. A 
1H-NMR 
spectrum of the supernatant (Fig. 16) showed that it did not contain residues of 
Ru(phen)2(OTf)2, as shown in the next page (the signal at ca. 4.7 ppm is due to residual 
water suppression). 
 
Figure 14. 
1
H-NMR (H2O/D2O) with water suppression spectrum of purified Ru(phen)2(BAP)2. 
The four signals lying in the 1-3 ppm region refer to the four methylene groups of 
the amino-functionalised pendant. The signals in the 7-8 ppm region refer to the 
aromatic phenanthroline hydrogens and have been attributed through a 
bidimensional scalar correlation NMR experiment 1H-1H COSY (Fig. 15). 
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Figure 15. Aromatic region of a 
1
H-
1
H COSY NMR experiment (in D2O) of purified 
Ru(phen)2(BAP). 
 
It was decided to keep Ru(phen)2(BAP) in the form of water solution (i.e. the 
reaction supernatant) in order to avoid further steps that might be source of 
contamination. The concentration of the Ru(phen)2(BAP) water solution was 
determined via UV-VIS spectroscopy employing the Lambert-Beer equation A = c ε l, 
in which the molar extinction coefficient of Ru(phen)3
2+
 was used (equal to 
ε450nm=19100 cm
2mol-1 in water45). The concentration of Ru(phen)2(BAP) in the 
supernatant resulted equal to 4.14 mM. 
After synthesising and characterising the model complex Ru(phen)2(BAP), it was 
conjugated to two different polyamidoamine polymer: zwitterionic PhenISA and 
cationic PhenAN. (Scheme 5)  
  
Scheme 5. Synthesis scheme of PhenISA-Ru (left) and PhenAN-Ru (right). 
The Ru(phen)3 moiety was introduced by reacting the polymer with 
Ru(phen)2(OTf)2, in the same way used for the BAP ligand. The polymers were purified 
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from unreacted Ru(phen)2(OTf)2 via ultrafiltration using a 3000 Da MWCO cut-off 
membrane and lyophilised. 
The photophysical properties of the model compound Ru(phen)2(BAP) and of the 
two metallopolymers were then measured on aerated aqueous solution (see Fig. 16). 
 
Figure 16. Excitation (solid line) and emission spectra (dashed line) of Ru(phen)2(BAP) (blue) 
PhenISA-Ru (green) and PhenAN-Ru (red) in aerated water solutions. 
 
The excitation and emission profiles of the Ru(phen)2(BAP) fragment are not 
significantly altered upon conjugation with the two different polyamidoamines. 
The UV-VIS spectrum shows two characteristic absorption peaks (at 420 nm and 
450 nm for the free complex, with a slight blue shift for the polymeric complexes, see 
Table 3). Such peaks have been attributed to metal-to-ligand charge transfer (MLCT) 
transitions and their molar extinction coefficients are high enough to consider an 
application of this metalorganic complex as photodynamic therapy sensitizer. The 
emission spectrum presents a single broad peak without distinguishable fine 
structures associated to single transitions between vibrational levels of different 
electronic levels, centred in the region around 610 nm. The excitation and emission 
spectra do not overlap, stating that the Stoke shift is quite large (more than 150 nm).  
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Table 3 Comparison of the photophysical properties of Ru(phen)2(BAP), PhenISA-Ru and PhenAN-
Ru. 
 
The excited state lifetimes and quantum yields for the different ruthenium 
compounds are reported in Table 3. Interestingly, while both excitation and emission 
spectra, as well as lifetimes are almost not altered by the conjugation to the PAAs, 
quantum yields showed an increase after conjugation. This fact could be attributed to 
the rigidity assumed when bound to the polymer or to a sort of protection by the 
polymeric systems, which makes the luminescent complex less subjected to collisional 
quenching by solvent molecules or other species. 
The ability of the three synthesized compounds to generate singlet oxygen upon 
irradiation was then tested using DHN.  
The experiments were performed by mixing in a cuvette a methanol solution of 
DHN and a water solution of sensitizer (affording H2O:methanol 9:1 as final mixture). 
The cuvette was irradiated for a total period of five minutes, stopping every minute to 
record the UV-VIS spectrum and measure absorbance at 297 nm. This experiment was 
carried out for Ru(phen)2(BAP), PhenAN-Ru and PhenISA-Ru, using 
tris(bipyridine)ruthenium(II) or methylene blue as standard. The known quantum 
yield of Ru(bpy)3
2+ in water (41 %)46 and of methylene blue in methanol (50 %)47 was 
used to estimate the quantum yields of the three newly synthesized compounds by a 
comparative method.  
Working at short times, the reaction kinetics can be considered pseudo-first 
ordered. The rate equation, in these conditions, is the following. 
 
abs
 (nm)
 

exc 
(nm) 
em 
(nm)  (ns) Φ % 
Ru(phen)2(BAP) 425, 446 450 612  492 2.7 
PhenISA-Ru 413, 442 450 614  580 4.1 
PhenAN-Ru 419, 448 450 608  533 3.6 
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The kinetic constant (kobs) can easily be estimated by using the logarithmic form of 
the rate equation, and corresponds to the negative slope of a plot of ln(At/A0) versus 
time. In Figure 17, the reaction rates for the photo-oxidation of DHN in the presence 
of the different sensitizers are shown. 
 
 
Figure 17. Semi-logarithmic plots of 
1
O2 generation rate for the various sensitizers. 
 
In order to evaluate the quantum yields of singlet oxygen generation φΔ, the 
following formula must be taken into account:  
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where νi is the initial rate of reaction between DHN and 
1O2, I indicates the 
photons absorbed by the sensitizer and the apex std indicates the corresponding 
values for the standard.  
It must be noticed that, since polychromatic light source (and not a 
monochromatic one) was used, the estimation of the intensity I must be made by 
numerical integration of Ilamp(λ)x(1-10
A(λ)) where Ilamp(λ) is the intensity of the incident 
light at different wavelengths, and A(λ) is the absorbance value at a certain 
wavelength of the sensitizer.  
Table 4 reports the φΔ values estimated by this method resulting a similar value for 
both the free phenanthroline complex and the zwitterionic and the cationic polymeric 
complexes. By this comparison, it is clear that the complex continues to generate 
singlet oxygen when stimulated by the proper light source even when appended to 
the polymer coil. 
 
These results show promising properties for a possible PDT application: in fact, 
these ruthenium complexes absorb in a lower energy region compared to the iridium 
complexes we studied at first, and with an higher molar extinction coefficient (for 
Table 4. Estimated 
1
O2 quantum yields φΔ of the studied compounds in water.  
 ΦΔ ν (×10
-5
) I 
Ru(bpy)3 
2+ 
 0,41 1.8817 1,23678505 
Ru(phen)2(BAP)  0,31 1.2028 1,051639781 
PhenAN-Ru 0,25 1.2369 1,314296454 
PhenISA-Ru 0,33 1.564 1,259413113 
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PhenISA-Ru ε450=19100 M
–1 cm–1 while for PhenISA-Ir ε378 = 4310 M
–1 cm–1 and ε417 = 
2300 M–1 cm–1). Moreover, their 1O2 quantum yields are also higher compared to the 
iridium based photosensitizers. 
One of these metallopolymers, in particular, has shown in preliminary studies 
some peculiar cell uptake properties, that are currently under investigation in 
collaboration with the group of Dr. Anna Salvati of University of Groningen. 
 
2.7 Platinum based photosensitizers 
The polymer PhenAN was also labelled with a platinum complex and the efficiency 
of PhenAN-Pt was tested in vitro as photodynamic therapy sensitizer. In literature 
different examples of platinum based complexes used in PDT therapy are reported.  
One family of complexes that was found to have peculiar luminescent properties is 
the cyclometalated platinum diimine complex one. These complexes have a 
[(C^N)Pt(N^N)] general formula. Of particular note is that these square planar Pt(II) 
complexes, in water, self-aggregates as a result of π-π Pt-Pt interactions. This 
phenomenon heavily affects the photophysical properties, that typically exhibit red 
shifted absorption and emission bands.48 For these reasons we thought of 
synthesizing a PhenAN-Pt polymer complex bearing the [(ppy)Pt(Phen)]+ moiety and 
then study its photophysical properties. This metallopolymer was produced by 
reacting PhenAN with the dimeric precursor Pt2(µ-Cl)2(ppy)2, whose synthesis has 
been already reported in literature (see Scheme 6).49 
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Scheme 6. Synthesis of PhenAN-Pt polymer complex. 
 
The conjugation to the phenantroline fragment of the polymer was carried out 
under nitrogen atmosphere at 50 °C, in order to avoid any possible degradation of the 
polymer. The reaction was followed via NMR and UV-VIS spectroscopies and 
conducted in the solvent mixture THF/H2O in the ratio 1:2. It was necessary to use a 
double amount of water with respect to THF because of the low solubility of PhenAN 
in non-aqueous media. Meanwhile, the THF was necessary in order to solubilize the 
platinum dimer, not soluble in pure water. The UV-VIS spectrum of the PhenAN-Pt, 
along with its emission spectrum, are shown in Fig. 18.  
The metallo-polymer UV-VIS spectrum shows two characteristic absorption bands: 
the first one centered at 270 nm and attributed to a ligand centered transition (LC), 
while the second centered at 314 nm and attributed to a metal-to-ligand charge 
transfer (MLCT) transition. The emission spectra show three different peaks: a main 
one at 370 nm and two others at 474 nm and 498 nm. Taking into account the very 
low quantum yield (φ < 1%) that was estimated using an integrating sphere, it was 
supposed that the complex has two emitting states: a singlet state, responsible for 
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the emission at 370 nm, and a triplet state, responsible for the peaks at 474 nm and 
498 nm. Unfortunately the peculiar aggregation behavior that is seen for this family of 
compunds48 was not observed for the complex [(ppy)Pt(Phen)]+ once conjugated with 
the PhenAN polymer. Indeed, PhenAN-Pt showed only the photophysical properties 
typical for the free molecular Pt complex. 
 
 
Figure 18. Absorbance (solid line) and emission (dashed line) spectra of PhenAN-Pt. 
 
Similarly, to what was done for the Ir- and Ru-based photosensitizers, the polymer 
ability to generate singlet oxygen upon irradiation was tested. Due to the 
considerably blue-shifted absorption of this Pt complex we used an UV lamp for this 
experiment (see Exp. part). 
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Figure 19. Semi-logarithmic plots of 
1
O2 generation rate for PhenAN-Pt (blue) and Ru(bipy)3
2+
 (red). 
The quantum yield of this compound, measured using Ru(bipy)3
2+ as a standard, 
was found equal to 28% (Fig 19 reports the singlet oxygen generation rate). 
Unfortunately, the blue-shifted absorption of PhenAN-Pt is a significant drawback for 
a possible PDT application, due to the low penetration of light at its absorption 
wavelength. Nevertheless, in the next future the ability of the complex to be excited 
by two-photon absorption will be investigated. In the case the two-photon absorption 
(TPA) properties will not be found, the orthometalated ligand will be substituted with 
other such as for example acetylide ligand, so that an effective TPA complex can be 
obtained.50 
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3. Conclusions 
The new luminescent metallopolymer 1P presented here is of interest in several 
respects. Upon light absorption, bis(cyclometalated) Ir complexes appended to the 
polymer give rise to triplet metal-to-ligand charge transfer excited states that can 
either radiatively decay or react with 3O2 and can then be exploited for either imaging 
or PDT applications. It has been found that photoluminescence can be triggered by 
two-photon excitation, which offers advantages over traditional one-photon 
excitation in terms of less cellular damage and deeper light penetration in vivo. 
Moreover, preliminary tests have shown that 1P is internalized by living HeLa cells, 
which is an important asset for PDT applications. Therefore, from the point of view of 
imaging applications, 1P provides an efficient water-soluble cell staining agent capable 
of TPE imaging that is well tolerated by cells. 
Moreover, binding to the polymer improved the photophysical properties of the Ir 
complexes, doubling their lifetimes and photoluminescence quantum yields, most 
likely because the metal centers, being buried within lipophilic ligand cages, are 
diluted and segregated into polymer tasks in an environment that is more rigid and 
somewhat protected from water (and possibly from O2). In fact, several examples 
reported in the literature have used similar approaches to shield triplet excited states 
from quenchers that would prevent applications in bioimaging or photocatalysis.51  
Notably, in the present case, segregation did not hinder the ability of the Ir 
complexes contained in 1P to sensitize 
1O2 generation. The rate of 
1O2 generation 
for 1P was lower than that for the free complex 1M as shown by photo-oxidation of 
DHN, but the rate difference was not dramatic. Then, 1P maintained the capability of 
inducing apoptosis by irradiation for a short time in a large fraction of irradiated cells. 
The percentage of dead cells was lower than that observed in the PDT tests sensitized 
by 1M, but 1P caused much less necrosis than 1M. Thus, the experiments reported here 
indicate that binding of the Ir sensitizers to the PhenISA copolymer allows them to 
avoid the significant cellular damage caused by the free complex 1M. 
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This is just one of the beneficial effects expected from the binding of metal 
emitters to polyamidoamines, whose biocompatibility has already been 
evidenced.22 Moreover, for in vivo applications, it is expected that binding of the 
sensitizers to a nanometric carrier will increase their circulating time and favor their 
effective accumulation into solid tumors by the EPR effect. 
The present work therefore provides proof of principle that binding of Ir triplet 
emitters to polyamidoamines affords conjugates with potential as both cell imaging 
agents and sensitizers of 1O2 generation. For improving such potential as it relates to 
clinical applications, further work will be necessary to tailor the ligand sphere of the 
metal and to shed light on the mechanism of cellular penetration and intracellular 
localization. 
As a next step, new photosensitizers containing different metals (Ru and Pt) were 
synthesized and tested for 1O2 generation, showing, especially in the case of 
ruthenium, promising properties. 
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4. Experimental Part 
Synthesis of Model Complex [Ir(ppy)2(bap)]Cl (1M·Cl) 
In a Schlenk tube, 34.7 mg of [Ir(ppy)2Cl]2 (3.24 × 10
–2 mmol) was dissolved in 9 mL 
of anhydrous, freshly distilled THF. A solution of 4-(butyl-4-amino)-1,10-
phenanthroline24,27 (bap, 16.2 mg, 6.45 × 10–2 mmol) in water (9 mL) was then added 
at room temperature. The mixture was heated at 70 °C. The starting turbid 
suspension rapidly turned to a clear yellow solution, and the color observed under UV 
irradiation changed from blue (fluorescence of free phen) to orange following the 
formation of the luminescent Ir complex. Reaction progress was monitored by 1H 
NMR spectroscopy. Heating was stopped after 5 h, and the mixture was stirred 
overnight. The solvent was evaporated under vacuum, and the product was isolated 
by precipitation from THF/Et2O (1:2) and dried under vacuum. Final treatment of the 
solid with Et2O (2 mL × 3) followed by vacuum evaporation to dryness gave 1M·Cl. 
Isolated yield: 69%. UV–vis (H2O) MLCT absorptions: λabs 378 nm (ε = 4690 M
–1 cm–1) 
and 417 nm (ε = 2610 M–1 cm–1). 1H NMR (D2O, 300 K, 9.4 T): δ 8.60 (1H, CH(9), dd, J = 
8.5, 1.0 Hz), 8.33 (1H, CH(5), d, J = 9.5 Hz), 8.30 (1H, CH(7), dd, J = 5.2, 1.0 Hz), 8.18 
(1H, CH(2), d, J = 5.3 Hz), 8.16 (1H, CH(6), d, J = 9.5 Hz), 8.02 (2H, CH(6′), pseudo d, J = 
7.9 Hz), 7.85 (2H, CH(3″), d, J = 7.6 Hz), 7.75 (2H, CH(5′), m), 7.70 (1H, CH(8), dd, J = 
8.5, 5.2 Hz), 7.58 (1H, CH(3), d, J = 5.3 Hz), 7.40 (2H, CH(3′), pseudo t, Japp = 6.7 Hz), 
7.08 (2H, CH(4″), pseudo t, Japp = 7.2 Hz), 6.95 (2H, CH(5″), pseudo t, Japp = 7.2 Hz), 6.80 
(2H, CH(4′), pseudo t, Japp = 6.7 Hz), 6.46 (2H, CH(6″), d, J = 7.4 Hz), 3.28 (2H, CH(δ), 
t, J = 7.00 Hz), 2.95 (2H, CH2(α), t, J = 7.30 Hz), 1.82 (2H, CH2(γ), m), 1.72 (2H, CH2(β), 
m). 13C NMR (D2O, 300 K, 9.4 T): δ 151.4 (CH(5)), 150.5 (CH(2)), 149.0 (CH(3′)), 138.4 
(CH(9)), 138.4 (CH(5′)), 131.9 (CH(6″)), 130.5 (CH(5″)), 127.9 (CH(6)), 126.2 (CH(8)), 
125.9 (CH(8)), 124.9 (CH(3″)), 124.1 (CH(7)), 127.9 (CH(6)), 123.3 (CH(4′)), 122.6 
(CH(4″)), 119.8 (CH(6′)). FAB-MS m/z: calcd for C38H33N5Ir [M+], 752; found, 752 (with 
the expected isotopic pattern). Elemental analysis: Anal. Calcd for C38H33N5IrCl: C, 
57.97; H, 4.22; N, 8.89. Found: C, 57.52; H, 4.35; N, 8.73. For determining the amount 
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of NMR silent 1M (i.e., 1M present in the form of nanoaggregates), a sample of 1M (∼1 
mg) was dissolved in CD2Cl2 in an NMR tube, and the intensities of its resonances 
were calibrated against an internal standard (CH3CN, 1 μL). The solution was 
evaporated to dryness in the NMR tube. The residue was dissolved in D2O; 1 μL of 
standard was added, and the calibration was repeated, showing intensities of the 
resonances corresponding to ∼75% with respect to those of the CD2Cl2 solution. 
Synthesis of zwitterionic copolymer PhenISA 
N,N′-Bis(acrylamido)acetic acid (404.7 mg, 1.94 mmol, 96% purity from 1H NMR 
analysis) and NaOH (86.1 mg, 1.94 mmol) were dissolved in 1.780 mL milli-Q water. 
pH (9-10) was assessed by universal indicator. 4-(4′-aminobutyl)-1,10-phenanthroline 
(50.2 mg, 0.194 mmol, 97% purity from 1H NMR analysis) was added. The reaction 
was left for 7 days at room temperature under gentle stirring, and then 2-
methylpiperazine was added (178.6 mg, 1.75 mmol). The mixture was maintained 
under the same conditions for an additional 21 days, until the cloudy suspension 
became a honey-like viscous solution. After this period, the crude reaction mixture 
was diluted with milli-Q water (10 mL) and acidified to pH 3 by the addition of few 
drops of concentrated hydrochloric acid. The water polymer solution was then 
treated with an excess of morpholine, in order to saturate the terminal residual 
double bonds on the polymer. The solution was purified by ultrafiltration through a 
membrane with a nominal cutoff of 1000 Da and the retained portion was recovered 
by freeze-drying, affording a pale pink and fluffy solid. 
 
Preparation and Characterization of 1P 
A water solution (2 mL) of PhenISA (57.3 mg, 7.29 × 10–3 mmol of bap) was treated 
with 1 mL of a THF solution containing 4.6 mg of [Ir(ppy)2Cl]2 (4.29 × 10
–3 mmol, 1.15 
equiv), giving a turbid solution that became clear as the temperature rose to 50 °C. 
The yellow color of the solution did not change significantly during the reaction, 
whereas under UV illumination, the orange luminescence of the complex increased 
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progressively. After 6.5 h, the mixture was concentrated under reduced pressure to 
remove most of the THF prior to purification by dialysis, which was performed against 
water with a 50 kDa cutoff dialysis tube (Spectrapore) for four days at room 
temperature. Finally, the dialyzed solution was lyophilized, affording a luminescent 
fluffy yellow solid. UV–vis (H2O) MLCT absorptions: λabs 378 nm (ε = 4310 M
–1 cm–1) 
and 417 nm (ε = 2300 M–1 cm–1). 1H NMR (D2O, 300 K, 9.4 T), majority part signals: δ 
8.85 (1H, NHCO(4)), 8.75 (1H, NHCO(7)), 5.49 (1H, CH(5)), 3.49 (1H, CH2(1)), 3.46 (1H, 
CH2(12)), 3.40–3.20 (accidentally overlapped signals: 1H, CH2(13); 1H, CH(15); 1H, 
CH(16)), 3.19–3.04 (accidentally overlapped signals: 1H, CH2(1); 1H, CH(10)), 3.03 (1H, 
CH2(12)), 2.87 (1H, CH2(13)), 2.71 (1H, CH2(16)), 2.66 (2H, CH2(2)), 2.60 (2H, 
CH2(9)). 
13C NMR (D2O, 300 K, 9.4 T): δ 58.2 (CH(5)), 56.4 (CH(15)), 55.5 (CH2(16)), 52.1 
(CH2(10)), 49.3 (CH2(13)), 48.9 (CH2(12)), 48.1 (CH2(1)), 30.6 (CH2(9)), 30.0 (CH2(2)), 
13.9 (CH3(17)). Elemental analysis: Anal. Calcd for 
(C13H22N4O4)0.94 (C24H27N5O4)0.06 (C22H16ClN2Ir)0.053 (H2O)2 (CF3SO3H)0.3: C, 43.58; H, 6.64; 
N, 14.00; Ir, 2.44. Found: C, 43.83; H, 6.77; N, 14.18; Ir, 2.45. The Ir content was 
measured by ICP-AES spectroscopy after a known amount of lyophilized polymer was 
digested in a mixture of concentrated HCl and HNO3 in a 1:1 ratio for 24 h at room 
temperature. 
Photochemical Stability of 1M and 1P 
A sample of 1P (0.8 mg) was dissolved in 2.5 mL of an H2O/MeOH (85:15) mixture, 
corresponding to [Ir] = 4.1 × 10–5 M. After saturation by O2 (bubbled directly into the 
cuvette for 10–15 min), the solution was irradiated through a cutoff optical filter 
(>390 nm) for 240 min overall, and UV–vis absorption spectra were collected after 30, 
60, 90, 180, and 240 min of irradiation. The same procedure was employed for 
compound 1M in the solution obtained by dissolving 2.6 mg of 1 in 10 mL of an 
H2O/MeOH (85:15) mixture, and then diluting the solution 1:10 (final [1M] = 3.3 × 10
–
5M). 
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Photoreaction of 1M and 1P with DHN 
In a volumetric flask (10 mL), 3.2 mg of 1M (4.1 × 10
–3 mmol) was dissolved in an 
H2O/MeOH (85:15) mixture containing 6.0 mg of DHN (3.7 × 10
–3 mmol). This solution 
was diluted 1:10 to obtain a final [1M] = 4.1 × 10
–5 M and [DHN] = 3.7 × 10–4 M. Before 
irradiation, the solution was saturated with O2 by bubbling directly in the cuvette for 
10 min. The solution was then irradiated through a cutoff optical filter (>390 nm) for a 
total of 150 min, while spectra were recorded every 5 min for the first hour, then at 
90, 120, and 150 min. The same procedure was followed for the photoreaction 
involving 1P using 0.7 mg of 1P (8.9 × 10
–5 mmol of Ir) in 2.5 mL of the H2O/MeOH 
mixture containing DHN ([Ir] bound to PhenISA = 3.6 × 10–5 M). 
 
Cell Culture and Treatment 
The HeLa cell line52 was cultured at 37 °C with 5% CO2 in complete DMEM (10% 
FBS, 2 mM L-glutamine, 10 mM HEPES, 100 μM nonessential amino acids, and 
penicillin plus streptomycin). Cultures at ∼80% confluence were routinely split 1:10 in 
10 cm culture dishes. Cell cultures that were 70–80% confluent were incubated with 
either 1M or 1P in DMEM plus 1% FBS. After incubation, the cells were washed three 
times in PBS, and then complete DMEM was added. 
Figure 20. Emission spectrum of the Xenon lamp used for the photochemical 
experiments (390 nm cut off filtered). 
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TPE Measurements and Cellular Uptake 
The laser source was a mode-locked Ti:sapphire laser (Mai Tai HP, Spectra Physics) 
with pulses of 120 fs full width at half-maximum and 80 MHz repetition frequency. 
The optical setup was built around a confocal scanning head (FV-300, Olympus) 
mounted on an upright optical microscope (BX51, Olympus) equipped with a high 
working distance objective (NA = 1.1, wd = 2 mm, 60×, water immersion, Olympus). 
Nonconfocal TPE imaging was performed using the FV-300 scanning unit after 
removing the largest pinhole from the pinhole wheel. The objective simultaneously 
focused the laser beam on the sample and collected the signal in epifluorescence 
geometry through the non-descanned collection channels described hereafter. The 
non-descanned detection system (ND unit) collected the emitted light right above the 
microscope objective lens, thereby avoiding the complex optical path back to the 
photomultipliers in the FV-300 scanning head. The signal reaching the ND unit is fed 
to three Hamamatsu analog output photomultipliers (HC125-02, Hamamatsu) whose 
21 mm diameter photocathode ensured the collection of most of the light during 
scanning. The ND unit has been designed to minimize the distance between the 
entrance pupil of the objective and the active area of the detector. The fluorescence 
signal was filtered by 485/50, 535/50, and 600/40 band-pass filters to select the 
fluorescence light and remove scattering and undesired autofluorescence from the 
sample, and it was processed by means of Fluoview 5.0 software (Olympus). 
Images were recorded at different times after the addition of the Ir complexes (∼2 
h for 1M, 100 μL of a 5.5 × 10
–4 M solution affording a 26 μM concentration in the well; 
∼12 h for 1P, 100 μL of a 4.7 × 10
–4 M solution affording a 22 μM concentration in the 
well). Two-photon excitation at 840 nm was exploited (with an excitation power of 15 
mW). Autofluorescent bleed through was verified on nonstained samples by 
measuring fluorescence emission in the presence and absence of the band-pass filter 
selecting the emission of the samples. Images shown in this Article are the result of 2 
kalman average scans with 10 or 6 μs of residence time per pixel, depending on the 
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zoom factor. The field of view of the 512 × 512 pixel images was 157 × 157 μm2 or 79 
× 79 μm2, as indicated in the caption of Fig. 10. 
Flow Cytometry 
After treatment for 4 and 6 h, the adherent cells were harvested from the culture 
dishes with trypsin-EDTA (Euroclone) and collected in complete DMEM, washed 3 
times in fluorescence-activated cell-sorting (FACS) buffer containing phosphate 
buffered solution (PBS) with 2 mM EDTA and 2% fetal bovine serum (FBS), and then 
processed for the annexin V/7ADD assay (Biolegend) following the manufacturer’s 
instructions. Stained cells (∼5 × 104) were acquired with a CANTO II flow cytometer 
(BD Pharmingen) and analyzed with FlowJo software (Treestar). 
Viability Test in the Dark 
HeLa cells at 80% confluency were cultured and treated with 1M or 1P as described 
in the cellular uptake section, and then a trypan blue exclusion test (that selectively 
stains dead cells) and a Neubauer cell counting chamber were used to count the total 
cell number and the percentage of dead cells. All conditions were tested in triplicate. 
Synthesis of model complex Ru(phen)2(BAP) 
7.0 mg 4-(4’-aminobutyl)-1,10-phenanthroline (BAP, 0.02788 mmol) and 16.0 mg 
Ru(phen)2(OTf)2 (0.0210 mmol) were mixed with 2 mL milli-Q water, affording a brick 
red suspension. Under nitrogen atmosphere and constant stirring, the system was 
heated at 55°C for 4 hours and then left at room temperature overnight. The cloudy 
suspension quickly homogenised and turned into a brown solution, which exhibited 
orange luminescence when excited by 366 nm UV light. At the end of the reaction 
time, pH was adjusted to 11.6 with 1M NaOH in order to precipitate unreacted 
Ru(phen)2(OTf)2, which was pelleted by centrifugation and discarded. Ru(phen)2(BAP) 
was stored as water solution and concentration was determined via UV-Vis analysis 
(4.15 mM). 
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Synthesis of cationic copolymer PhenAN 
A bisacrylamide (0.514 mmol) was dissolved in 500 μL milli-Q water under inert 
atmosphere, together with a secondary amine (0.465 mmol) and 4-buthilamine-1,10-
phenanthroline (0.051 mmol). The concentrated suspension was stirred for 1 hour at 
room temperature. The mixture was then warmed at 50 °C, and left to react under 
nitrogen for 14 days, until the cloudy suspension became a honey-like viscous 
solution. The as obtained solution was then diluted by the addition of 3 mL of milli-Q 
water and the basic pH lowered adding further aliquots of concentrated hydrochloric 
acid until pH 3 was reached. The water polymer solution was then treated with an 
excess of morpholine, in order to saturate the terminal residual double bonds on the 
polymer. The solution was purified by ultrafiltration through a membrane with a 
nominal cutoff of 1000 Da and the retained portion was recovered by freeze-drying, 
affording a pale pink and fluffy solid. 
Synthesis of PhenISA-Ru 
PhenISA (60 mg, 0.0113 mmol of minor monomer) was dissolved in 2.5 mL milli-Q 
water. Ru(phen)2(OTf)2 (7.5 mg, 0.0099 mmol) was added to the solution and mixed. 
The solution was heated at 50°C for 60 minutes in a microwave reactor. After the 
reaction, the solution showed intense, red color and exhibited orange luminescence 
when exited by 366 nm UV light. The excess Ru(phen)2(OTf)2 was removed by 
ultrafiltration through a membrane with a nominal cutoff of 3000 Da. After 
purification, the solution showed bright yellow color and its photoluminescence was 
preserved. The purified solution was eventually lyophilised, affording a yellow, fluffy 
solid (30 mg, yield 50%). 
Synthesis of PhenAN-Ru 
PhenAN (56 mg, 0.0078 mmol of minor monomer) was dissolved in 2.5 mL milli-Q 
water. Ru(phen)2(OTf)2 (6.8 mg, 0.0090 mmol) was added to the solution and mixed. 
The solution was heated at 50°C for 60 minutes in a microwave reactor. After the 
reaction, the solution showed intense, red color and exhibited orange luminescence 
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when exited by 366 nm UV light. The excess Ru(phen)2(OTf)2 was removed by dialysis 
using a 10000 MWCO membrane. After dialysis, the solution showed bright yellow 
color and its photoluminescence was preserved. The dialyzed solution was eventually 
lyophilized, affording a yellow, fluffy solid (40 mg, yield 72%). 
Photoreaction with DHN as a test of 1O2 production (ruthenium) 
A 1.1∙10-5 M solution of [Ru(bpy)3]Cl2 in milli-Q water and a 3.3∙10
-3 M solution of 
DHN in methanol were prepared (concentrations were determined via UV-VIS 
analysis). The DHN solution was diluted 1:10 with the [Ru(bpy)3]Cl2 solution, to obtain 
a final solution of [Ru(bpy)3]Cl2 1.0∙10
-5 M and DHN 3.3∙10-4 M in water and methanol 
9:1. Before irradiation, the solution was saturated with O2 by bubbling directly in the 
cuvette for 10 min. The solution was then irradiated through a cutoff optical filter 
(>390 nm) for a total of 5 min, while spectra were recorded every minute. The same 
procedure was followed for the photoreaction involving Ru(phen)2(BAP), PhenISA-Ru 
and PhenAN-Ru, starting from 1.1∙10-5 M solutions in milli-Q water (concentrations 
refer to the ruthenium complex and determined via UV-vis analysis). 
Synthesis of (Ppy)2Pt2Cl2 
206 mg of K2PtCl4 (PM: 415.09; 0.48 mmol) were dissolved in 4 mL of milliQ water, 
affording a red limpid solution. A 20 mL flask was charged with 68.85 μL of 2-
phenylpyridine (PM: 155.2; 0.48 mmol; d: 1.086 mg/mL) and 4 mL of ethoxyethanol. 
The platinum solution was added to the flask, the mixture turned red/orange. The 
mixture was heated up at 70 °C, in an oil bath, and stirred for 8 h. After 10 min an 
abundant white precipitate was formed and the solution appeared more limpid. At 
the end of reaction time there was a greenish precipitate and the solution was yellow. 
The solution was filtered on a G3 glass filter, the precipitate was washed with 3 mL of 
water and 2 mL of acetone. The filtrate was purified, for isolating the by-product, 
using a G4 glass filter. 114.7 mg of green product was obtained (PM:771.2; 0.187 
mmol; yield 61%).  
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PhenAN-Pt 
A schlenk, under nitrogen atmosphere, was charged with 10.5 mg of PhenAN (PM: 
334.45; 0.031 mmol) dissolved in 4 mL of milliQ water. In a separate backer 24.3 mg 
of (2-phenylpyridine)2Pt2Cl2 (PM: 771.2; 0.031 mmol) were dissolved in 2 mL of THF 
and then added slowly to the polymer’s solution. The solution was stirred for 24 h at 
50 °C. After 15 min the color of the solution changed from green to yellow. At the end 
of the reaction the solution was put in an ice-water bath to induce the precipitation of 
the non-reacted precursor of Pt. The solution was transferred in a 50 mL round 
bottom flask and the THF was evaporated at the rotant evaporator. The supernatant 
was discarded, the precipitate was dissolved in milliQ water, purified by 
centrifugation and finally frizzed-dried. 10.5 mg of PhenAN-Pt was obtained as a 
green fluffy solid.  
Photoreaction with DHN as a test of 1O2 production (platinum) 
A PhenAN-PT solution ([Pt]=1.2∙10-5 M) in milli-Q water and a 3.3∙10-3 M solution 
of DHN in methanol were prepared (concentrations were determined via UV-Vis 
analysis). The DHN solution was diluted 1:10 with the PhenAN-Pt solution, to obtain a 
final solution of [Ru(bpy)3]Cl2 1.0∙10
-5 M and DHN 3.3∙10-4 M in water and methanol 
9:1. Before irradiation, the solution was saturated with O2 by bubbling directly in the 
cuvette for 10 min. The solution was then irradiated with an UV lamp (see Fig. 21) for 
a total of 60 min, while spectra were recorded at 0, 5, 10, 20, 30, 45 and 60 min.  
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Figure 21. Emission spectrum of the UV-lamp used for the Pt photochemical experiments. 
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Chapter 2: SPION@SiO2-Re@PEG 
nanoparticles as magneto-optical dual probes 
and sensitizers for photodynamic therapy 
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1. Introduction 
Many dual magneto-optical probes have already been reported,1-5 in which iron 
oxides magnetic NPs bear light emitters, like quantum dots (QDs)6 or organic 
fluorophores.7 However the high toxicity of QDs limits their application in diagnosis, 
while organic fluorescent molecules often present drawbacks, such as high 
photobleaching, short lifetimes, and emission energy close to cell autofluorescence. 
The use of organometallic complexes emitting from triplet states can overcome these 
disadvantages, due to their generally high photostability, large Stokes shifts, which 
prevent self-quenching and overlapping with cell autofluorescence, and long 
lifetimes, which allow improving the sensitivity by the use of time-resolved 
techniques. For these reasons phosphorescent metal complexes have been often 
proposed for imaging techniques.8  
Among these phosphorescent emitters, diimine complexes of fac-Re(CO)3
+ have 
been attracting much interest since long time, for their remarkable photophysical 
properties,9 which have been exploited in a variety of fields, either for biomedical 
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applications,10 or material science.11 Like other d6 transition-metal complexes, these 
species exhibit an intense long-lived emission, originating from triplet metal-to-ligand 
charge transfer (3MLCT) excited states. The strongest emissions occur either from 
mononuclear cationic complexes 12,13 or from dinuclear species in which two metal 
centres are bonded to the same chromophore.14 The direct conjugation of a 
luminescent mononuclear rhenium complex “Re(L)(CO)3
+” to magnetite NPs has been 
recently reported,15 and this nanosystem is proposed as multimodal probe (MRI T2 
contrast agent, optical probe, and potential  and  emitter through the use of 
186/188Re hot isotopes for SPECT -  - or radiotherapy - ). 
It has been recently proven that some of these rhenium complexes are endowed 
with another important property for biomedical uses, i.e. they are efficient sensitizers 
for the generation of singlet oxygen, 16-20 by triplet-triplet energy transfer. Singlet 
oxygen production is at the base of photodynamic therapy (PDT),21-24 which has 
become more and more attractive as a valid coadjuvant (or even alternative) to 
chemotherapy in cancer cure and as a new method for killing pathogens in localized 
infections. 
PDT requires a photosensitizer, i.e. a molecule that can be photo-excited in a 
triplet state and is able to transfer energy to molecular oxygen, converting it from 
triplet to singlet state (eq 1).  
3S1*  +  
 3O2   
1S0  +  
1O2  (1) 
Among the various species used as photosensitizers we can list organic dyes as 
methylene blue25 or rose Bengal,26 as well as porphyrins,21 chlorines,23,27 
phthalocyanines,21 porphycenes,28,29 and metal complexes of Ru,21 Ir,30,31,55 Pt 32-33and 
Re.16-20 Many different nanomaterials for PDT containing a transition metal complex 
as photosensitizer have also recently appeared in the literature,34-38 One only of the 
above nanosized systems, constituted by silica NPs, involved the use of rhenium 
complexes.38 
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In this work we have prepared a dual probe nanocomposite, constituted by an iron 
oxide magnetic core and a compact silica shell functionalized with a luminescent 
complex, viz. [Re(phen)(CO)3(py-upts)]CF3SO3 (py-upts = 1-(pyridin-4-yl)-3-(3-
(triethoxysilyl)propyl)urea). The silica shell has been coated by a polyethyleneglycol 
(PEG) layer. Actually, pegylation, though known to partly affect the efficiency of NPs 
uptake, is a very effective method to reduce their toxicity.39 Moreover, polyethylene 
glycols in vitro enhance the NPs stability and in vivo allow the NPs to avoid 
macrophage recognition, uptake and clearance from systemic circulation.40 The 
photophysical and relaxivity properties of the Fe3O4@SiO2-Re@PEG nanocomposites 
have been measured, to check the possible mutual interference between the 
magnetic core and the luminescent shell. Preliminary cell penetration tests have been 
conducted on human lung adenocarcinoma A549 cells to investigate the 
internalization of Fe3O4@SiO2-Re@PEG NPs as well as the molecular probe, by means 
of two photon excitation (TPE) confocal microscopy. The ability of the 
nanocomposites to act as PDT agents has also been investigated, both in cuvette and 
in vitro. 
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2. Results and discussion 
2.1. Synthesis of the superparamagnetic iron oxide nanoparticles (SPION) 
Thermal decomposition of iron oleate in 1-octadecene was chosen as the synthetic 
way to produce oleic acid-coated iron oxide NPs.41. The synthesis resulted in magnetic 
NPs with a diameter size distribution centred at 10.4 ± 1.3 nm (from DLS analysis in 
hexane, Fig. 1).  
 
Figure 1. DLS size distribution by  numbers of a diluted sample of Fe3O4@OA. 
 
The transmission electron microscopy (TEM) images (see Fig. 2) were in good 
agreement with the DLS data, showing a size distribution of the magnetic core 
centred at 9.4 ± 1.3 nm. 
 
 
Figure 2 TEM micrograph of the SPIO@OA NPs 
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2.2. SPION silica coating 
The oleate shell imparts high hydrophobicity to the synthesized particles. For this 
reason, the core surface was coated with SiO2, improving water solubility. 
Furthermore, due to silica well-known and versatile surface chemistry, this surface 
could also be used as anchoring point for further functionalization. The silica shell was 
grown in a reverse microemulsion environment (see Experimental part). and the 
reaction was stopped after 6 hours, when DLS indicated the prevalence of NPs with a 
hydrodynamic diameter of about 45 nm (Fig. 3).  
Figure 3. DLS size distribution by intensities and by numbers of a diluted sample of 
Fe3O4@SiO2 NPs suspended in milliQ water. The number size distribution indicates that the 
population with the largest size (and then the highest scattering power) is negligible with 
respect to the smaller one. 
 
 
2.3. Synthesis of the complex [Re(phen)(CO)3(py-upts)]OTf 
In order to produce a multifunctional theranostic agent, able to act as both a 
luminescent probe and as a photosensitizer for photodynamic therapy a 
[Re(phen)(CO)3(py)]
+ complex has been conjugated to the NPs surface. A covalent 
linking was achieved functionalizing the pyridine ligand was functionalized with a 
triethoxysilane moiety, which could be hydrolysed in order to bind to the silica 
surface: this step would prevent the possible release of the luminescent rhenium 
complex from the silica matrix. The ligand 1-(pyridin-4-yl)-3-(3-
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(triethoxysilyl)propyl)urea,42 hereafter py-upts, was obtained as depicted in Scheme 1, 
using a slightly modified literature procedure.43   
 
Scheme 1. Reaction scheme for the synthesis of the py-upts ligand. 
Subsequently the [Re(phen)(CO)3(py-upts)]OTf complex was prepared, by 
exchanging with py-upts the labile triflate ligand in the precursor [Re(phen)(CO)3(OTf)] 
complex (Scheme 2).44  
 
Scheme 2. Synthetic route to the complex [Re(phen)(CO)3(py-upts)]OTf.  
The reaction was conducted in anhydrous ethanol, to avoid the early hydrolysis of 
the three ethoxy groups of the silane moiety, and its progress was monitored by 1H 
NMR (Fig. 4). After the ligand exchange/substitution the complex luminescence 
changed from a feeble orange to a much stronger yellow. 
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Figure 4. 
1
H NMR spectrum of the complex [Re(CO)3(phen)(py-upts)]OTf during the coordination 
reaction of pyridine ligand on rhenium atom (300 K, MeOD, 9.7 T). 
 
2.4.  [Re(phen)(CO)3(py-upts)]OTf grafting 
The luminescent [Re(phen)(CO)3(py-upts)]OTf complexes were then anchored to 
the silica shell, by treating the Fe3O4@SiO2 NPs, dispersed in ethanol, with an ethanol 
solution of the complex, using ammonia to catalyse the triethoxysilyl moiety 
hydrolysis(Scheme 3, second step). The mixture was refluxed for 5 h, and the 
precipitate was recovered by centrifugation (see Exp. part).  
 
Scheme 3. Schematic steps diagram of the synthesis of PEG-capped magneto-luminescent 
Fe3O4@SiO2-Re@PEG NPs. 
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The obtained solid was not only strongly luminescent but also wasily recoverable 
using an external permanent magnet (Fig. 5), thus immediately hinting at the 
obtainment of a dual magneto-luminescent nano-system. 
 
 
Figure 5. Digital photographs of an aqueous suspension of Fe3O4@SiO2-Re@PEG NPs nearby a 
permanent magnet, observed under solar light (left) and UV lamp (right). 
This two-step procedure was indeed necessary, since different trials of introducing 
the luminescent ligand inside the microemulsion ended up in its destabilization, 
producing significant aggregation of the NPs. 
 
2.5. PEGylation of the silica surface 
While the synthesized Fe3O4@SiO2-Re NPs were indeed easily dispersed in water, 
the overall stability of the colloid was unfortunately lacking and in few hours the NPs 
completely settled. For this reason, the NPs were stabilized by capping their surface 
with triethoxysilyl-functionalized polyethylene glycol molecules (last step in Scheme 3 
and Scheme 4). 
 
Scheme 4. The preparation of the PEG silanized by formation of a carbamate link. 
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This PEG shell would also help them avoid recognition from the reticulo-
endothelial system, improving their lifetime for any in vivo future use.46  
 
2.6. Characterization of Fe3O4@SiO2-Re@PEG nanoparticles 
The hydrodynamic diameter of the final Fe3O4@SiO2-Re@PEG NPs, after the 
coating with the PEG500-silane, increased from 45 nm to about 80 nm (Fig. 6). The 
presence of the polymer shell strongly improved the stability of the colloid over time, 
reducing the formation of irreversibly aggregated NPs. Moreover, the ζ-potential of 
the NPs changed from -20 mV to 0 mV, as expected with the binding of the uncharged 
PEG chains.  
 
Figure 6. DLS size distribution by intensities and by numbers of a diluted sample of Fe3O4@SiO2-
Re@PEG NPs suspended in milliQ water. 
 
Thermogravimetric analysis, performed on a dry pellet of the nanocomposite (Fig. 
7), showed a weight loss of about 60%, likely ascribable to loss of PEG and of the 
ligands on the rhenium complex. 
 80 
 
 
Figure 7. Thermogravimetric analysis (TGA) of a dried sample of Fe3O4@SiO2-Re@PEG NPs. 
 
The nanocomposite morphology was analyzed by transmission electron 
microscopy (Fig. 8), which revealed a spherical form and an almost quantitative 
presence of a single magnetic core per core/shell nanocomposite, a major advantage 
of the chosen microemulsion-based procedure. The size distribution of the 
nanocomposite showed a single population centred at 40 ± 3.5 nm. 
 
Figure 8. TEM micrograph of the e core/shell SPIO@SiO2–Re@PEG NPs, with the corresponding size 
distribution histograms. 
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The amount of Re on the NPs was estimated by ICP-AES analysis, corresponding to 
a loading of ca. 6000 Re atoms per NPs. This loading well compares with the one 
obtained for related luminescent complexes covalently embedded into silica NPs 
(4600 Ru complexes per NP, with diameters of ca. 60 nm).47 The Re concentration on 
the NPs provided by ICP agrees with that estimated from the MLCT absorption band 
at 375 nm (ε = 3300 M-1 cm-1), after spectral correction for the light scattering 
contribution of the NPs, by using a double logarithmic plot (Fig. 9).48,49  
 
Figure 9. Absorbance spectrum correction for the light scattering (LS) contribution: spectra of 
Fe3O4@SiO2-Re@PEG NPs before (red, Aexperimental = A + ALS, with ALS = kλ
-n
) and after (blue) correction. 
Inset: Double logarithmic plot of the absorbance spectrum: the linear extrapolation indicates the 
scattering contribution and enables log k and -n to be evaluated as intercept and slope of the straight 
line, respectively. 
 
2.7. Photoluminescence properties of the precursor Re complex and of the 
Fe3O4@SiO2-Re@PEG NPs 
The photophysical characterization of the free complex [Re(phen)(CO)3(py-
upts)]OTf and of the corresponding Fe3O4@SiO2-Re@PEG nanocomposite was 
performed in dilute, air equilibrated, water solution (about 1.0 × 10−5 M), as well as in 
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the solid state. In order to evaluate the influence of the amide group in the para 
position of the pyridine ligand, the photophysical properties of the precursor complex 
were compared with those of the already known [Re(phen)(CO)3(py)]OTf complex,
13 
containing the unsubstituted pyridine ligand. The most relevant photophysical data 
are listed in Table 1 and the corresponding absorption and emission spectra are 
displayed in Fig. 10.  
 
Figure 10. a) UV−vis absorption and b) normalized photoluminescence spectra (λex= 375 nm) of 
[Re(phen)(CO)3(py-upts)]OTf (black and dashed traces) and Fe3O4@SiO2-Re@PEG (gray traces) in air 
equilibrated water at room temperature. 
 
The UV-vis absorption spectra of both the free complexes and the NPs showed a 
strong band at about 275 nm, ascribed to ligand-centred (LC) π- π* transitions, and a 
weaker broad band, centred at about 370 nm. The latter band is ascribable to a spin 
allowed dπ (Re) → σ*(phen) metal-to-ligand charge transfer transition (1MLCT), by 
comparison with for analogous cationic Re(I) tricarbonyl complexes.12,13  
Upon optical excitation both the free complexes displayed a broad and featureless 
emission band in the green-yellow region of the visible spectrum, arising from an 
excited state that can be described as a triplet MLCT state.9 This was confirmed by the 
quenching of the emission on going from de-aerated to air equilibrated solution 
(yields dropping from 0.117 to 0.070 for [Re(phen)(CO)3(py)]OTf,
 and from 0.053 to 
0.038 for [Re(phen)(CO)3(py-upts)]OTf) and by the solvent-dependence of the 
emission maximum, which results red-shifted of about 20 nm on going from CH2Cl2
13 
to water (see Table 1) for the complex [Re(phen)(CO)3(py)]OTf. 
 83 
 
The MLCT nature of the excited state was further supported by the influence of 
the pyridine substituents on the absorption and emission spectra. Actually, the 
introduction of the electron-donating (by resonance effect) amide group in the para 
position of the pyridine ligand, afforded a red-shift of about 13 nm of the emission 
maximum of [Re(phen)(CO)3(py-upts)]OTf with respect to [Re(phen)(CO)3(py)]OTf. 
This is in line with the presence of the electron-richer py-upts ancillary ligand, 50 which 
raises the HOMO level, then lowering the energy of the MLCT transition. The red shift 
of the emission energy, observed for the complex [Re(phen)(CO)3(py-upts)]OTf, was 
accompanied by a slight decrease of the photoluminescence quantum yield () and of 
the lifetime of the excited state (Table 1), in agreement with the EGL (Energy Gap 
Law).51  
 
Table 1. Photoluminescence data for the molecular Re complexes and for the Fe3O4@SiO2-Re@PEG 
NPs, in aerated water solution and in solid (room temperature, λex = 375 nm). 
 
Compound Water solution, air solid 
 λem/ nm  / ns Φ λem/ nm  / ns Φ 
[Re(phen)(CO)3(py)]OTf 567 454 0.070 530 
740 (46%) 
2570 (54%) 
0.158 
[Re(phen)(CO)3(py-upts)]OTf 580 257 0.038 553 
993 (30%) 
2032 (70%) 
0.119 
Fe3O4@SiO2-Re@PEG NPs 553 
409 (22%) 
1738 (78%) 
0.060    
 
The photophysical properties of the complexes were investigated also in the solid 
state, showing a blue shift of the emission maxima with respect to the solution, in 
agreement with the rigidochromic effect usually observed for mononuclear rhenium 
complexes.52 An increase of the  values was also observed, indicating that, in the 
rigid environment, the roto-vibrational motions, responsible for the non-radiative 
deactivation pathways of the excited states, were partially reduced.11 
Some interesting differences in the photophysical behaviour were observed on 
going from the molecular complexes to the NPs. The emission maximum of the NPs in 
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water solution was considerably blue-shifted with respect to the corresponding 
[Re(phen)(CO)3(py-upts)]
+ complex in the same conditions, and very similar to the 
value measured for this complex in the solid state. Moreover, for the NPs the excited 
state lifetimes were longer and the emission quantum yields higher than the values 
measured for the corresponding py-upts complex in solution. This can be attributed 
both to the confinement of the complex in the rigid silica environment and to its poor 
exposition to the solution, hampering the deactivating action of water. However, the 
complex embedded in the more external layers of the (porous) silica shell remains 
sensitive to the oxygen presence, as indicated by its ability to still generate singlet 
oxygen (see Paragraph 2.9). 
 
2.8. Relaxometry properties of Fe3O4@SiO2-Re@PEG NPs 
The 1H NMR longitudinal and transverse relaxation times of the Fe3O4@SiO2-
Re@PEG NPs were measured at room temperature in the frequency range to cover 
most of the typical fields for MRI tomographs, used both in clinics (H = 0.2, 0.5, and 
1.5 T) and in research laboratories, as specified in the experimental part.53 The 
efficiency of the contrast agents was evaluated in the usual way: the nuclear 
relaxivities, both r1 and r2, were calculated as the inverse of the relaxation times 
normalized for contrast agent concentration, according to eq. 1  
  ri = [(1/Ti)meas - (1/Ti)dia]/c ,  i = 1, 2   (1) 
where (1/Ti)meas is the measured value on the sample with iron concentration  
c = 0.119 mmol/L, and (1/Ti)dia refers to the nuclear relaxation rate of the milliQ water 
used as host solution.  
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Figure 11. Longitudinal (top) and transverse (bottom) relaxivities of Fe3O4@SiO2-Re@PEG 
NPs (red circles) dispersed in water. Data are compared with the commercial compound 
Endorem® values (black squares). 
 
Figure 11 shows the r1 and r2 nuclear relaxivities of Fe3O4@SiO2-Re@PEG NPs 
together with the values for the commercial contrast agent Endorem. The displayed 
r2 values for υ> 5MHz (r2 > 30 s
-1mM-1) guarantee an appreciable contrast in the MR 
images once the NPs are used, as some of us already demonstrated on other T1 
and/or T2 relaxing NPs of completely different types.
54  
 
 
 86 
 
2.9. Singlet oxygen generation by Fe3O4@SiO2-Re@PEG nanoparticles 
The photochemical stability of the photosensitizer was preliminarily tested, by 
irradiating for 1 h a sample of the free complex [Re(phen)(CO)3(py-upts)]OTf, 
dissolved in water saturated with O2 (Fig. 12). The superposition of the absorption 
spectra recorded at five different times indicated the high photostability of the 
photosensitizer in these conditions. 
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Figure 12. Photochemical stability test: UV-vis absorption spectra at different irradiation times 
(numbers in the legend indicate minutes) of a water solution of [Re(phen)(CO)3(py-upts)]OTf (1.3×10
-5
 
M) saturated with O2. 
  
The efficiency of the Fe3O4@SiO2-Re@PEG NPs toward singlet oxygen generation 
was assessed by using 1,5-dihydroxynaphthalene (DHN) as indirect marker of the 1O2 
presence: it reacts quantitatively with 1O2 to give the oxidized species Juglone (5-
hydroxy-1,4-naphtalenedione, Scheme 5), according to equation 2.55-57 
 
                                          DHN + 1O2   Juglone + ½ 
3O2 (2) 
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Scheme 5. Photochemical oxidation of DHN to Juglone in the presence of a photosensitizer (PS). 
This reaction allows indirect monitoring of the 1O2 production following the 
decrease of the UV-Vis absorption band of DHN at 297 nm (accompanied by the 
increase of the juglone band at 427 nm). Fig. 13a shows the spectra recorded for the 
first 60 min of irradiation of a sample of NPs suspended in a MeOH/H2O (80:20) 
mixture, in the presence of DHN. 
The reaction in the initial stages follows a pseudo-first order kinetics,  = 
kobs[DHN], provided that the oxygen concentration within this interval of time can be 
considered constant.55 By plotting as a function of the irradiation time the values of 
ln(A/A0) for the DHN absorption at 297 nm (Fig. 13b), the kinetic constant kobs for 
reaction 2 can be estimated. 
The reaction was also carried out employing as photosensitizers the precursor 
complex [Re(phen)(CO)3(py-upts)]OTf, or the analogue [Re(phen)(CO)3(py)]OTf 
complex (for comparison), and methylene blue (MB) as standard.  
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Figure 13. A) UV−vis absorption spectra recorded at different irradiation times (from 0 to 360 min λ, > 
390 nm) on a solution containing Fe3O4@SiO2-Re@PEG NPs (150 μg/mL) and DHN (10
-4
 M) in 2.5 mL of 
MeOH/H2O (80/20) bubbled with O2 for 10 min. B) Photo-oxidation of DHN in the presence of different 
sensitizers: methylene blue (∆), [Re(phen)(CO)3(py-upts)]OTf (), [Re(phen)(CO)3(py)]OTf (O), and 
Fe3O4@SiO2-Re@PEG NPs (◊). At and A0 represent the absorbance measured at 297 nm (the maximum 
of the DHN absorption band) at time t and time 0, respectively. 
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The quantum yields for singlet oxygen generation (ΦΔ) were determined using 
equation 3: 
ΦΔ = ΦΔ
 std × (i I
std / i
std
 I)  (3) 
where i is the initial rate of reaction (2), I indicates the photons absorbed by the 
studied sensitizer, and the apex std labels the corresponding values for the standard 
(methylene blue in our case, ΦΔ = 0.50 in MeOH).
58 The values of i were provided by 
the product kobs[DHN]i ([DHN]i being 1×10
-4 M), while the values of I were estimated 
by numerical integration of Isource(λ)(1-10
-A(λ)), where Isource(λ) is the intensity of the 
incident light at different wavelengths and A(λ) is the absorbance of the considered 
sensitizer. It must be pointed out that the ΦΔ values estimated for dyes entrapped 
into nano-supports are affected by significant uncertainties, because of light 
scattering (that can be only partly corrected) and of many possible matrix effects, 
which are difficult to accurately evaluate.59  
Table 2 reports the data for MB and for the rhenium photosensitizers, either free 
or supported on the NPs. The ΦΔ values evaluated for the free Re complexes (0.26 – 
0.29) well compare with those reported for analogous tricarbonyl Re complexes (0.20 
– 0.26) in water solution,17,60 while are lower than that evaluated for the organic dye 
MB. 
However, it is interesting to note that a completely different behavior is observed 
when the photosensitizers are entrapped in a silica layer. Actually, for MB a strong 
decrease in the 1O2 release (about two orders of magnitude) was observed.
62 This 
might be due to some triplet-triplet annihilation process, arising from the close spatial 
confinement of a large number of emitters with very long excited state lifetimes, as it 
is typical of the triplet states of organic dyes. On the contrary, for the rhenium 
complex, which has a relatively short lifetime of the triplet state, the efficiency in 
singlet oxygen generation was maintained. Indeed, only a moderate decrease of ΦΔ 
was measured for the Fe3O4@SiO2-Re@PEG NPs (from 0.26 for the free complex to 
0.21 for the NPs, see Table 2). Most likely, such reduction results from the fact that 
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3O2 has to diffuse across the NP coating in order to quench the triplet excited state of 
the anchored dyes and from the possibility of entrapment of generated 1O2 in the NP 
matrix. 
 
Table 2. Pseudo first-order kinetics parameters and 
1
O2 generation quantum yields for the photo-
oxidation of DHN using the standard MB, the molecular complexes and the Fe3O4@SiO2-Re@PEG NPs, 
in oxygenated water solution. 
 
 
2.10. Cell uptake and PDT cytotoxicity of the Fe3O4@SiO2-Re@PEG nanoparticles 
The cell uptake of the nanocomposites was preliminarily investigated, to find the 
time scale useful for the PDT assays. The uptake by A549 cells was monitored by 
confocal microscopy, exploiting the photoluminescence of the Re complexes, and in 
particular the possibility to promote their emission by two-photon excitation (TPE). 
Two-photon excitation microscopy (as described first by Denk et al.)63 uses near-
infrared laser light to excite chromophores with a (non-linear) quadratic dependence 
of the excitation probability from the laser power, inducing optical sectioning without 
the need of a pinhole (spatial filter). It presents many advantages for in-vivo 
applications: the near-infrared light displays a deeper penetration in highly scattering 
tissues, and it induces a much lower photodamage of the sample with respect to UV 
radiation. The intrinsic optical sectioning, moreover, limits the possible phototoxic 
effect to the focal plane only, and increases the detection efficiency of the whole 
system, since it does not require descanning optics nor pinholes in the revelation 
path, allowing the use of large active area detectors. 
Cells were incubated either with the molecular probe [Re(phen)(CO)3(py-upts)]OTf 
or with the Fe3O4@SiO2-Re@PEG NPs, at different concentrations, and observed after 
 
 ×10
-1
 
(min
-1
) 
I 
(mW cm
-1
) 
ΦΔ 
Methylen Blue 17.8 4.64 0.50 
[Re(phen)(CO)3(py-upts)]OTf 5.30 2.64 0.26 
[Re(phen)(CO)3(py)]OTf 2.91 1.31 0.29 
Fe3O4@SiO2-Re@PEG NPs  0.925 0.90 0.21 
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both 4 h and 24 h through TPE confocal microscopy. Nuclei were stained with the 
viable nuclear dye Hoechst (blue), just before the microscopy evaluation. 
The internalization of the free Re complex was hampered by its low solubility in 
aqueous media, which led to the formation of microsized aggregates, well visible in 
the images acquired after 4 h of incubation (Fig 14a). However, a moderate cell 
uptake was observed at longer times (24 h, Fig 14b), and the complexes accumulated 
in the cytoplasm, forming small endosomal-like clusters.  
Figure 14. TPE microscopy images of [Re(phen)(CO)3(py-upts)]OTf , result of the projection and 
superposition on the xy plane of 10 single planes acquired along the z axis at 0.5 μm steps, at 4 h 
(panel A) and 24 h (panel B) of incubation. 
 
On the contrary, internalization and accumulation of the NPs can be seen in the 
perinuclear region of the cells already after 4 h of incubation (Fig. 15), although their 
persistence in the cytoplasm at longer times was not confirmed. Actually, the feeble 
luminescence observed after 24 h (Fig. 15) was mainly localized outside the cell 
membranes, suggesting that most of the probes had been excreted by the cells. On 
the bases of these results an incubation time of 4 h was set for the cytotoxicity assays. 
 
 
A B 
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Figure 15. TPE microscopy images, result of the projection and superposition on the xy plane of 10 
single planes acquired along the z axis at 0.5 μm steps, of A549 cells incubated with SPIO@SiO2–
Re@PEG NPs (19 μg mL
−1
, corresponding to [Re] = 0.95 μM) for 4 h (panel B) and 24 h (panel C). Panel A 
shows untreated A549 cells used as control for the same experiment. The blue color is due to the 
staining of nuclei with Hoechst. 
 
The cytotoxic effect of the Fe3O4@SiO2-Re@PEG NPs was assessed both in dark 
and light conditions, to investigate the ability of the NPs to induce an increase in cell 
death when photo-activated. Cells were incubated with different concentrations of 
NPs for 4 h, then were either irradiated for 10 min with light from a 150 W NDL lamp 
or kept in the dark for the same time, and finally incubated again for 3 h or 16 h. At 
the end, the cell viability was evaluated by the MTT test. The results are summarized 
in Fig. 16. 
After 3 h and 16 h post irradiation (p.i.), a dose dependent effect induced by the 
NPs was observed, with a statistically significant increase in cell mortality after 
irradiation of the cells, compared to the dark exposure, testifying for an effective 
photodynamic response. 
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Figure 16. Cell viability (MTT assay) of A549 cells exposed to Fe3O4@SiO2-Re@PEG NPs for 3h and 16h 
post irradiation (p.i.). Full bars=dark conditions; Striped bars = light conditions: cells were exposed to 
NPs for 4h, irradiated for 10 min and incubated for 3h or 16h again. *Significantly different from 
control; 
#
Significantly different light vs dark conditions (ANOVA + Fischer LSD test,p < 0.05). 
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The slight cytotoxic effect in the dark observed for cells exposed to the highest NP 
concentrations should be attributed to the whole nanostructure, rather than to the 
sensitizer (i.e. the Re complex). Indeed the [Re(phen)(CO)3(py-upts)]OTf complex 
alone did not induce any cytotoxicity, as shown by viability tests performed by 
exposing A549 cells for different times (4h or 24h) to increasing concentrations of the 
complex (see Fig. 17). 
 
Figure 17. Cell viability results (MTT) after incubation of A549 cells for 4 h and 24 h with the free 
complex [Re(CO)
3
(phen)(py-upts)]OTf. 
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3. Conclusions 
A multifunctional nanocomposite, designed for being a bimodal imaging probe 
that can be exploited also for PDT, has been prepared and characterized. As shown by 
the results, each component of the nanocomposite preserved the ability to perform 
its function. The superparamagnetic iron oxide cores, even if coated by the thick layer 
of silica and PEG, remained able to act as T2 agents for MRI, providing a good contrast 
ability, as demonstrated by the relaxivity profiles.  
At the same time, the luminescence properties, as lifetimes and 
photoluminescence quantum yields, were even improved by the entrapment of the 
emitting rhenium complex in the silica shell, due to increased rigidity of the 
environment and to reduced interaction with the water. Finally, the Re complexes 
anchored to the NPs were still able to act as 1O2 photosensitizer, with only a 
moderate reduction of the quantum yields with respect to the free complex. 
Preliminary investigation has revealed easy cellular uptake and increased 
cytotoxicity upon irradiation with respect to the dark, even if with a low efficiency. 
This might be related to the NP localization at subcellular level, which is known to 
have strong influence on cell response to photoactivation.18,21,64 Further studies on 
the internalization mechanism and on the subcellular localization will be necessary to 
assess the true potential of these nanocomposites. In a parallel way the performances 
of the diagnostic and therapeutic functionalities integrated in the Fe3O4@SiO2-
Re@PEG NPs can be optimized: the T2 contrast ability would benefit from a larger size 
of the SPIO core and a smaller thickness of the silica shell, while the luminescence 
properties as well as the capability of 1O2 generation would be improved by an 
increased Re loading. 
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4. Experimental Part 
 
Synthesis of Fe3O4@OA NPs  
The synthesis of magnetic NPs was performed following a literature procedure.65 
Briefly, 1.48 g of Fe(OA)3 (OA = oleic acid, 1.6x10
-3 mol) freshly prepared from sodium 
oleate and FeCl3 were dissolved in 10.3 mL of 1-octadecene and added with 0.26 mL 
of oleic acid (ratio Fe(OA)3/OA = 5.70) under nitrogen. The mixture was heated at 3.3 
°C/min from room temperature to 320 °C and left at this temperature for 30 min. 
Then, the mixture was left to come back to room temperature. The brownish red 
color turned to deep dark brown at the end of the heating cycle. The suspension was 
then treated with an excess of ethanol (1:3) and centrifuged (15 min at 7550 g), 
repeating the washing procedure for three times. Finally, the NPs were re-suspended 
in 15 mL of n-hexane and stored at -20 °C under nitrogen. [Fe] from AAS = 6.45×10-2 
M, corresponding to 5 mg/mL Fe3O4 NPs. Hydrodynamic diameter from DLS = 10.4 ± 
1.3 nm, diameter from TEM = 9.5  0.9 nm. 
Coating of the Fe3O4 NPs with a SiO2 shell 
The silica coating was obtained by a synthesis conducted in a reverse 
microemulsion. 66,67 IGEPAL CO-520 (2.7385 g, 6.21 mmol) was dissolved by sonication 
(20 min) in 22 mL of cyclohexane, in a Schlenk round bottom flask. Then Fe3O4@OA 
NPs (0.82 mg) were added, together with aqueous NH3 (28%, 200 µL) and TEOS (150 
µL, 0.677 mmol) to give a brown clear solution. The microemulsion was stirred for 16 
h at room temperature, then treated with ethanol (20 mL) and centrifuged (7550 g, 
20 min). The precipitate was recovered and easily re-suspedend in 20 mL of ethanol 
by sonication. The purification procedure was repeated twice. 
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Synthesis of the py-upts ligand 
Glassware was anhydrified beforehand, and pyridine used as solvent was distilled 
just before use. In a Schlenk tube under nitrogen, 4-aminopyridine (0.300 g, 3.13 
mmol) and triethoxysilylpropylisocianate (0.976 g, 3.95 mmol, 1.2 equiv) were 
dissolved in 12.5 mL of anhydrous pyridine, giving rise to a pale yellow solution. The 
mixture was heated at 60 °C and stirred for 48 h, then pyridine was evaporated under 
vacuum, and the sticky beige solid was repeatedly washed with anhydrous Et2O and 
evaporated under vacuum to remove the traces of the remaining pyridine. Yield 85%. 
1H NMR (400 MHz, DMSO-d6): δ 8.84 (s, 1H, NHCO), 8.27 (m, 2H, CH), 7.35 (m, 2H, 
CH), 6.40 (t, J = 5.7 Hz, 1H, NHCO), 3.75 (quart, J = 6.9 Hz, 2H, CH2), 3.08 (quart, J = 6.6 
Hz, 2H, CH2), 1.49 (m, 2H, CH2), 1.15 (t, J = 6.9 Hz, 3H, CH3), 0.59 (m, 2H, CH2). 
 
Synthesis of the [Re(phen)(CO)3(py-upts)]OTf complex 
Re(CO)5OTf 
68 (37.2 mg, 7.8310-2 mmol) was dissolved in dry toluene (8 mL) under 
nitrogen, and added with 15.5 mg of 1,10-phenanthroline monohydrate (7.810-2 
mmol). The mixture was heated at 100 °C for 5 h. Finally, the temperature was 
lowered to 0 °C, giving an orange powder, from which the intermediate product 
[Re(phen)(CO)3(OTf)] was isolated by washing with toluene (3 mL, 2 times) and drying 
under vacuum. Yield 96 %. The progress of the reaction was monitored by IR 
spectroscopy and the final IR spectrum showed (CO) bands (CH2Cl2) at 2035 (vs), 
1935 (s) and 1915 (s) cm-1. The pyridine ligand py-upts (20.9 mg, 0.0644 mmol) was 
dissolved in 1 mL of anhydrous ethanol under nitrogen. Then, a sample of 
[Re(phen)(CO)3(OTf)] (38.6 mg, 0.0643 mmol), dissolved in 2 ml of EtOH, was added. 
The initial suspension was heated at 50 °C and left to react under magnetic stirring 
and nitrogen for 48 h, obtaining a clear and yellow solution. In order to avoid the 
hydrolysis of the ethoxy groups, the resulting complex [Re(phen)(CO)3(py-upts)]OTf 
was not isolated and was stored at 4 °C in ethanol solution under nitrogen. The 
completeness of the coordination of py-upts was assessed by 1H-NMR. 1H NMR (400 
MHz, MeOD) δ 9.72 (dt, J = 5.1, 1.2 Hz, 2H), 8.95 (dt, J = 8.3, 1.2 Hz, 2H), 8.25(s, 2H), 
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8.13 (dd, J = 8.3, 5.1 Hz, 2H), 8.05 (d, J = 6.0 Hz, 2H), 7.19 (d, J = 6.0 Hz, 2H), 3.79 
(quart, J = 7.2 Hz, 6H), 3.11 (m, 2H), 1.53 (m, 2H), 1.18 (t, J = 7.2 Hz, 9H), 0.57 (m, 2H). 
FTIR (CO): 2034 (vs), 1934 (br, s) cm-1 (ethanol); 2033 (vs), 1924 (br, s) cm-1 (water). 
 
Synthesis of PEG500-Silane (N-(3-triethoxysilyl)propyl-O-PEG(OMe)-carbamate)  
The functionalization of PEG monomethylether was performed by a slightly 
modified literature procedure.69 In a two naked flask a sample of PEG500 
monomethylether (1 g, 2 mmol) was dissolved in 25 mL of anhydrous toluene under 
nitrogen, together with 3-(triethoxysilyl)propyl isocianate (625 µL, 2.5 mmol). The 
solution was then heated to 85 °C for 24 h. The reaction was monitored through FTIR 
spectroscopy (Fig 18), by following the appearance of the carbamate band (at 1728 
cm-1) and the concomitant decrease of the isocianate band (at 2272 cm-1). The 
toluene solution was evaporated under reduced pressure. The residue was dissolved 
in CH2Cl2 and precipitated as white solid by addition of n-hexane. The crude 
precipitate of PEG500-silane was washed for three times with few mL of n-hexane to 
separate all the unreacted 3-(triethoxysilyl)propyl isocianate. Finally, PEG500-silane 
was dried under reduced pressure in vacuum. 1H NMR (400 MHz, CDCl3) δ 5.02 (br m, 
NHCOO, 1H), 4.22 (t, J = 4.4 Hz, 2H, CH2), 3.83 (quart, J = 7.03 Hz 6H, CH2), 3.66 
(pseudo s, CH2CH2O PEG chain), 3.40 (s, 3H, OCH3), 3.18 (q, J = 3.2 Hz, 2H, CH2), 1.63 
(pseudo q, Japp = 7.5 Hz, 2H, CH2), 1.24 (t, J = 7.03 Hz 9H, CH3), 0.58 (m, 2H, CH2). 
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Figure 18. FTIR spectra (carbonyl region) of the isocianate-triehtoxysilane (blue trace) 
with the isocyanate CO stretching at 2272 cm
-1
 and of the formation of a carbamate 
link between the isocyanate-triethoxysilane and the OH of PEG molecule (red trace, CO 
carbamate at 1728 cm
-1
). 
 
Functionalization of the NPs with [Re(phen)(CO)3(py-upts)]OTf and PEG-Silane 
The ethanol suspension of Fe3O4@SiO2NPs was treated with an ethanol solution of 
the complex [Re(phen)(CO)3(py-upts))]OTf (310 µL, containing ca. 1 mg of complex) 
and a few drops of aqueous NH3 (28%), as catalyst. The suspension was refluxed for 5 
h, by magnetic stirring under nitrogen, then the mixture was cooled to room 
temperature, and treated with H2O (4 mL), aqueous NH3 (28%, 600 µL) and PEG500-
Silane (60 µL, ca 0.126 mmol). The reaction was allowed to proceed under magnetic 
stirring for 48 h. Then, the NPs were isolated by centrifugation (15 min at 7550 g) and 
finally suspended in 20 mL of milliQ water and stored at 4 °C for further uses. FTIR 
(water) (CO): 2033 (vs), 1924 (br, s) cm-1. The content of Fe and Re in the mother 
solution was determined by ICP-AES on a sample digested as follows: 1.00 mL of the 
NP suspension was dried on a sand bath, added with 1 mL of a 70:30 mixture of 
concentrated HCl and HF (36% and 48%, respectively), and allowed to react for 30 min 
under sonication in a Teflon vial at room temperature. The excess of HF was 
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quenched by addition of H3BO3 (2 mmol). Then, a HNO3:H2O2 mixture (1:2 ratio, 1.5 
mL) was added and left to react overnight at room temperature. [Fe] from ICP-AES = 
1.2 × 10-4 M (6.7 pm Fe); [Re] from  
ICP-AES = 3.8 × 10-5 M. 
 
Photochemical stability test on [Re(phen)(CO)3(py-upts)]OTf 
A sample of [Re(phen)(CO)3(py-upts)]OTf was dissolved in water saturated with O2. 
The solution was exposed to visible light (by using a 150 W / NDL lamp, 390 nm cutoff 
filter, 142 mW/cm2 see Fig 19), and UV−vis absorption spectra were recorded every 
15 min for 1 h. 
 
Figure 19. Emission spectrum of the lamp.  
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 Singlet oxygen production 
In a quartz cuvette 0.555 mL of the above described mother solution of Fe3O4@SiO2-
Re@PEG NPs were added to 1.70 mL of a H2O/MeOH 80:20 mixture, affording a [Re] = 
1×10-5 M. Subsequently 1,5-dihydroxynaphthalene (DHN) (0.25 mL of a MeOH 
solution 1×10-3 M) was added to give a [DHN]= 1×10-4 M. Oxygen was bubbled in the 
cuvette for 10 min. The solution was then irradiated with visible light (λ > 390 nm) and 
the reaction was followed by acquiring UV-Vis absorption spectra at different times. 
The same procedure was followed for the photoreactions involving other 
photosensitizers, i.e. [Re(phen)(CO)3(py)]OTf 
(1×10-5 M), and methylene blue (MB, 8×10-7 M, the much lower concentration being 
necessary to balance the much higher molar absorptivity of MB). 
 
In vitro cytotoxicity study in dark and light conditions 
Fe3O4@SiO2-Re@PEG-NPs were sonicated 30 minutes at 40 kHz (Sonica – Soltec) 
just before the use in order to obtain a homogenous dispersion and then different 
volumes of the stock suspension were added directly in the culture medium to obtain 
the working concentrations. The alveolar epithelial cells A549 from human lung 
carcinoma, purchased from ECACC (European Collection of Cell Cultures), were 
routinely maintained in OptiMEM 10% FBS, at 37°C, 5% CO2 and seeded in 6 multi-
well plates for the cell uptake assays. Images of treated- cells were recorded after 
exposure for 4h or 24h to: a) 50 μL of a 760 g/mL suspension of NPs affording a NP 
concentration of 19 g/mL, corresponding to a [Re] = 0.95 M in the well; b) 50 μL of 
a water solution (3.2 × 10-4 M) of the precursor molecule [Re(phen)(CO)3(py-upts)]OTf, 
affording a final [Re] = 8.0 M in the well. Two photon excitation at 840 nm was 
exploited (with an excitation power on the sample of about 15 mW). 
The alveolar epithelial A549 cells from human lung carcinoma were also seeded in 
12 multi-well plates for cell viability evaluation. Cells were exposed to increasing 
concentrations of NPs (1.9; 9.5; 19; 38; 76 μg/mL) and then incubated for 4h at 37 °C, 
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5% CO2 to allow NP internalization. At the end of this pre-incubation period the A549 
cells were irradiated with the 150 W/NDL lamp light (200 mW cm-2) for 10 min in 
order to photoactivate the internalized nanostructured compound and then they 
were incubated again for 3 h or 16 h. Not irradiated cells exposed at the same 
concentrations of NPs were used as reference (dark conditions). At the end of the 
exposure, cells were rinsed with PBS and the working MTT solution prepared in 
culture medium at a concentration of 0.3 mg/mL was added. After 2h the MTT 
solution was removed and the purple MTT reduction product (formazan salts) was 
solubilized with DMSO. The optical density of each sample, proportional to cell 
viability, was measured at 570 nm using 690 nm as reference wavelength with a 
multiplate reader. The experiments were replicated three times and results were 
expressed as mean±SE. Statistical differences were verified using One way ANOVA 
followed by Fischer LSD test (p < 0.05). 
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1. Introduction 
Peptide Nucleic Acids (PNAs)1 are synthetic polyamide mimics of natural DNA and 
RNA, in which the (desoxy)ribose-phosphate backbone is replaced by N-(2-
aminoethyl)glycyl neutral repeating units (Chart 1). The nucleobases, linked to the 
backbone through methylencarbonyl linkers, lie at the right distance to pair with the 
nucleobases of natural DNA or RNA single strand, with high affinity and sequence 
specificity.  
 
Chart 1. A peptide nucleic acid repeating fragment. 
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Compared to DNA, PNAs show improved resistance to enzymatic biodegradation 
by proteases and nucleases; moreover, their duplexes with DNA or RNA strands are 
characterized by higher chemical/thermal stability compared to double-stranded DNA 
or RNA. These features make PNAs an attractive tool for gene therapy, improving the 
poor in-vivo stability of nucleic acids and their ineffective cell-uptake. Unfortunately, 
PNA also shows some major drawbacks, mainly poor solubility in physiological media 
and very low ability to pass the cellular membranes. These issues need to be resolved 
in order to effectively apply PNA to gene-therapy purposes. 
An answer could be represented by the conjugation of PNA strands to 
superparamagnetic iron oxide. A SPION-PNA system could be suitable for both 
diagnosis and therapeutic application by taking advantage, on one hand, of ability of 
PNA to target in a very specific manner DNA and RNA sequences, and on the other 
hand by exploiting the superparamagnetic properties of NPs, whose potential in 
biomedicine is well established. The method here reported gives access to hybrid 
inorganic-organic systems made of iron oxide NPs and PNA strands, obtaining 
magnetic PNA with good water solubility, suitable for applications as contrast agents 
for MRI and heat mediators in MFH. 
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2. Results and discussion 
2.1  Synthesis of the iron oxide nanoparticles 
Here we adopted a synthetic methodology in which oleate-capped iron oxide 
SPIONs are produced via decomposition of iron pentacarbonyl in high-boiling 1-
octadecene, in the presence of oleic acid (OA) as capping agent.2 It is known that the 
SPION size can be tuned by varying the relative concentrations of iron precursor and 
capping agent.3,4 The literature procedure that we used produces SPION with an 
average diameter of 10 nm, using a 4:1 OA:Fe molar ratio. In order to improve the 
SPIONs magnetic properties we tried to increase their size by varying the OA:Fe molar 
ratio. In fact, an increase in this parameter resulted in a concomitant increase in 
diameter (measured by dynamic light scattering analyses, DLS, Fig. 1 and by 
transmission electron microscopy, TEM, Fig. 2).  
 
Figure 1. DLS size distribution by intensities (left) and numbers (right) of 
SPION6 (top, mean diameter = 23.3 ± 1.6
 
), SPION7 (middle, mean diameter 
26.6 ± 3.0 nm), SPION8 (bottom, mean diameter = 38.95 ± 9.2 nm). 
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The size increment was dramatically sensitive to OA:Fe ratio, as can be clearly 
observed in the graphs reported in Fig. 3. As expected, the mean particle size 
distributions measured by DLS were significantly larger than the ones obtained by 
TEM measurements, since DLS returns a hydrodynamic diameter that takes into 
account not only the magnetic core, but also the OA shell, and the interacting solvent.  
Figure 2. TEM images of (top) SPION6 (mean diameter = 11.8 ±2 nm), 
(middle) SPION7 (mean diameter = 17.0 ±1.9 nm), (bottom) SPION8 (mean 
diameter = 13.5 ± 3.4 nm and 29.9 ± 2.6 nm), and corresponding size 
distribution histograms. 
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Figure 3. Mean size of the SPION obtained with different OA:Fe molar ratios, as measured by DLS 
(intensities distribution, blue squares) and TEM (red diamonds). For SPION8 the values of the bigger 
population were plotted. The value at OA:Fe = 4 is from the literature.
5
 
Of the different samples the SPION7 sample, obtained with an OA:Fe ratio equal to 
7, was chosen for the prosecution of the work thanks to its favourable properties (and 
will be named simply a “SPION” from now on). The sample consisted in highly 
spherical monodisperse NPs with a mean diameter of 17.0 nm. This size is suitable for 
biological application, being still smaller than the critical size/volume that marks the 
transition between single- and multi-domain magnetic NPs. Moreover, the other two 
samples exhibited several shortcomings (polydispersion, polycrystalline/amorphous 
structure), which are detrimental for their magnetic properties. 
 
2.2  Ligand exchange 
In order to impart the necessary water solubility and biocompatibility, the oleate 
layer was exchanged with dimercaptosuccinic acid (DMSA). This coating agent 
effectively stabilizes magnetic NPs over a wide pH range by the electrostatic repulsion 
arising from the negative charge present on their surface even at relatively low pH 
values (pKa of DMSA: 2.71, 3.43, 9.65, 12.05).
6 Besides providing SPION stability in 
physiological conditions, DMSA also offers the further benefit of two functional 
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groups (COOH and SH), which can be both exploited for the covalent bonding of a 
variety of organic molecules.7 
To perform the ligand exchange we used a literature methodology8 (see Scheme 
1), modified by the use of sonication during the reaction, which allowed a significant 
shortening of the exchange time (40 min vs. 12-24 h of the literature procedures), 
while maintaining the quasi-quantitative recovery of the water-dispersed SPION. 
 
Scheme 1. The ligand exchange procedure affording the SPION@DMSA here used for PNA conjugation. 
Different binding modes of the carboxylate groups on the magnetite surface are depicted in the 
scheme, taking into account also the possibility of oxidative coupling of SH groups.
9
 
The so obtained SPION@DMSA suspensions were very stable for several months if 
stored under N2 at pH > 9. The -potential (Fig. 4) was negative even at quite low pH, 
as expected from the above reported pKa values.  
Figure 4. Variation with pH of ζ-potential of SPION@DMSA. 
DLS measurements performed on samples at pH 9 showed (Fig. 5) in the 
distribution size graph (intensities) two distinct peaks centred at 146 ± 42 nm and 44 
± 8 nm, indicating a certain degree of aggregation. However, the hydrodynamic 
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distribution by numbers showed that the aggregated population represented only a 
minority of the whole sample of suspended particles. 
 
Figure 5. DLS size distribution of SPION@DMSA ( water at pH = 8.9) by intensities (left) and numbers 
(right). 
 
The morphology of DMSA-stabilized SPION was investigated by Tapping Mode 
Atomic Force Microscopy (TM-AFM), which showed that the NPs maintained the 
spherical-like shape observed before ligand exchange (see Fig. 6a). By analysis of 
several images, the overall size (magnetic core and DMSA shell coating) was 
estimated as 20.6 ± 2.0 nm (averaged value over 40 observations), in the same range 
as observed by TEM for precursor SPION@OA. Again, this dimension is significantly 
smaller than the value measured by DLS due to the contribution to the hydrodynamic 
diameter of the solvating water that surrounds the NPs. 
AFM phase images have also been acquired, to evidence the coating shell 
surrounding the iron core. Such images are produced by mapping the phase angle 
shifts across the sample,10 which bring information about mechanical properties 
besides the topography features. As shown in Fig. 6b, AFM phase image allows the 
visualization of the soft NP coating (white areas) as well as of their stiffer magnetic 
core (darker areas). 
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Figure 6. AFM images of SPION@DMSA samples adsorbed on a mica support. (a) AFM topography 
image. Besides single SPION, some small aggregates are also observed, most likely formed in the 
deposition step.
 
Scan area 800x800 nm
2
. Vertical scale 30 nm. (b) AFM phase image, which allows 
the visualization of the coating (white rings) and of the NP magnetic core (darker areas, partially 
eclipsed by the external coating). Scan area 300x300 nm
2
. For both the images, scale bar = 100 
nm. 
 
2.3  Conjugation of PNA to SPION 
For the conjugation of the PNA strand to SPION we investigated two different 
methods, using a PNA standard sequence containing all four nucleobases, namely 
GTAGATCACT. Since DMSA contains two different functional groups (-COOH and -SH), 
two PNA sequences were synthesized (chart 2), displaying a terminal free amino 
group and a maleimido group, respectively, to verify the possibility of conjugation of 
PNA onto SPION through the amide bond formation reaction between PNA 1 and –
COOH groups of DMSA, or through a Michael-type addition between PNA 2 and –SH 
groups of DMSA (Scheme 3). 
 
Chart 2. The two PNA decamers here prepared. 
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The widely used11 coupling reaction between COOH and NH2 groups, mediated by 
the zero-length cross linker EDC (1-ethyl-3-(3-dimethylaminopropyl)carbodiimide 
hydrochloride), was performed in the presence of NHS, which gave the corresponding 
succinimidyl ester of the COOH groups, more stable in the aqueous environment then 
the corresponding isourea intermediate ester (bottom of Scheme 3). This strategy has 
been previously used also for binding functional molecules (such as PEG,12 2-
deoxyDglucose,13 or the NIRF dye IRDye800CW 14) to the surface of NPs covered with 
DMSA. Unexpectedly, in our case this method did not work well. Some irreversible 
aggregation was observed (even in repeated trials) just a few minutes after the 
addition of EDC to the initially clear suspension of SPION@DMSA and NHS, possibly to 
the shielding of the negatively charged carboxy groups. This likely hampered the 
subsequent conjugation with PNA 1. In fact, the elemental analysis of the isolated 
final product clearly indicated that PNA was not the main species linked to the SPION 
surface, the measured C/N ratio being much higher (2.16, after subtraction of the 
carbon content due to DMSA, see Table 1) than expected for bound PNA (1.60). 
A different approach was therefore developed, involving the Michael addition of a 
thiol group of DMSA to the double bond of the maleimide-functionalized PNA 2 (top 
of Scheme 3). 
An Ellman’s assay was preliminarily performed, to assure the presence of 
accessible SH groups on the SPION surface. The Ellman’s reagent 5,5’-dithiobis-(2-
Scheme 3. Schematic representation of the two routes that have 
been investigated for binding PNA to SPION@DMSA. 
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nitrobenzoic acid), DTNB,15 is commonly used for the quantification of thiol groups. It 
promptly reacts with thiolate groups in a thiol-disulfide exchange reaction that 
affords 2-nitro-5-thiobenzoic acid (NTB) (see scheme in Fig. 7). The deprotonated 
form of NTB absorbs in the blue region (maximum at 412 nm, ɛ = 14150 M-1 cm-1 at pH 
= 7.3).16 For this reason the reaction medium must be at pH > 6, to ensure complete 
deprotonation of NTB.17  
Here the reaction of DNTB with SPION@DMSA was performed at room 
temperature, for 90 min in the dark, and at pH = 8.3 (by using a phosphate buffer). An 
excess of DTNB had to be used, to allow DNTB to reach all the SH groups on the 
crowded surface of the SPION@DMSA. The DTNB reactant is responsible for an 
intense peak at 318 nm (blue trace in Fig. 7), whose tail overlaps with the peak of 
interest of the NTB anion. Due to such DTNB excess, as well as to the absorption of 
the SPION remaining in solution even after a centrifugation cycle (see red trace in 
Figure 7), a reliable quantification of the SH groups per SPION was unfeasible. 
However, the NTB peak was clearly recognizable (see the inset of Fig. 7), confirming 
that accessible SH groups were present on the SPION@DMSA surface. 
   
Figure 7. UV-Vis spectra of i) supernatant of the reaction between SPION@DMSA and Ellman’s 
reagent (for 90 min in the dark) after centrifugation (green trace); ii) an aliquot of the same 
SPION@DMSA suspension used for the Elman assay, subject to the same centrifugation procedure (red 
trace), iii) the starting buffered solution of the Ellman’s reagent used for the assay (blue trace). The 
inset shows the comparison at longer wavelengths between the spectrum of the reaction mixture 
(green trace) and the spectrum addition of the red and blue traces (violet trace). 
The feasibility of the addition of SPION surface SH groups to a maleimide moiety 
was then tested using a maleimide-rhodamine B adduct, expressly prepared by 
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reacting 2-(aminoethyl)-maleimide with rhodamine-B isothiocyanate, as depicted in 
Scheme 4.18  
 
 
Scheme 4. Synthesis of the maleimide-rhodamine B adduct prepared for testing the feasibility of the 
maleimide addition to the SH groups on the SPION surface. 
The reaction between the rhodamine-maleimide adduct and SPION@DMSA was 
conducted for 24 h at room temperature in the dark, to avoid the early 
photochemical decomposition of the chromophore. After accurate washing of the 
SPION, to remove all the unreacted chromophores, an UV-Vis spectrum of the 
suspension showed the superposition of the typical rhodamine peaks at 528 and 559 
nm with the broad absorption/scattering profile of iron oxide SPION (Fig. 8).  
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Figure 8. UV-Vis spectra of the suspension of SPION@DMSA-Mal-ROD (Mal-ROD = maleimide-
rhodamine adduct) before centrifugation (blue trace) and of the supernatant solution after 
centrifugation (red trace). 
The UV-Vis spectrum of the supernatant, measured after a further centrifugation 
cycle, showed very weak absorptions, due both to rhodamine and iron oxide SPION, 
attributable to the slight fraction of NPs not removed in the centrifugation procedure. 
This indicated that the maleimide-rhodamine adduct had been really grafted to 
SPION, further confirming the presence on the NP surface of SH groups suitable for 
the Michael addition reaction. 
On the basis of these results, the functionalized PNA 2 was reacted with 
SPION@DMSA, and the Michael addition was completed in 4 h at room temperature 
at neutral pH, under ultrasonic irradiation. The colloidal suspension, which remained 
clear throughout the coupling procedure, was centrifuged to isolate the 
functionalized NPs (SPION@DMSA-Mal-PNA), while removing the unreacted PNA 
excess.  
 
2.4  Characterization of SPION@DMSA-Mal-PNA 
TEM images (Fig. 9) collected on the SPION@DMSA-Mal-PNA demonstrated that, 
as expected, the conjugation process did not affect neither the morphology nor the 
average size of the NP magnetic cores.  
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Figure 9. A representative bright field TEM image of SPION@DMSA-Mal-PNA. 
Moreover, DLS measurements showed the same size distribution with respect to 
the unfunctionalized SPION@DMSA (Fig. 10), proving that the aggregation state of the 
conjugated NPs was not affected. 
 
 
Figure 10. DLS size distribution of SPION@DMSA-Mal-PNA ( water at neutral pH) by intensities (left) 
and numbers (right). 
 
The UV-Vis spectrum of SPION@DMSA-Mal-PNA suspended in water is reported in 
Fig. 11 along with that of the SPION@DMSA precursor. Their spectral difference (blue 
trace of the inset) clearly highlights the presence of the typical absorption peak of 
PNA nucleobases at 260 nm, slightly shifted with respect to the position (250 nm) for 
the free maleimide-PNA sequence (green trace in the inset), in line with previous 
evidence obtained on maghemite-PNA adducts.19  
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Figure 11. UV-Vis spectra of water suspended SPION@DMSA-Mal-PNA (black trace) and SPION@DMSA 
(red trace). Inset: blue trace, spectrum difference between SPION@ DMSA-Mal-PNA and 
SPION@DMSA; green trace, spectrum of maleimide-PNA. 
The adducts have also been investigated by FTIR spectroscopy and Fig. 12 
compares the spectrum of SPION@DMSA-Mal-PNA (lower trace) with that of 
SPION@DMSA (upper trace). In the latter trace, the absorption at 589 cm-1 is 
attributable to the Fe-O-Fe stretching modes of the spinel structure of magnetite,9,20 
while the presence of DMSA is indicated by the weak absorptions at about 2900 cm-1 
(due to aliphatic νCH modes), and by the broad bands at 1632 and 1396 cm
-1, which 
are related to the asymmetric and symmetric stretching of the COO- groups of 
DMSA.21 The strong and broad νOH band at ca. 3400 cm
-1 indicates the presence of 
water on the NP surface, and therefore the absorption at 1632 cm-1 also includes 
contribution from the OH bending modes. The main difference between the two 
traces of Fig. 4 is constituted by the presence in the lower trace of a series of 
relatively weak absorptions in the 1100 – 1400 cm-1 region, due to the C-N stretching 
modes of the nucleobases and of the PNA amide skeleton.22 The nucleobases and the 
amide CO groups of PNA also contribute to the broad absorption at ca. 1660 cm-1, 
which is more intense and slightly shifted with respect to the spectrum of the 
SPION@DMSA precursor.  
SPION@DMSA 
SPION@DMSA-Mal-PNA 
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Figure 12. FTIR spectra of (a) SPION@DMSA; (b) SPION@DMSA-Mal-PNA. 
To prove the effectiveness of the addition of PNA 2, elemental analyses were 
performed on the dried NPs. Data are reported in Table 1. 
Table 1. Elemental analysis of the SPION – PNA conjugates here prepared and of the 
precursors SPION@DMSA and PNA 1 and 2. 
 SPION@DMSA-
Mal-PNA 
SPION@DMSA-
PNA 
a 
SPION@DMSA PNA 1 
b
 PNA 2
 b
 
C% 10.23 8.03 3.36 47.57 48.85 
H% 1.40 1.73 0.75 5.03 4.86 
N% 3.97 2.16 n.d. 29.79 28.25 
C/N  1.73
c
 2.16
c
 --- 1.60 1.73 
a
 NPs prepared by the amide bond formation between NH2 of the PNA and the COOH on SPION (see 
Scheme 3 for clarity).  
b
 Calculated values. 
c
 Calculated by subtracting the C% due to DMSA from the total C%.  
a) 
b) 
589 
1263, 
1233 
573 1386 
1110 
3436 
2940 
2872 
1658 
1396 
1632 
3436 
2890 
2932 
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The analyses showed the expected significant increase of both C and N (which was 
originally < LOD) content after interaction with PNA (the H% values were not 
considered, since the use of water as solvent affects the reliability of these data). 
Noteworthy, the C/N ratio for the SPION@DMSA-Mal-PNA adduct (after subtraction 
of the DMSA contribution) was in perfect accord with the calculated value for the 
Mal-PNA strand here used. On this bases, the PNA loading onto the SPION@Mal-PNA 
was calculated to be about 14% w/w, corresponding to a molar ratio of ca. 1:15 with 
respect to DMSA. Each SPION@DMSA-Mal-PNA NP, which is covered by ca. 6000 
DMSA molecules, is therefore loaded with ca. 400 PNA strands. 
On the contrary, the C/N ratio for the NPs SPION@DMSA-PNA prepared from PNA 
1 (Scheme 3) was much higher than the one of PNA, suggesting that, as above 
discussed, the sample was largely contaminated by impurities with a higher C/N ratio, 
likely deriving from reagents (EDC, NHS) used in the coupling procedure and only 
partially removed. 
Finally, ζ-potential measurements on the SPION@DMSA-Mal-PNA colloid (Fig. 13) 
showed a decrease of the negative surface charge with respect to SPION@DMSA, 
from -44.5 ± 1.0 mV to -27.7 ± 4.0 mV, in line with the bonding of a positively charged 
species such as PNA to the negatively charged native NPs. 
  
 
Figure 13. ζ-potential profiles of SPION@DMSA (red traces) and SPION@DMSA-Mal-PNA (green 
traces) in water, at pH 7.4. 
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2.5  Magnetic and relaxivity properties of SPION 
Thermal energy released by SPION during the action of an alternating magnetic 
field is the crucial parameter for the success of the MFH treatment. The capability of 
releasing heat is normally quantified by the SAR (Specific Absorption Rate), which 
describes the absorbed power per mass unit. In the linear regime, i.e. when the 
magnetization varies linearly with the magnetic field (low field amplitude and low 
energy barrier compared to thermal energy) the SAR depends on the field parameters 
and on the intrinsic properties of the SPION (equation 1),23a where ν and H0 are the 
frequency and amplitude of the oscillating field, MS is the saturation magnetization, T 
is the temperature kB the Boltzmann constant,  is the mass density, V is the particle 
volume and T the time required by the particle’s magnetic moment to reverse its 
orientation. 
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Thus, to maximize the SAR SPION must exhibit specific magnetic characteristics.23 
Indeed, while the SAR can be also increased by using higher frequencies and stronger 
magnetic fields, these parameters cannot be increased above a fixed threshold, due 
to severe limitation imposed by the biological systems.24 On one hand, the SAR 
reaches its maximum value when the reversal time equals the time corresponding to 
the working frequency  = 183 kHz, i.e. τ = 1/(2πν). For magnetite NPs this condition 
is satisfied for size in the 16-19 nm range25 as is the case of SPION7. On the other 
hand, larger SAR will be obtained with higher saturation magnetization, which 
therefore  should be as close as possible to the bulk magnetite value (92 emu/g).26 
Magnetic measurements were performed on powder samples of SPION7, both 
before and after the ligand exchange, using a SQUID magnetometer. The main 
magnetic parameters of the measured samples are listed in Table 2. 
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Figure 14. Magnetic data on SPION@OA (upper panels) and SPION@DMSA (lower panels): a,d) ZFC-
FC magnetization curves; b,e) Magnetization at 300 K; c,f) Enlargement of the low field region of the 
hysteresis cycle at 2.5 K. 
As shown in Fig. 14a the zero field cooled – field cooled, ZFC – FC, magnetizations 
of SPION@OA display the characteristic blocking process of single domain NPs. The FC 
magnetizations exhibit a plateau at low temperature, which can be ascribed to 
interparticle interactions, which are not negligible when NPs are measured as dried 
powders. The blocking temperature, estimated, as a first approximation, from the 
maximum of the ZFC curve, is TB = 250 K, indicating that at room temperature the NPs 
are in the superparamagnetic regime, which is a fundamental requisite for the 
proposed applications. This result is confirmed by the absence of remanence (Fig. 
14b) observed in the room temperature magnetization vs field curve. Conversely, at 
low temperature (Fig. 14c) magnetic irreversibility is observed, with a coercive field HC 
= 500 Oe and reduced remanence R = MR/MS = 0.3, comparable with the data 
reported in the literature for magnetite NPs of similar size.27 Most importantly, the 
saturation magnetization is high (MS = 85 emu/g) and comparable to the value of bulk 
magnetite. A fit to the Langevin function of the low field part of the M(H) curve28 gives 
a magnetic moment value per particle, μ of ca. 5104 μ B, which is consistent with the 
size and magnetization of the NPs, confirming their good quality. 
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Table 2. Blocking temperature (TB), coercive field (HC), saturation magnetization (MS) and reduced 
remnant magnetization (M0T/M5T) of SPION7 NPs with different coatings. 
The magnetic data of SPION@DMSA reported in Fig. 14d-f show that the ligand 
exchange does not affect the good magnetic characteristics: TB lower than room 
temperature, no remanence at 300 K and high MS value. The same holds true for the 
NPs after their conjugation to PNA (Fig. 15). 
 
Figure 15. Magnetic properties of SPION@DMSA-Mal-PNA (solid triangles) and SPION@DMSA 
(empthy circles): ZFC-FC magnetization curves (top right); magnetizations at 300 K (top left); 
Enlargement of the low field region of the hysteresis loops at 2.5 K (bottom). 
Magnetic hyperthermia measurements were made by recording the evolution of 
temperature of the SPION@DMSA samples dispersed in water (0.77 mg/mL Fe) 
 TB (K) HC (Oe) 
 
Ms (emu/g) M0T/M5T 
SPION@OA 250 460 87 0.30 
SPION@DMSA 270 430 82 0.36 
SPION@DMSA-Mal-PNA  270 430 80 0.36 
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exposed to an alternating magnetic field of 17 kA/m and 183 kHz for 5 minutes. The 
temperature kinetics is shown in Fig. 16. Despite the small temperature increase 
observed, the sample has a remarkable SAR = 65 W/g Fe, which makes it a suitable 
candidate for future application in MFH treatments. 
 
Figure 16. Temperature kinetics of a water suspension of SPION7@DMSA, 0,77 mg/mL Fe, during the 
exposure to the alternating magnetic field (17.1 kA/m, 183 kHz). The starting temperature was 295 K. 
 
The ability of SPION@DMSA and SPION@DMSA-Mal-PNA to affect water nuclear 
relaxation times was also measured, to evaluate their effectiveness as MRI contrast 
agents. In Fig. 17 the 1H-NMR dispersion (NMRD) profiles for SPION@DMSA as well as 
for SPION@DMSA-Mal-PNA are reported, where the nuclear longitudinal (r1) and 
transverse (r2) relaxation rates were evaluated in the usual way (equation 3), in which 
(1/Ti)meas indicates the measured value on the sample with iron concentration c = 0.5 
mmol/L, and (1/Ti)dia the nuclear relaxation rate of the water used as host solution.  
ri = [(1/Ti)meas - (1/Ti)dia]/c   i = 1, 2                  (3) 
It can be evinced that the sample is able to effectively shorten both longitudinal 
(T1) and transverse (T2) relaxation times and therefore it strongly enhances the 
correlated relaxivities.  
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Figure 17. Longitudinal (a) and transverse (b) NMRD profiles of SPION@DMSA (green circles) 
and SPION@DMSA-Mal-PNA (blue stars) compared to commercial compound Endorem® (black 
squares). In the inset of panel a, the longitudinal NMRD profiles of the commercial contrast 
agent Dotarem dispersed in water or in saline buffer measured at two different temperatures 
are reported. The inset shows the extremely good performances of both our samples also as T1 
relaxing agent. In the inset of the panel b, longitudinal and transverse relaxivities are plotted 
together of SPION@DMSA (the same results are obtained also for SPION@DMSA-Mal-PNA), to 
show the equivalence of r1 and r2 values at low frequency, as predicted by the theory (see the 
text). 
In particular, the r2 (the crucial parameter for a superparamagnetic iron oxide 
material) is 2 or 3 times higher than the corresponding value of the commercial 
contrast agent Endorem® at the typical frequencies of the clinical instrumentation [ca. 
8.5, 21.3 and 63.9 MHz (magnetic fields of 0.2, 0.5 and 1.5 T, respectively)]. 
Furthermore SPION@DMSA possess better r1 values (more than one order of 
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magnitude) with respect to the routinely used positive contrast agent Dotarem® (see 
inset in Fig. 17a) at those frequencies/fields. This property opens the possibility to use 
SPION@DMSA as positive and negative contrast agent at the same time, depending 
on the experimental parameters used in the pulse NMR sequences during the 
acquisition of MR images.29 Interestingly, SPION@DMSA shows no difference 
between r1 and r2 at the zero field limit (see inset in Fig. 17b) as predicted by theory, 
an experimental result obtained only recently in the literature.30 The equivalence of r1 
and r2 at low proton Larmor frequencies would have been unattainable if our sample 
was not well dispersed in water without any unwanted particle aggregation.  
The slight influence of the further functionalization on the relaxivity curves is 
explained by two characteristics of SPION@DMSA-Mal-PNA: on one side the higher 
steric hindrance as evinced by AFM (NP overall size = 25.6 ± 2.6 nm), on the other side 
the poor solubility of PNA sequence. Both these properties oblige the water 
molecules to stay faintly further from the magnetic core of the SPIONs or, at least, to 
follow a more difficult pathway if compared to the case of SPION@DMSA. 
Consequently, lower values for the r1 NMR dispersion profile and for low proton 
Larmor frequencies of r2 are found, while substantially the same r2 values of 
SPION@DMSA sample are obtained at  > 0.1 MHz. Therefore, the PNA presence did 
not influence significantly the relaxivity efficiencies of these nanosystems, whereas 
the functionalization provides a significant added value. 
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2.5  Conjugation of antimiR-9 PNA ventamer to SPION@DMSA 
After successfully proving that a standard PNA decamer could indeed be linked on 
the SPION surface we moved to a bigger (ventamer) sequence, able to selectively bind 
and suppress the biological effects of miR-9, a non-coding microRNA that is 
overexpressed in brain tumors and in breast cancer, where it is considered pro-
metastatic and a negative regulator of its target E-cadherin, a metastasis suppressor. 
The functional knockdown of miR-9 can avoid metastasis formation by highly 
malignant cancer cells.31 
To this end an antimiR-9 PNA sequence was synthesized, bearing a maleimide 
group on one end and a fluorescein group on the other (see Chart 3).  
 
Chart 3. The structure of the functionalized antimiR-9 PNA sequence. 
The luminescent properties that would be endowed by this latter group would not 
only help in determining if the PNA sequence could indeed be conjugated to the 
SPION but also provide a useful tool for cell staining and imaging. 
The conjugation reaction was performed using the same procedure established for 
the standard sequence, at room temperature, for 4 hours under ultrasonication.  
In fact, after several washing cycles (see Exp. part), the luminescent emission of 
fluorescein could still be seen on the SPIONs (see Fig. 18), proving the effective 
conjugation of this bigger PNA sequence. 
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Figure 18. Photoluminescence spectra of SPION@DMSA-antimiR-9-fluo. 
 
To further prove the effectiveness of the addition of the antimiR-9 PNA elemental 
analyses were performed on the dried NPs. Data are reported in Table 3. 
Table 3. Elemental analysis of the SPION@DMSA-antimiR-9-fluo
 
 
 SPION@DMSA-
antimiR-9-fluo 
SPION@DMSA antimiR-
9-fluo PNA   
C% 10.84 3.34 42.70 
H% 1.31 0.75 3.86 
N% 3.95 n.d. 22.13 
C/N  1.90
b
 --- 1.93 
a
 Calculated values. 
b
 Calculated by subtracting the C% due to DMSA from the total C%.  
The analyses showed the expected significant increase of both C and N (which was 
originally < LOD) content after interaction with PNA (the H% values were not 
considered, since the use of water as solvent affects the reliability of these data). 
Interestingly, the PNA loading was calculated to be about 13.6% w/w, a similar value 
to the one found previously for the standard sequence. Due to the higher molar mass 
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of this PNA ventamer, this correspond to molar ratio of ca. 1:30 with respect to 
DMSA. Each SPION@DMSA-antimiR-9-fluo NP is therefore loaded with ca. 200 PNA 
strands. 
Moreover, ζ-potential measurements on the SPION@DMSA-antimiR-9-fluo 
acetone suspension showed a decrease of the negative surface charge with respect to 
SPION@DMSA, from -27.0 ± 0.5 mV to -9.5 ± 2.3 mV, in line with the bonding of a 
positively charged species such as PNA to the negatively charged native NPs.  
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3. Conclusions 
A novel and effective strategy for binding PNA oligomers onto the surface of 
superparamagnetic iron oxide NPs has been developed. This work also addressed 
some of the drawbacks shown by previous literature reports, namely providing the 
desired water solubility and colloidal stability to the PNA. The use of thermal 
decomposition as a synthetic route allowed precise control onto the magnetic core 
size, an important parameter for both diagnostic and therapeutic properties.  
A detailed characterization of the morphological, magnetic and relaxivity 
properties of the SPION showed that these NPs could act as both MRI contrast agent 
and as heat sources for hyperthermia. These properties are unaffected by PNA 
conjugation. 
A second SPION-PNA nanoconjugate, functionalized with a PNA oligomer designed 
for targeting specific non-coding microRNAs (miRNA), was also successfully 
synthesized. Further experiments will aim at exploring its biological interaction and 
antisense properties. 
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4. Experimental Part  
Synthesis of SPION7@OA 
The synthesis of SPION was performed following a slightly modified literature 
procedure.2 Briefly, in a 50 mL three-necked round bottom flask 13.9 mmol of oleic 
acid (4.38 mL, d= 0.895 g/mL; 70% purity) and 2 mmol of Fe(CO)5 (236 µL, d= 1.49 
g/mL) were dissolved under inert atmosphere in 4 mL of 1-octadecene. This solution 
was then heated from room to 320 °C at a rate of 15 °C/min and refluxed for 3 h. 
During this time the reddish solution turned to black. The solution was then cooled to 
120°C at a rate of 5 °C/min and maintained at that temperature for 2 more hours in 
air to allow oxidation of Fe(0). The solution was cooled down to room temperature at 
a rate of 5 °C/min. The SPION were subsequently isolated by centrifugation of the 
reaction mixture after addition of ca 70 mL of acetone (3 × 20 min at 7197 round 
centrifugal force, rcf) followed by removal of the yellow supernatant. The isolated 
particles were then re-suspended in 15 mL of hexane and stored under nitrogen 
atmosphere at -25 °C for further uses. The same procedure was followed for the 
synthesis of SPION6@OA and SPION8@OA, using different amounts of oleic acid (1.90 
mL and 4.9 mL, respectively), corresponding to 6 and 8, respectively, equivalents, with 
respect to Fe(CO)5.  
 
SPION@DMSA 
A sample of SPION7@OA in hexane solution (3 mL, 11 mg/mL Fe as measured by 
AAS) was treated with 8 mL of acetone and centrifuged (4 min, 7197 rcf) to remove 
the excess oleic acid. The NPs were then suspended in 9 mL of hexane and moved to a 
Schlenk flask under nitrogen atmosphere. To this suspension a solution of DMSA 
dissolved in acetone (43.5 mg in 9 mL) was added, followed by 15 μL of TEA. The 
Schlenk flask was then moved to an ultrasonic bath and the reaction mixture was kept 
at 50 °C for 40 min, maintaining the suspension under nitrogen atmosphere for the 
whole sonication time. The SPION were then collected with a magnet and then 
centrifuged first with 20 mL of acetone (10 min, 7197 rcf) and then with 20 mL of 
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water (30 min, 7197 rcf). The washed SPION were then re-suspended in 10 mL of 
water and stored under nitrogen atmosphere at 4 °C for further uses. 
 
Preparation of SPION@DMSA-PNA 
The SPION@DMSA carboxyl groups were first activated by adding 12.4 mg EDC 
(0.065 mmol) and 46 mg NHS (0.4 mmol) to 5 mL of SPION@DMSA water suspension 
(0.56 mg/mL Fe). The addition of EDC apparently destabilized the NP colloid, resulting 
in visible aggregation. The suspension pH was then changed to 4.5 by careful addition 
of HCl and the activation reaction continued for 2h in an ultrasonic bath. Then the 
activated SPION were added dropwise to a solution of 5 mgPNA 1 dissolved in 0.5 mL 
of CH3CN and 1 mL of phosphate buffer (pH 8, 5 mM). The suspension pH was 
adjusted to 8 by careful addition of NaOH solution. The reaction mixture was first 
placed in an ultrasonic bath and left under ultrasonic irradiation for 2h at room 
temperature and then left on a shaking plate overnight. The NPs were then purified 
via centrifugation with water (3 ×, 15 min, 7197 rcf) and subsequently collected in a 
Schlenk flask under inert atmosphere. 
 
Ellman’s assay 
An aliquot of 200 μL of SPION@DMSA suspension (0.56 mg/mL Fe) was diluted 
with 3 mL of phosphate buffer (pH 8.3, 0.05 M). To this suspension 1 mL of Ellman’s 
reagent solution (3 mg dissolved in 10 mL phosphate buffer) was added. As a 
comparison two solutions, containing only SPIONs and only Ellman’s reagent, 
respectively, were prepared. After 90 min of incubation in the dark the suspensions 
were centrifuged and the supernatant absorbance at 412 nm was measured by UV-Vis 
spectroscopy (Fig. 7). 
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Synthesis of the RhodamineB-maleimide adduct 
The synthesis (depicted in Scheme 4) involved at first the preparation of mono-
protected N-Boc-ethylenediamine, that was performed according to a literature 
procedure.32 N-(2-Aminoethyl)maleimide was then prepared by another literature 
method,33 and reacted with rhodamine B isothiocyanate, in an NMR tube under 
nitrogen atmosphere: 3,3 mg of RhodamineB-NCS (6.15 × 10-3 mmol) were dissolved 
in 0.5 mL of deuterated methanol and treated with 1.6 mg of N-(2-
aminoethyl)maleimide trifluoroacetate salt (5.12 × 10-3 mmol) and 0.85 μL of Et3N. 
The reaction was carried out overnight at RT and its progress was monitored following 
the decrease of the sharp singlet at 6.91 ppm due to the CH on double bond of N-(2-
aminoethyl)maleimide that, once reacted, slightly shifted to upper fields (ca 6.89 
ppm) and split in multiple singlets due to the different isomers. The concentration of 
rhodamine-B-maleimide adduct was estimated to be 0.006 M using its known molar 
attenuation coefficient (ε=87000 at 559 nm).34 
 
Reaction between RhodamineB-maleimide adduct and SPION@DMSA 
In a Schlenk flask under nitrogen atmosphere 100 μL of SPION@DMSA (0.78 
mg/mL Fe) were diluted with 2 mL milliQ water. To this suspension 17 μL of the 
functionalized rhodamine solution were added. The reaction was incubated in the 
dark for 24 h. The NPs were collected by centrifugation (20 min × 7197 rcf) and re-
dispersed in water for three times, in order to remove all the unreacted Rhodamine-
B. The purified NPs were then suspended in 2 mL milliQ water and their absorbance 
was measured via UV-Vis spectroscopy (Fig. 8). 
 
Preparation of SPION@DMSA-Mal-PNA 
A suspension of 5 mL of SPION@DMSA (0.56 mg/mL Fe) was added to a solution of 
5 mg of PNA 2 dissolved in 0.5 mL of milliQ water under inert atmosphere. The pH of 
the reaction mixture was adjusted to 7 and the reaction carried out under ultrasonic 
irradiation for 4 h at room temperature. The NPs were then collected with a 
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permanent magnet, re-suspended in 5 mL water and centrifuged (3×, 15 min at 7197 
rcf). The isolated SPION were then stored under nitrogen atmosphere. 
 
Preparation of SPION@DMSA-Mal-antiMIR9 
In a schlenk flask under inert atmosphere, antiMIR9 PNA (1.5mg) was first 
dissolved in 0.15 mL DMSO and subsequently diluted with 1 ml water. To this solution 
3ml of water suspension of SPION@DMSA (1.5mg Fe3O4) were added. The solution pH 
was adjusted to 6.9 by careful addition of 0.1M NaOH. The reaction was conducted 
for 5 h at RT in an ultrasonicating bath. The NPs were recovered via centrifugation (30 
min at 7197 rcf) and washed twice with milliQ water (6 mL, 15 min at 7197 rcf) before 
being re-dispersed in 6 mL milliQ water. 
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1. Introduction 
In magnetic separation-based blood purification (MBP), magnetic particles 
functionalized with capturing moieties bind to pathogens, which are subsequently 
removed from the blood by magnetic separation. In this technique, functionalized 
magnetic NPs (MNPs) are injected into the bloodstream in an external loop (akin to 
dialysis) and subsequently removed magnetically, after a suitable contact time has 
passed in order to ensure pathogen capture (see Fig. 1). 
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Figure 1. The process of magnetic blood purification (MBP).
1
 
 
The feasibility of the process has been demonstrated in recent years in various in 
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vitro and in vivo settings.2 Magnetic blood purification is especially beneficial if high-
molecular weight compounds or cells need to be cleansed, since such compounds are 
insufficiently removed by current blood purification systems, such as hemofiltration 
or hemosorption. Utilizing freely diffusing, spherical particles offers superior surface 
accessibility and hence speeds up the binding process substantially compared to 
traditional processes. For this reason, sepsis was thought as a potential application of 
MBP. Sepsis is a severe, potentially life-threatening medical condition3 Despite major 
technological advances in recent years, sepsis mortality remains disturbingly high. The 
management of sepsis patients is technically challenging and costly, with only a few 
therapeutic options available.4 Early diagnosis and identification of the microbe 
causing this sepsis has a major impact on the patient’s outcome.5 However, diagnosis 
remains challenging as most sepsis patients present clinical symptoms 
indistinguishable from those who suffer from non-infectious systemic inflammatory 
response syndrome (SIRS).3,6 One of the major problems in diagnostics is the typically 
extremely low bacterial concentration in human sepsis patients (ca. 10 colony forming 
units (cfu) per mL), leading to long blood culture times and high numbers of false 
negatives.7 Diagnostic uncertainty, in conjunction with the direct dependence of 
patient outcome on early antibiotic treatment, has led to an overuse of antibiotics. 
Treating all patients who show SIRS symptoms without a proper diagnosis not only 
increases costs, but leads to other complications and increases microbial resistance, 
which is equally undesirable.  
Here, we performed theoretical and experimental studies to investigate whether a 
newly developed human IgG1 monoclonal antibody against poly-N-acetylglucosamine 
(PNAG),8 which binds to all but one of the pathogens responsible for the 10 most 
frequent nosocomial infections, can be immobilized on magnetic beads, in order to 
efficiently capture and detect pathogenic bacteria without the need for prior 
pathogen identification. We demonstrate quantitative capturing efficacies and 
degradation of the beads under physiological conditions, both being critical 
parameters for effective translation of the approach into clinical settings.  
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2. Results and discussion 
2.1 Mathematical modelling of bacterial capture 
A mathematical model was developed as a first thing to elaborate upon the 
benefits brought by a magnetic particle-based blood purification process over 
traditional blood purification systems for capturing bigger target entities, such as 
bacteria. The required contact times for pathogen binding will have a significant 
influence in determining the final efficiency of the extracorporeal magnetic blood 
purification process. This contact time should be ideally in the seconds/minutes 
range, since the whole blood volume (about 5 L in an adult human) must be purified 
in a time span not longer than few hours without having an extracorporeal blood 
volume higher than 300 mL.  
In order to estimate the contact times required for efficient target capturing as a 
function of target size, we developed a model for the calculation of (i) the adsorption 
of small molecules on the surface of magnetic particles and, in analogy, (ii) the 
number of magnetic particles adsorbed on the surface of bacteria. Both the particles 
and the bacteria are modeled as spheres. First, we calculated the time required to 
remove small target molecules, such as ions, proteins or bacterial toxins, using a 
magnetic bead number concentration of 1010 per mL. The contact times required for 
both small molecule targets (1 nm, 1 mM concentration range) and medium sized 
targets, such as endotoxins, (10 nm, nM concentration range) are well below 1 
minute, which is in good agreement with previously reported experimental findings 
(Fig. 2a).2(a),9 Small molecules however, being able to freely diffuse in the inside of 
porous absorbent, are removed at a sufficiently high efficiency via traditional blood 
purification processes, such as hemodialysis, hemofiltration or hemosorption.10 
However, this is no longer true for bigger molecules and cells that can interact only 
with the external surface area of the traditionally used absorbents. For this reason, 
the use of spherical particles could provide considerable advantages. Thus, we first 
calculated the time-dependent evolution of the number concentration of bacteria 
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(Staphylococcus aureus, 1 mm, 104 colony-forming units (cfu) per mL) as a function of 
particle number concentration. It becomes evident that when using 300 nm beads, 
there are no unbound bacteria left after 180 s (Fig. 2b). After 10 min, every bacterium 
is bound by 10 or more magnetic beads (Fig. 2c). Most importantly, calculations also 
show that particles are in excess for most clinically relevant bacterial concentrations 
(Fig. 2d, for bacteria concentrations from 102–104 cfu per mL).  
 
Taken together, these calculations show that there is a window of opportunity 
where effetive binding of bacteria can be achieved by reasonable concentrations of 
magnetic beads (1010–1012 particles per mL) in clinically relevant times (few minutes). 
Additionally, these calculations demonstrate that capturing times are critically 
dependent on the particle number and increase to less appealing minimal contact 
times (>>10 min) for particle number concentrations of 109 per mL or less, 
significantly limiting the throughput process. Importantly, these calculations also 
Figure 2. Simulations of magnetic particle-pathogen binding: a) time evolution of 
unbound small molecules with a size of 1 and 10 nm, in nanomolar and micromolar 
concentration range, respectively, b) time evolution of bacteria with no bound 
particles, as a function of particle concentration (Np, c) time evolution of the number of 
particles attached to bacteria for a bacteria concentration of 10
4
 per mL and a particle 
number concentration of 10
10
 per mL. The bacteria number concentration has been 
normalized by their initial concentration, d) time evolution of bacteria with no bound 
particles, as a function of bacteria concentration (Nb). 
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show that while for small molecules traditional blood purification systems work well, 
the binding of bacteria and larger targets becomes inefficient as conventional systems 
are limited by low surface accessibility (typically equivalent to 108 to 109 particles per 
mL).11   
2.2 Functionalization and characterization of commercial iron oxide 
nanoclusters  
In the next step, we sought to demonstrate experimentally that bacteria can 
indeed be bound within reasonable time frames using commercial 300-nm large 
magnetic beads at a concentration 1010 particles per mL. These beads are actually 
nanoclusters composed by 10 nm primary iron oxide NPs and are characterized by a 
saturation magnetization of 40 emu per g and a specific surface area of 10 m2 per g. 
Their surface is functionalized with A/G hybrid protein, a recombinant fusion protein 
containing immunoglobulin G (IgG)-binding region from both bacterial protein A and 
G. These proteins are able to bind immunoglobulins at their fragment crystallizable 
(FC) region and are used by different bacterial strains in order to avoid opsonization 
and phagocytosis. These proteins were exploited as anchoring points in order to 
attach the newly developed human IgG1 monoclonal antibody against poly-N-
acetylglucosamine (PNAG) (Fig. 3a-b).  
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Figure 3. a) magnetic particle-based capturing agents were assembled using protein A/G-coated 
Fe3O4 (PAG-MNP) nanoclusters and a human antibody against poly-N-acetylglucosamine (PNAG), b) 
TEM micrographs of functionalized antiPNAG-PAG-MNP nanoclusters, c) the hydrodynamic size of the 
Fe3O4-PAG nanoclusters before and after antibody-functionalization measured in phosphate-buffered 
saline (PBS) by NP tracking analysis (NTA), d) mean size, e) polydispersity index  and f) ζ-potential of 
beads suspended in phosphate buffered saline (PBS), and PBS supplemented with 1% and 10% fetal 
bovine serum (FBS), respectively, measured by dynamic light scattering (DLS). 
 
Measurement of the hydrodynamic particle size in physiological medium via 
Nanoparticle Tracking Analysis (NTA) showed narrow particle size distributions 
centered around 300 nm before and after functionalization, indicative of the good 
colloidal stability of the particle dispersions (Fig. 3c). Particle number concentration 
measurements were also performed on the NTA using diluted dispersions in order to 
adjust particle number concentrations for subsequent experiments. Carbon, nitrogen, 
and hydrogen measurements further confirmed the successful binding of the PNAG-
antibody to the particle surface. The colloidal stability of the functionalized particle 
suspensions in protein-rich physiological media (PBS + 1% serum) was further 
analyzed by measuring size distributions and the ζ potential of the functionalized 
particles, yielding a mean average diameter of 366 ± 2 nm in phosphate buffered 
saline (PBS) and 385 ± 2 nm in serum-containing PBS and ζ potential values of -20 and 
-17 mV in serum-free and serum-containing PBS, respectively (Fig. 3d–f). 
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In order to demonstrate the feasibility of the assembled agent for capturing 
bacteria, we first confirmed that the beads can be recovered quantitatively through 
magnetic separation. While the efficiency of the separation at a contact time of 10 s 
was only 57.1%, it increased at higher separation times, achieving 91.8% separation at 
1 min and 99.9% separation at 5 min. At a separation time of 20 min, the iron signal 
was indistinguishable from the background level of PBS (Fig. 4).  
 
Figure 4 Bead capturing efficiency from suspension measured by Inductively Coupled Plasma Mass 
Spectroscopy (ICP-MS). as a function of separation time. 
 
Importantly, particles are eventually degraded over time at acidic pH conditions 
comparable to lysosomal pH (Fig. 5). This is a fundamental characteristic that needs to 
be properly assessed, along with the particle biocompatibility, in order to assure that 
the fraction that will escape the magnetic capturing step will have negligible effects.  
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2.3 Bacteria capturing efficiency 
Bacteria capturing was further investigated with the aim of demonstrating the 
theranostic potential of the approach (Fig. 6a). For capturing bacteria, samples 
containing pathogenic bacteria (S. aureus, ATCC 6538) at various concentrations (102, 
103, 104 bacteria per mL) were prepared in physiological media. Particles at a 
concentration of 1010 particles per mL were subsequently added to the bacteria 
contaminated samples. After 10 min, the particles were separated from the 
supernatant by placing a 1 cm3 neodymium permanent magnet (1.37 T) next to the 
sample tube. Bacteria quantification in the supernatant and on the particle surface via 
plating and optical absorption revealed that the bacteria were efficiently captured by 
the anti-PNAG- functionalized beads (capturing efficacy 98%, Fig. 6b). In contrast, 
bacteria capturing by the protein A/G-functionalized beads (control) without antibody 
was significantly less efficient (<40%).  
 
Figure 5. Particle degradation over time in 10 mM citrate buffer at pH 3.0 and pH 4.5. 
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The theranostic potential was subsequently demonstrated by subjecting the 
pathogen-loaded beads to quantitative polymerase chain reaction (qPCR) based 
identification of the bacterial strain. Indeed, it was possible to detect and identify S. 
aureus on the beads via qPCR (Fig. 6c). The captured bacteria can further be visualized 
using electron microscopy despite the fact that magnetic beads were present in large 
excess as expected, based on the modelling data (Figs. 2d and 6d).  
Interestingly, the bacteria showed significant re-growth on the beads, which could 
potentially speed up blood culture process: the re-growth of bacteria enriched on the 
beads is significantly more pronounced compared to the untreated supernatant (Fig. 
7). 
 
Figure 7. a) Bacteria samples incubated with PNAG-PAG-MNP show normal growth rate compared 
to controls (no beads). b) Measurements of re-growth of S. aureus in the untreated supernatant (no 
beads) and on collected beads show enrichment of bacteria on the beads.  
Figure 6. a) Theranostic concept: body fluid is subjected to magnetic blood purification where 
circulating pathogens are removed. Magnetic beads loaded with bacteria can then be 
recovered from the separator and subjected to diagnostic analysis, b) bacteria removal 
efficiency for S. aureus at two different bacteria concentrations (10
3
 and 10
4
 cfu per ml) and a 
NP number concentration of 10
10
 per mL, c) quantitative polymerase chain reaction (qPCR) 
detection of bacteria in the supernatant and on the beads, d) scanning electron micrograph 
showing the particle pellet after separation with bacteria captured by magnetic particles 
(arrow), scale bar = 4 μm. 
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2.4 Cytotoxicity and degradation 
In order to be appealing for clinical application, however, safety concerns have to 
be addressed since a small fraction of the magnetic beads will escape magnetic 
capture step and end up in the bloodstream. To that end, we demonstrated that 
there is no detectable effect on cell viability even after prolonged contact of up to 24 
h for the used particle concentrations (1010 particles per mL, see Fig. 8a).  
We also demonstrated that the uptake of particles into monocytes (THP-1 cells) is 
very limited within the intended contact times (10 min or less). Measurement of the 
side scattering intensity using flow cytometry showed a time-dependent increase 
indicative of the particle uptake (Fig. 8b). While a minor shift in the side scatter 
intensity was observed 10 min after incubation, it subsequently increased and at 24 h 
a considerable shift was seen, indicative of significant particle uptake into human 
blood monocytic cells.  
 
Figure 8. a) Monocyte viability after 24 h exposure to relevant particle concentrations (10
10
 
particles per mL, 5 × 10
5
 monocytes per mL) and b) particle uptake into monocytes measured by the 
increase in granularity (side scattering) in flow cytometry at different contact times and 
corresponding light microscopy images of monocytes incubated with particles for 10 minutes and 
24 h, respectively (b).  
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3. Conclusions 
This proof of principle study demonstrates for the first time the theranostic 
potential of a magnetic separation-based body fluid purification approach. Bacteria 
can be captured from suspension and can subsequently be identified on the magnetic 
beads. This study forms the groundwork for a theranostic process where the bacterial 
load can be reduced and bacterial spread can be limited. 
Meanwhile, magnetic beads loaded with bacteria can be recovered from the 
separator and subjected to diagnostic analysis, hence decreasing both the time to 
diagnosis (as compared to blood culture due to bacteria enrichment) and the time to 
therapeutic administration of the appropriate antibiotics. 
While the therapeutic efficacy of pathogen removal remains to be demonstrated 
in clinics, the proposed theranostic approach is sought to help reduce the overuse of 
antibiotics by allowing rapid bacteria identification and identification of resistance 
genes. In future it may at the same time provide a treatment modality to bridge the 
time to diagnosis when appropriate antibiotic therapy can be administered. 
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4. Experimental Part 
Magnetic carrier assembly  
Magnetic capturing agents were assembled using nanoclusters functionalized with 
a recombinant fusion protein A/G (PAG, Bio-Adembeads PAG, Ademtech, Pessac, 
France). The PAG lacks albumin-binding domains, cell wall binding regions and other 
non-specific binding domains. Magnetic beads were washed thoroughly (3x) with PBS 
containing 0.65% Tween 20 (pH 7.5). Then, fully human PNAG monoclonal antibody 
(obtained from Prof. G. Pier, Harvard University) was added in PBS (1 mg per 10 mL 
beads) and incubated for 1 h at room temperature on a linear shaker. Then, the 
unbound antibody was removed by washing the beads three times in PBS containing 
0.65% Tween 20 (pH 7.5). Where applicable, the beads were re-suspended in 200 mM 
triethanolamine containing 20 mM dimethyl pimelimidate dihydrochloride (DMP). 
The beads were then thoroughly washed and re-suspened in PBS at a concentration 
of 1011 particles per mL. Particle size measurements were made in buffer using a 
Nanoparticle Tracking Analysis (NTA) device (NS500, Nanosight) and a ZetaSizer (901 
configuration). The ζ potential was measured on a ZetaSizer in 10% PBS (pH 7.4).  
 
Particle capturing efficacy  
In order to quantify the separation efficiency under a magnetic field, a 1 mL PBS 
solution containing 500 mg per mL of the NPs was gently shaken by hand for 10 min 
and afterwards placed next to a 10 mm NdFeB cube magnet (Supermagnete, 1.37 T) 
for 10 s. 500 microliters of the supernatant solution were removed, and the iron 
content was quantified using Inductively Coupled Plasma Mass Spectroscopy 
(ELEMENT 2 ICP-MS, Thermo Scientific) in order to determine the separation 
efficiency. This procedure was repeated for other three separation times, 1, 5 and 20 
min, respectively.  
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Bacteria removal  
Methicillin resistant S. aureus, among the most prevalent pathogens in human 
blood, was used as the model bacterium in this study. Bacteria from glycerol stocks 
were grown on tryptic soy agar (TSA) plates. A single colony was transferred to 10 mL 
of 30% tryptic soy broth (TSB) with 0.25% glucose and incubated overnight at 160 rpm 
and 37 °C. The overnight culture was diluted to a final OD600 of 0.01 with fresh 30% 
TSB + glucose and incubated until it reached an OD600 of 1.0, corresponding to 
approximately 108 colony forming units (cfu) per mL. The cells were harvested via 
centrifugation at 13 000g for 5 min. The pellet was washed three times with sterile 
PBS, and then re-suspended in PBS to obtain 103 and 104 cfu per mL. 500 mL of the 
bacterial suspension were mixed with 50 mL magnetic beads. Beads without antibody 
modification and PBS without beads were used as controls. The mixtures were 
incubated at room temperature on an orbital shaker for 10 min. Beads were collected 
for 5 min using an iron neodymium permanent magnet. The supernatant and the 
collected beads were resuspended in 10 mL PBS. 200 mL of the suspensions were 
plated on agar plates and incubated overnight at 37 °C.  
 
Bacteria detection and identification  
The above-mentioned collected beads were also utilized for S. aureus DNA 
purification with GenEluteTM Bacterial Genomic DNA Kit (Sigma-Aldrich). The isolated 
DNA was further used as the template for in vitro identification and quantification of 
S. aureus genomes using qPCR. The Primerdesignt genesigs Kit (Primerdesign Ltd) 
containing S. aureus specific primers and PrecisionTM Master Mix was used. The 
primers used in this study allow amplification of femB and have the following 
sequence: 50-TTA CAG AGT TAA CTG TTA CC-30 and 50-ATA CAA ATC CAG CAC GCT CT-
30. qPCR was performed according to the manufacturer’s instruction.  
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Particle uptake into monocytic cells  
For particle uptake measurements, particles (1010 particles per mL) were incubated 
with human monocyte cells (THP-1 cell line, ECACC 88081201) at a concentration of 5 
x 105 cells per mL (equivalent to the monocyte concentration in blood) for 10 min, 6 h 
and 24 h, respectively. To detect apoptosis and necrosis induced by the NPs used, the 
cells were stained using the FITC annexin V Apoptosis Detection Kit II (BD 
Biosciences). For staining, 5 mL of FITC annexin V (component no. 51-65874X) and 5 
ml propidium iodide (PI, component no. 51-66211E) were added to 1·105 cells and 
incubated for 15 minutes. After addition of binding buffer (component no. 51-
66121E), the samples were analyzed using flow cytometry with a Gallios Flow 
Cytometer (Beckman Coulter). The shift of the cell population after NP incubation was 
recorded with forward and side scatter. The fluorescence of PI and fluorescein 
isothiocyanate (FITC)-coupled annexin V was detected in fluorescence channels 1 and 
4, respectively. Cadmium sulfate (15 mM) and staurosporine (0.5 mM) served as 
positive controls and were added to the cells 3 h before cell harvest. Untreated and 
water treated cells served as the negative controls. To detect possible interferences 
of the NPs with the assay, the control cells were spiked with the same amount of NPs 
used in all other samples directly during the staining procedure to ensure no uptake 
and therefore no biological effect on the cells.  
 
Particle stability and degradation  
The degradation of the NPs was measured at both pH 4.5 (mimicking lysosomal 
conditions) and 3.0 (in order to observe a faster degradation) in 10 mM citrate buffer 
solution. Incubation mixtures were prepared containing 50 mg mL-1 of the NPs in a 
total volume of 2 mL. The rate of degradation of the NPs was measured at different 
time points (day 1, 2, 3, 6, 9, 15, 21) by measuring the concentration of degraded iron 
using ICP-MS (ELEMENT 2 ICP-MS, Thermo Scientific).  
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Chapter 5: Evaluation of magnetic 
nanoparticle properties for magnetic blood 
purification 
 
1. Introduction 
The use of magnetic NPs as blood cleansing agents has recently been proposed as 
an appealing treatment modality for a great number of pathogens.1 In this technique 
functionalized magnetic nanoparticles (MNPs) are injected into the bloodstream in an 
external loop (akin to dialysis) and subsequently magnetically removed after a 
suitable contact time has passed, in order to ensure an effective pathogen capture.  
For a future magnetic blood purification application on humans, several properties 
of the used magnetic nanoparticles are fundamental. They need to have a sufficiently 
high mobility to capture the desired target in a relatively short time (in the order of 
seconds to minutes) while also being recovered magnetically with high efficiency. 
Moreover, their biodegradability and biocompatibility must also be assessed, in order 
to assure that for those NPs escaping the magnetic capture step and ending up 
entering in the bloodstream the toxicity is negligible.  
These different properties are all highly dependent on the NP size and their 
composition.  
For this reason, we decided to compare different types of synthesized and 
commercial magnetic NPs to find the best possible candidate for magnetic blood 
purification applications. 
 160 
 
The main particles of interest are made by iron oxide nanoclusters synthesized 
through an emulsion electrospinning procedure, starting from oleate-capped iron 
oxide MNPs.  
Electrospinning is a fiber production technique that, thanks to the phenomenon of 
coulombian repulsion, generates fibers of micro- or nanometric thickness, starting 
from polymer solution or polymer melts. This method, in principle, has been known 
since the 1930s but has received an increasing scientific interest in recent decades. In 
the most common electrospinning setup polymer solutions are filled into a syringe 
and slowly pumped out at a defined speed. The syringes needle is put under a high 
voltage with an oppositely charged collector at a defined distance. The electrostatic 
repulsion of the induced surface charges leads to a deformation of the droplet into a 
so-called Taylor cone at the nozzle to increase the surface area. If the voltage is 
increased further, a liquid jet is ejected from the Taylor cone. Strong longitudinal 
stretching forces cause a thinning of the liquid jet which becomes increasingly 
unstable resulting in a whipping motion. During this whole process, the polymer 
solvent can evaporate from the liquid jet leaving a polymer fiber that is finally 
deposited on a collector in random orientation (Fig.1).  
 
Figure 1. Schematic diagram of horizontal set up of electrospinning apparatus.
2
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The resulting membrane possesses a high porosity with pore sizes depending on 
the fiber diameter and a thickness depending on the electrospinning time. This 
process avoids the high temperatures and/or harsh chemical treatment used in other 
process, thus being suitable for the production of fibers using large and complex 
molecules.  Many different polymers ranging from polysaccharides to synthetic 
polymers and polymer blends can be electrospun from various solvent systems or 
even melts. The thickness of the membranes, their porosity and the fiber diameters 
can be controlled by adjusting the electrospinning parameters like the solution 
viscosity, the pumping speed and the applied voltage amongst others. For these 
reasons, electrospun membranes have been investigated for various applications 
ranging from material sciences to the biomedical sector.  
In emulsion electrospinning either water-in-oil or oil-in-water emulsions with a 
polymer in the continuous phase are used for the electrospinning process. Depending 
on the concentration of the dispersed phase and its evaporation behavior, the 
emulsion droplets are incorporated into the nanofibers. The longitudinal stretching 
forces responsible for the thinning of the liquid jet and the nanosized diameter of the 
fibers can also cause a stretching of the droplets. At high droplet concentrations, the 
stretched droplet can merge and create a fiber with a continuous liquid core. 
Emulsion electrospinning can be used to incorporate substances into the fibers that 
are not soluble or dispersible in the electrospinning solvent, e.g., hydrophilic drugs 
into hydrophobic polymers or, in our case, hydrophobic NPs embedded in hydrophilic 
polyvinyl alcohol (PVA) fibers (vide infra). 
In order to ensure that the size of the emulsion droplet was on the nano scale a 
particular type of emulsion, a miniemulsion, was used. Generally, emulsions can be 
classified into macro-, micro- and miniemulsions. On one extreme macroemulsions 
contain heterogeneous, mostly micrometer sized droplets; while, on the other 
extreme, microemulsions contain monodisperse nanosized droplets. Miniemulsion 
are an intermediate category, in which droplet are still in the nanosized range. They 
lack however the thermodinamical stability of the microemulsion, being only 
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kinetically stable. Moreover, they require lower amounts of surfactant to be formed, 
provided that a high-shearing technique, such as ultra-sonication is used. Ideally, in a 
miniemulsion system, both coalescence and Ostwald ripening are suppressed. In this 
process, driven by a decrease in surface area and hence of the surface tension, an 
increase in size of the bigger droplets and a concomitant decrease in size of the 
smaller ones are observed. This process increases the droplet polydispersity and 
should thus be avoided. Due to the prevention of these processes, single droplets in 
miniemulsion can be considered as separate nanoreactors. Thanks to these properties 
miniemulsions are ideal for the creation of organic, inorganic and hybrid NPs without 
using high surfactant concentrations.3  
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2. Results and discussion 
2.1 Synthesis of iron oxide nanoclusters 
The primary oleate-coated iron oxide NPs were synthesized by co-precipition from 
iron (II) and iron (III) chloride in the stoichiometric ratio 1:2, respectively, in the 
presence of oleic acid (Scheme 1). 
 
This procedure was chosen instead of thermal decomposition because it allows a 
fast and gram-scale synthesis of magnetic NPs with moderato-to-high magnetic 
saturation, while its main drawback, poor size control, is rather unimportant for the 
purpose of producing magnetic NP clusters.  
These NPs mainly once dispersed in hexane, showed a main population with a 
hydrodynamic diameter centered at 18.2 ± 1.9 nm measured by Dynamic Light 
Scattering (DLS) (see Fig. 2). 
 
NH4OH, Oleic Acid
2 FeCl3·6H2O + FeCl2·4H2O
H2O, 70 ºC , 1h
Scheme 1. Schematic representation of the iron oxide MNPs synthesis via co-precipitation. 
Figure 2. Intensity (top) and volume (bottom) size distributions of the oleate-capped iron oxide 
MNPs. The volume distribution shows that the smaller population is also the main one. 
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The emulsion electrospinning technique was then used to produce larger magnetic 
nanoclusters starting from these primary particles. 
The MNPs were first dispersed in octane and then a miniemulsion was prepared, 
dispersing the organic phase in a 1% Sodium Dodecyl Sulphate (SDS) water solution 
via tip sonication. This miniemulsion was then mixed with a 15% wt Polyvinyl-alcohol 
(PVA) solution and the resulting mixture was subjected to emulsion electrospinning. 
Electrospinning is a fiber production method which uses electric force to draw 
charged threads of polymer solutions, creating fibers with nanometric diameter.  
In this case, the octane micelles containing the MNPs are also spun along with the 
fiber, forming magnetic nanoclusters embedded in PVA. This process is schematized 
in Figure 3. 
 
 
Figure 3. Schematic illustration of the fabrication of electrospun nanoclusters (left, reproduced 
from reference 
4
) and STEM micrograph of the nanoclusters embedded in PVA nanofibers (right). 
 
The magnetic nanoclusters were recovered dissolving the PVA fibers and then 
purified magnetically from the smaller fractions, obtaining a population with a mean 
hydrodynamic diameter of ca 315 nm (see Fig. 4). 
Figure 4. STEM micrograph of the water dispersed iron oxide nanocluster (left, scale bar = 500 nm) and 
DLS measurements of their size dispersion before and after magnetic fractionation (right). 
1 µm 
Supernatant 
Mean Int. = 213 
nm 
Purified fraction 
Mean Int. = 315 
nm 
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This method based on emulsion electrospinning has the advantage of both being 
easily up-scalable and reproducible. Moreover, this same technique could be easily 
applied to different types of hydrophobic NPs, without any significant modification to 
the procedure, producing water soluble clusters. 
 
2.2 Synthesis of iron oxide/carbide nanoclusters 
In order to investigate the possibility of producing nanoclusters with a higher 
magnetic saturation, carbon-coated iron carbide MNPs, produced by vacuum spray 
pyrolysis5, were functionalized with palmitic acid molecules (see Scheme 2). 
  
Scheme 2. Functionalization of carbon-coated iron carbide NPs 
These functionalized NPs were subsequently used to prepare a mixed 
miniemulsion with the iron oxide MNPs in a 1 to 9 ratio, which was then subjected to 
the same electrospinning procedure descripted above, thus obtaining nanoclusters of 
comparable size, formed by a blend of iron oxide and iron carbide MNPs (see Fig. 5). 
 
Figure 5. STEM micrograph of the water dispersed iron oxide/carbide nanocluster (left, scale bar 
= 500nm) and DLS measurements of their size dispersion before and after magnetic 
fractionation (right). 
Supernatant 
Mean Int. = 200 nm Purified fraction 
Mean Int. = 334 nm 
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2.3 Magnetic nanoparticles evaluation 
The clusters magnetic separation efficiency, biodegradability and cytotoxicity were 
then evaluated, along with those of two different commercial iron oxide NPs: Bio-
adembeads PAG® (having a similar diameter of 300 nm, see previous chapter for 
further details) and (1 µm large polystyrene based nanocluster particles, currently 
used for   the adsorption or coupling of various bioreactive molecules or cells), in 
order to verify their possible application for magnetic blood purification: 
2.3.1 Biodegradability assay 
The degradation kinetics of the MNPs were measured in citrate buffer solution (pH 
4.5 and 5.5, 10 mM, mimicking lisosomal conditions) and in PBS by quantifying the 
amount of dissolved iron at different time points. This experiment is currently in 
progress. We expect that the degradation rate of the 1 µm large Dynabeads® will be 
slower the the one for our electrospun nanoclusters due to i) the lower surface area 
caused by the bigger particle size and ii) the presence of a highly crosslinked 
polystyrene backbone.  
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2.3.2 Magnetic recovery efficiency 
In order to evaluate the magnetic recovery efficiency, the MNPs were suspended 
in phosphate buffered solution (PBS) and subsequently precipitated with a permanent 
magnet. Quantification at different separation times of the iron concentration in the 
supernatant was obtained by ICP-MS analysis, and these results used to determine 
the amount of leftover MNPs. The results of this assay are reported in Fig. 5. It can be 
seen that all the different particles achieved satisfying recovery efficiency at a 
reasonable separation time of 5 minutes. Moreover, the synthesized nanocluster 
reach an high separation efficiency, almost matching the bigger (and thus both less 
mobile and endowed with a lower specific surface area) dynabeads, with the iron 
carbide-doped clusters showing an higher recovery rate compared to the ones 
containing only iron oxyde NPs. 
 
 
Figure 6. Capturing efficiency at different separation times, measured by quantifying the amount of 
leftover MNPs by ICP-MS. Inset: magnification of two longest separation times. 
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2.3.3 Cytotoxicity 
A cytotoxicity assay was conducted on THP-1 human monocytic cell line at 
different MNPs concentrations, measuring the lactate dehydrogenase (LDH) released 
into the media from damaged cells as a biomarker for cellular cytotoxicity.  
Lactate dehydrogenase (LDH) is a cytosolic enzyme present in many different cell 
types. Plasma membrane damage releases LDH into the cell culture media. 
Extracellular LDH in the media can be quantified by a coupled enzymatic reaction in 
which LDH catalyzes the conversion of lactate to pyruvate via NAD+ reduction to 
NADH. Diaphorase then uses NADH to reduce a tetrazolium salt (INT) to a red 
formazan product that can be measured at 490 nm. The level of formazan formation 
is directly proportional to the amount of LDH released into the medium, which is 
indicative of cytotoxicity. The results of this assay are reported in Fig. 6. The MNPs 
show good biocompatibility, except for the iron oxide nanoclusters at high 
concentration. This odd result must be confirmed with further experiments.  
 
 
Figure 7. THP-1 cell viability after 24h incubation with different concentration of NPs, measured by 
LDH assay. 
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3. Conclusions 
These comparative assays between these NPs show that the produced magnetic 
nanocluster characteristics are suitable for a possible magnetic blood purification 
application, being both biocompatible and easily recoverable. 
Further work will be mainly aimed at developing surface functionalization 
procedures, in order to endow the nanoclusters with specific targeting properties. 
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4. Experimental Part 
 
Synthesis of oleate acid capped superparamagnetic iron oxide nanoparticles  
The synthesis of oleate-capped iron oxide NPs was done similarly to a method 
reported in literature.6,7 
Briefly, in a 500 mL three-necked round bottom flask under inert atmosphere, 24.3 
g FeCl3∙6H2O (90 mmol) and 11.9 g FeCl2∙4H2O were dissolved in 100 mL MilliQ water. 
This solution was degassed bubbling N2 for 30 min, after which 40 mL of an 
ammonium hydroxide solution (28% NH3 in water) were added dropwise before 
adding 15 mmol oleic acid. Under vigorous stirring, the reaction was kept at 70 °C for 
1 h and at 100 °C for 2 h while constantly refilling the evaporating water with 
deionized water. After complete evaporation of excess NH3, the reaction mixture was 
cooled to room temperature and put on top of a permanent magnet to precipitate 
the magnetic NPs. The particles were washed several times with deionized water and 
dried under vacuum before further uses. 
 
Synthesis of iron oxide nanocluster  
For the formation of iron oxide containing miniemulsion droplets, 1 g of oleate-
capped iron oxide NPs were redispersed in an octane/toluene solution (0.5 and 1 g, 
respectively). The resulting black dispersion was mixed with 15 mL of 0.1% SDS, 
forming a macro emulsion, that was subsequently subjected to ultrasonication under 
ice cooling using a Branson Digital Sonifier with ½ inch ultrasonication tip (3 min, 50% 
amplitude, 10 s pulse, 5 s pause) in order to form a miniemulsion. 
The iron oxide containing miniemulsion was then heated to 80 °C under magnetic 
stirring for 1 h, in order to remove part of the organic phase.  
The miniemulsion was then mixed in a 1:2 ratio with a 15% PVA stock solution 
(Mw = 205.000 g·mol-1) to form a 10 wt% PVA miniemulsion. Emulsion electrospinning 
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was then performed via a previously described electrospinning setup,8,9 which was 
placed in a climate chamber to have good control over the spinning conditions. The 
emulsion was then spun at 24 °C and at a relative humidity of 50% (20 cm distance, 5 
μL·min-1 feed rate, 0.8 mm tip diameter, +12 and -5 V and 0.1 mA) and the fibers 
collected on top of an aluminum foil or on a carbon coated copper grid. The fiber 
mesh was then removed from the support and dissolved in milliQ water (around 10 
mL each 100 mg of PVA mesh), and the clusters recovered by centrifugation (10 min x 
10.000 rcf). In order to remove the smaller-sized fraction of the clusters they were 
subjected to magnetic sedimentation partitioning them in aliquots of 5 mL, placing 
them on a permanent magnet for 5 min and removing the supernatant before adding 
fresh nanocluster solution. They were finally re-suspended at a concentration of 1.5 
mg per mL 
Synthesis of oleate capped iron carbide nanoparticles  
Carbon-coated iron carbide NPs (100 mg) were suspended in 0.5 mL of 1% SDS 
solution. The diazonium salt of 4-(2-aminoethyl)aniline was prepared in situ by mixing 
in an ice bath a solution of 21.8 mg 4-(2-aminoethyl)aniline (0.16 mmol) dissolved in 2 
mL H2O and 60 μL concentrated HCl with a solution of 16 mg sodium nitrite (0.23 
mmol) in 1.2 mL water. The NPs- and diazonium salt solution were then mixed and 
left reacting 30 min in an ultrasonic bath. The functionalized NPs were recovered with 
a permanent magnet and washed with water and acetone before being dried in 
vacuo. 
Subsequently, the magnetic NPs were re-suspended, under inert atmosphere, in 4 
mL anhydrous DMSO. To this suspension palmitoyl chloride (485 μL, 1.6 mmol,) and 
Et3N (280 μL, 1.8 mmol) were added. The NPs were then left reacting in an ultrasonic 
bath for 90 min at RT. They were subsequently collected with a magnet and washed 
three times with acetone before being dried in vacuo. 
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Synthesis iron oxide/carbide mixed nanoclusters  
The mixed iron oxide/carbide clusters were synthesized following the same 
procedure used for the iron oxide clusters, starting from an emulsion made with 0.9 g 
of iron oxide NPs and 0.1 g of iron carbide NPs. 
Biodegradability assay 
The degradation of the NPs was measured at both pH 4.5 and 5.5 (mimicking 
lysosomal conditions) and in PBS in 10 mM citrate buffer solution. Incubation 
mixtures were prepared containing 50 g per mL of the NPs in a total volume of 2 mL. 
The rate of degradation of the NPs was measured at different time points (day 1, 2, 3, 
6, 9, 15, 21) by measuring the concentration of degraded iron using ICP-MS (ELEMENT 
2 ICP-MS, Thermo Scientific).  
 
Magnetic recovery measurements 
In order to quantify the separation efficiency of the different NPs under a 
magnetic field, a 1 mL PBS solution containing 500 g per mL of the NPs was gently 
shaken by hand for 10 min and afterwards placed next to a 40x40x20 mm NdFeB 
magnet (Supermagnete, 1.29-1.32 T) for 10 s. 500 microliters of the supernatant 
solution was removed, and the iron content was quantified using Inductively Coupled 
Plasma Mass Spectroscopy (ELEMENT 2t ICP-MS, Thermo Scientific) in order to 
determine the separation efficiency. This procedure was repeated for three other 
separation times, 1, 5 and 20 min, respectively.  
Cytotoxicity measurements 
Cytotoxicity measurements were carried out according to the protocol from the 
manufacturer using Promega CytoTox 96® Non-Radioactive Cytotoxicity Assay kit.  
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Chapter 6: A new catechol-functionalized 
poly(amidoamine) as an effective magnetite 
nanoparticle stabilizer 
 
 
 
1. Introduction 
Superparamagnetic iron oxide nanoparticles (SPIONs) have been in the spotlight in 
the last years as promising candidates for a plethora of different biomedical 
applications, due to both their high biocompatibility and peculiar magnetic properties, 
for both imaging (magnetic resonance imaging, MRI) and therapeutic purposes (e.g. 
magnetofluidic hyperthermia, MFH). These applications heavily depend on the 
magnetic properties of the material. Up to date thermal decomposition of 
organometallic precursor in high-boiling organic solvents is still the best method to 
produce SPIONs with high magnetic properties and has been widely used by many 
research groups. One of the main drawback of this technique, however, is that the 
resulting SPIONs are usually soluble only in organic solvent. In order to impart water 
solubility and stability to the NP colloid a suitable coating agent must be employed. 
These agents usually stabilize colloidal dispersions thanks to either the charge 
imparted to the NP surface or to the steric hindrance they provide. Both these 
properties can prevent NPs aggregation and sedimentation in physiological medium, 
which is a condition that must be attained for an in vivo use. Moreover, the coating 
agent should also ideally allow the NP to avoid opsonization and the consequent 
recognition from the reticulo-endothelial system, prolong their circulation time, 
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maximizing the probability to reach the target site by exploiting of the so called 
enhanced permeability and retention (EPR) effect.  
In order to transfer from organic to water phase the hydrophobic NPs several 
approaches have been described in the literature. One of the most used consists in 
exploiting little and hydrophilic organic molecules containing a functional group with 
a good affinity for the NP surface and a second functional group with water affinity.1 
Other approaches make use of an amphiphilic polymer able to form by intercalation 
stable weak interactions with the hydrophobic layer on the NP surface and exposing 
to the environment the hydrophilic part.2 Then this hydrophilic layer can be covered 
with more biocompatible polymers like dextran,3 silica4 or PEG.5 Nevertheless, these 
last strategies show as drawback the considerable increase the NP size, and the 
lowering of the magnetic properties of the core. 
In this work we aimed at developing a new coating agent for SPIONs, based on an 
amphoteric poly(amidoamine) (PAA), nicknamed ISA23 (see Scheme 1), which was 
previously found by Ferruti et al. to be biocompatible, biodegradable, and to exhibit 
“stealth-like” behaviour once injected into animals, the absence of which would lead 
to immediate identification and disposal after intravenous injection.6  
Scheme 1. ISA23 homopolymer. 
Moreover, this family of polymers is characterized by high chemical flexibility, 
being easily modified by adding different monomers during the polyaddition reaction. 
In this way different functionalities can also be introduced, and literally appended to 
the polymer backbone.7 These characteristics are what we aimed to impart, along 
with improved water solubility and stability, to SPIONs.  
Effective binding to the iron oxide surface was achieved functionalizing the 
polymer with catechol moieties, whose high affinity towards iron is already exploited 
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in a variety of natural siderophores.8 In particular, it is known that mussels exploit a 
protein rich in catechol and amine groups, which is particularly adhesive and is able to 
bind many different kind of material surfaces. Many macromolecules have been 
endowed with a catechol group with the aim to tightly bind and stabilize colloidal 
NPs. Nevertheless, the most effective strategy seems to be the cooperation of more 
catechol groups on a single stabilizing molecule (see Fig. 1). 
 
 
Figure 1. Representation of mussel adhesive protein, which contains multiple L-DOPA residues.
9
 
 
In order to introduce this functional group, nitrodopamine was chosen over 
dopamine thanks to its higher stability towards oxygen- and metal-catalysed oxidation 
and its stronger binding affinity compared to regular dopamine (see Scheme 2).  
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Scheme 2. The detailed reaction process of polymerization of dopamine and the binding between 
polydopamine/dopamine and metal substrate/metal ions. (A) Intramolecular cyclization; (B) 
rearrangement; (C) reverse dismutation reaction; (D) polymerization and cross-linking formation. 
 
In fact, this unwanted reaction was found to be the main problem in previous 
attempts aimed at functionalizing the ISA23 polymer with dopamine. The grey-ish 
dopamine containing polymer showed only a small percentage of catechol 
functionalities, as was evinced by 1H NMR spectra. 
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2. Results and discussion 
2.1 Synthesis of superparamagnetic iron oxide nanoparticles (SPION) 
Oleate-capped iron oxide NPs were first produced via thermal decomposition of 
iron pentacarbonyl in refluxing 1-octadecene using an upscaled procedure compared 
to the one from chapter 3 (see Exp. part).  
The so obtained magnetic NPs could easily be dispersed in hexane, showing a 
single population with a hydrodynamic size of 30.8 ± 1.4 nm measured by dynamic 
light scattering (DLS, Fig. 2). 
 
2.2 Synthesis of ISA23-nitrodopamine copolymer 
The synthesis of the ISA23 copolymer has already been described elsewhere6 and 
is based on the Michael-type polyaddition of 2-methylpiperazine onto the acrylic 
moieties of 2,2’-bisacrilamido acetic acid (BAC) (see Scheme 3). 
 
Scheme 3. Synthesis of ISA23. 
Catechol moieties were then introduced in the polymer by reacting the carboxyl 
groups of the polymer backbone with the free amino group of 2-nitrodopamine using 
1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC) as a crosslinking agent in a MES 
buffered solution. This reaction is completed in 4 h, in water and at room 
temperature (Scheme 4). 
Figure 2. Intensity size distribution for SPION@OA hexane suspension. 
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Scheme 4. Synthesis of ISA23-nitrodopamine. 
The polymer ISA23-ND was purified by filtering through a 3 kDa filter device for 
centrifugation, in order to retain the polymer while filtering off the nitrodopamine 
excess as well as the crosslinking agent and the buffer components. Finally, a 
lyophilisation process afforded a fluffy and yellow solid. 
In order to maintain the useful properties imparted by the amphoteric nature of 
the copolymer, only the 17% of the carboxyl group were functionalized (this fraction 
was determined by comparing the different intensities of the 1H-NMR signals of the H 
atom in  position of the carboxyl/amido group, see Fig. 3). 
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Figure 3. 
1
H-NMR spectrum of ISA23-nitrodopamine (ISA23-ND). 
 
The functionalized polymer (ISA23-ND from now on) also showed the typical UV-
Vis pH dependant absorption bands of nitrocatechols arising from different 
protonation states of the nitrodopamine catechol group10 (Fig. 4). At acidic pH two 
peaks are present centred at 305 (the most intense) and 378 nm, while on increasing 
the pH at ca 5 the band at 305 nm disappears, while the band at 378 nm becomes 
very intense and progressively shift at higher wavelengths on increasing the pH. 
Interestingly, a spectrum presenting a bimodal profile, corresponding to a double 
deprotonation, was obtained only after leaving the polymer in basic solution for some 
time (see orange trace in Fig 4). This showed to be a fully reversible transformation, 
as it was evidenced by careful addition of HCl. 
ISA23-ND 
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Figure 4. Uv-Vis absorbtion spectra at different pH for ISA23-ND. 
A TGA analysis performed on ISA23-ND in air showed different separate steps of 
weight loss, with complete degradation at around 550 °C (see Fig.5). The first step 
(until 200 °C) is due to hydration water evaporation, while the second step (200-350 
°C) could be attributable to the oxidation of the functional groups present along the 
polymer chain, and the last weight loss could be attributable to the oxidation of the 
carbon-based polymer backbone. Moreover, the TGA profiles for this class of 
polymers is very similar one to each other, as is the case of another copolymer based 
on the same bisacrylamide as for ISA23-ND but containing a different amine molecule 
polymerized in a minority part of the repeating units (in Fig. 5 indicated as ISA23SH), 
or to dendritic poly(amidoamine)s described in the literature.11 
 
Figure 5.TGA curve for ISA23-nitrodopamine (left); Comparison of TGA curves of ISA23-ND and 
ISA23SH (right). 
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It is well known that these polymers are able to self-assemble producing globular 
NPs.7 The DLS size distribution showed a main population formed by nanoaggregates 
of diameter minor than 10 nm, with some other bigger aggregates accounting only for 
a small fraction of the whole sample, as it can be seen from the intensity and volume 
distributions (see Fig. 6, top and bottom, respectively). 
 
 
 
 
 
 
 
 
 
The ζ-potential curve of the polymer nanoaggregates (see Fig. 7) can be easily 
explained looking at the backbone functional groups: at acidic pH both the carboxylic 
and the secondary amino groups are protonated, inducing a positive charge. As the 
pH moves from acid to basic there is a charge change from positive to negative 
passing from a zero point at ca pH 6, where the carboxylic groups are deprotonated 
and counteracts the positive charges of the residual amino groups, forming a 
zwitterionic compound. At basic pH both carboxyl and amino groups are 
deprotonated, resulting in a global negative charge.  
Figure 6. Intensity and volume size distributions for ISA23-
nitrodopamine (respectively top and bottom). 
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Figure 7. ζ-potential of ISA23-ND.  
The pKa values (2.2, 3.4, and 7.5) account for this behaviour and the distribution 
species in dependence of pH can be seen in Fig. 8. 
 
Figure 8. Species distribution of ISA23 in dependence of pH. 
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2.3  One-step ligand exchange 
Direct water transfer of the oleate coated SPIONs would theoretically be the most 
effective synthetic route and for this reason was the first focus. Unfortunately, the 
orthogonal solvents needed for the dissolution of the two compounds, the strongly 
hydrophobic oleate-coated NPs and the hydrophilic polymer, prevent a direct coating 
procedure in a common/shared solvent (see below). 
A first direct coupling attempt was done, following a literature procedure12 (which 
used a catechol functionalized chitosan) using ultrasonication to create an oil-in-water 
emulsion between a hexane dispersion of the oleate-coated NPs and an aqueous 
ISA23-ND solution. Unfortunately, this method did not afford an emulsion of the two 
phases, possibly because of the different chemical properties of our 
poly(amidoamine) compared to chitosan and/or because of the different 
ultrasonication devices used (tip vs bath ultrasonication). 
A second attempt was done adapting another literature procedure in which a 
similarly highly hydrophilic polymer was used.13 In this procedure a THF dispersion of 
the hydrophobic NPs was reacted with an ethanol solution of a catechol 
functionalized poly(acrylic acid)-PEG graft copolymer. In our case the polymer had to 
be dissolved in an aqueous solution, due to its insolubility in water. Unfortunately, 
upon mixing the two solutions an instantaneous clouding was observed, due to the 
precipitation of the polymer. This prevented any ligand exchange process in these 
conditions. 
At last, an effective one step ligand exchange was achieved, following a modified 
literature procedure.14 It consisted in a two-phase reaction between SPION@OA in 
hexane and an acidic (pH ca 3-4) solution of ISA23-ND, vortexing the non-stable 
emulsion for 72 h (see scheme 5). This pH value was found to be necessary to push 
the protonation of the leaving oleate molecules hepling them to pass to the organic 
phase.  
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Scheme 5. One-step oleic acid/ISA23-ND ligand exchange. 
 
After 24 h the colourless organic phase was removed and the water phase washed 
with 10 mL hexane in order to remove eventual oleic acid left from the ligand 
exchange. Leftover hexane was evaporated by rotary evaporator. The water 
suspended SPIONs were then washed from the polymer excess via centrifugation (see 
Exp. Part). The exchange reaction resulted in a clear brown suspension of stable 
water-dispersed SPION@PAA. DLS analysis of this sample showed a single population 
with a mean hydrodynamic diameter centred at ca 180 nm (see Fig.9).  
 
 
Figure 9. DLS intensity distribution of ISA23-nitrodpamine-coated iron oxide nanoparticles. 
ISA23-ND 
H
2
O/Hexane 1:0.75 
72h, RT, pH 3-4 
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The ζ-potential curve of these NPs behaves similarly to the free polymer one, 
further proving that the ligand exchange took place (see Fig. 10).  
 
The thermogravimetric analysis (TGA) profile showed substantially a single weight 
loss step between 150 °C and 450 °C, and that the organic fraction accounted for 
about the 15% of the total weight (see Fig.11, top). A comparison with the TGA profile 
of the free ISA23-ND polymer (reported in Fig 11, bottom) showed that the weight 
loss started at a temperature slightly lower, and was somehow accelerated by the 
presence of the iron oxide NPs.  
Figure 10. ζ-potential of SPION@ISA23-ND. 
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Figure 11. TGA curve for SPION@ISA23-nitrodopamine. 
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The NP cellular uptake was studied (in collaboration with Dr. Anna Salvati group in 
Groningen) on HeLa cells after incubation with 30 µg/mL of NPs for 24 h. since these 
particles are not fluorescent, reflected light microscopy was used to image them (see 
Fig. 12). In order to visualize the co-localization with cell suborganells, a lysosome 
fluorescent dye was also employed. 
 
Figure 12. Reflected light microscopy of Fe3O4@ISA23-ND. HeLa cells were exposed to 30 µg/mL of 
NPs for 24 h. Lysosomes (in green) were stained with Alexa 488.Left: merge of reflected light (white) 
and lysosome fluorescence (green); right: reflected light only of the same snapshot. 
From these images it can be concluded that the NPs could indeed be internalized 
by the cells: as it was expected, the NPs are mainly present inside the lysosomes, as a 
consequence of a probable endocytosis mechanism of internalization.  
Unfortunately, the synthesized NPs showed heavy aggregation when placed under 
a magnetic field, possibly deriving from an incomplete coating. For this reason, 
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achieving proper magnetic characterization of the NPs was not possible, proving their 
ineffectiveness as MRI-contrast agents. 
In order to avoid this detrimental effect over the SPION magnetic aggregation a 
two-step procedure was developed. 
 
2.4  Two-step ligand exchange 
For this purpose, we first used DMSA as a temporary water-transferring agent (see 
chapter 3) before reacting the NPs in water with ISA23-nitrodopamine.  
The first exchange OA/DMSA was carried out setting the NP:polymer ratio equal to 
1:10 and the pH value equal to 4. It was chosen to use an acid pH since in this 
condition the two reacting species have opposite charges so that the attraction 
between the positive polymer and the negative SPION@DMSA is expected to be 
enhanced, promoting the ligand exchange reaction. The mixture was sonicated for 4 h 
and the excess of polymer was removed through dialysis by using a membrane with a 
nominal cut-off of 50000 Da for two days. The trend of the surface charges, shown in 
the ζ-potential measurements versus pH, confirmed the coupling between the NPs 
and the polymer (see Fig. 13).  
 
Figure 13. ζ potential profile of SPIONS@ISA23-ND (BR23) measured at different pH. 
 
TEM analysis on this promising sample showed NPs with a diameter ranging 
between 5 and 15 nm with the mean distribution intensity at 9 nm, but mainly 
gathered in bigger aggregates. In this sense, TEM (Fig. 14) and DLS (Fig. 15) analyses 
agree, since by DLS only aggregates of NPs were visible. 
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Figure 14. TEM micrographs in bright field of Fe3O4@ISA23-ND. 
 
Figure 15. DLS analysis of Fe3O4@ISA23-ND after the dialysis. 
 
Due to these only partially positive results we decided to change the water 
transferring agent from DMSA to tetramethylammonium hydroxide (TMAOH): we 
thought that DMSA, being able to form intermolecular disulphide bonds when 
exposed to air, would be harder to remove compared to this latter molecule. Oleic 
acid capped SPIONs were first dried and then re-dispersed in a 0.125 M aqueous 
TMAOH solution (see first half of scheme 6).  
 
50 nm 100 nm 
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TMAOH
H2O, RT, 5 min,
ultrasonication
Isa23-nitrodopamine
H2O, 72h, RT, pH 3
 
Scheme 6. Two-step oleaic acid/isa23-ND exchange procedure: water transfer is first achieved using 
TMAOH, followed by coupling with the PAA. 
 
This procedure successfully transferred in water the SPIONs, obtaining stable 
dipersion with hydrodynamic size of 123 nm (Fig. 16 top). The number distribution 
showed that the vast majority of the hydrodinamic diameter of SPION@TMAOH were 
minor than 100 nm (Fig. 16 bottom). 
 
After washing the SPIONs@TMAOH in order to remove any TMAOH excess, the 
second exchange step was conducted in water at acidic pH and at room temperature, 
by reacting them with a threefold amount in weight of polymer under shaking for 72 
h (see second half of scheme 6). The obtained SPIONs@PAA showed a slight decrease 
in hydrodynamic diameter, peaking at 115 nm (Fig. 17 top). Again, number 
Figure 16. DLS intensity (top) and number (bottom) distribution of SPION@TMAOH. 
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distribution showed that the vast majority of the NPs had a mean hydrodynamic 
diameter minor than 100 nm (Fig. 17 bottom). 
 
The tendency of this kind of polymers to form aggregates with iron oxide NPs was 
highlighted in a previous work of our research group,15 even if in that case the 
procedure for the formation of the NPs-polymer nanocomposite was totally different. 
This is likely due to the spreading along the polymer chain of carboxylate groups, 
which have the potentiality to interact contemporarily with more than one NP. In 
order to have a precise picture of the kind of aggregate (if any in this case) it will be 
necessary to make some electron microscopy analysis in the next future. In the 
absence of this analysis, ζ-potential revealed to be essential in order to prove that at 
least the exchange took place. In fact, ζ-potential curve (Fig. 18) showed a much 
higher positive value at acidic pH, coherently with the binding of the amphoteric PAA. 
 
Figure 17. DLS intensity (top) and number (bottom) distribution of SPION@ISA23. 
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In order to further prove that the exchange took place, and also to endow our NPs 
with luminescent properties that could ease future biological studies, we thought of 
developing a second nitrodopamine-bearing PAA that was also functionalized with the 
fluorescent dye RhodamineB. 
To this end we used a second PAA, ISA23SH10%, bearing in 10% of its repeating 
units a thiol group (see Scheme 7). 
 
Scheme 7. Structure of the ISA23SH10%, copolymer. 
This polymer was then first reacted with nitrodopamine, following the same 
procedure that we used for the ISA23 homopolymer, resulting in functionalization of 
ca 10% of the free carboxyl groups (see Scheme 8).  
Figure 18. ζ-potential of SPION@TMAOH (blue) and SPION@ISA23 (red). 
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Scheme 8. Nitrodopamine conjugation to ISA23SH. For graphical clarity not all possible 
combinations of functionalized monomers are displayed. 
In a second step, Michael addition of the polymer thiol groups with 
ethylmaleimido-rhodamineB (see Exp. Part and chapter 3) produced the RhodamineB 
funtionalized polymer (see Scheme 9). 
 
Scheme 9. ISA23S-ND-RhodB synthesis. For graphical clarity not all the possible combinations of 
functionalized monomers are displayed. 
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This polymer was then used in a two-step ligand exchange procedure.  
SPION@TMAOH were reacted following the same procedure used with ISA23-ND, 
water dispersed SPION@ISA23SH-ND-RhodB. Any excess of polymer was then 
removed via centrifugation. 
The reaction resulted in water dispersed NPs with a hydrodynamic diameter of ca 
190 nm (see Fig. 20 top). This size increase, compared to the reaction performed with 
the ISA23-ND polymer is likely due to the harsh centrifugation procedure adopted to 
remove the leftover polymer excess before moving to the UV-Vis measurements (see 
Exp. part). In fact, DLS measurements performed before the centrifugation procedure 
on the reaction mixture (see Fig. 20 bottom) showed only a single population at 92 
nm (no polymer peak is seen, due to the superior scattering properties of the bigger 
iron oxide NPs compared to the free polymer aggregates).  
 
UV-Vis spectroscopy of the purified particles showed indeed a superposition of the 
RhodamineB absorption band (λMAX = 559 nm) to the broad iron oxide absorption (see 
Fig. 21). The UV-Vis spectrum recorder after centrifugation of this sample didn’t show 
the RhodamineB signal, proving that the reaction took place and that the 
RhodamineB functionalized polymer was indeed bound to the SPION surface. 
Figure 20. DLS intensity distribution of SPION@ ISA23SH-ND-RhodB, after (top) 
and before (bottom) the centrifugation procedure . 
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Figure 21. UV-Vis spectrum recorder for SPION@ ISA23SH-ND-RhodB (red line) and its supernatant 
after centrifugation (black line). 
Photoluminescence spectra were recorder for both SPION@ISA23SH-RodB and the 
free polymer. The excitation and emission spectra of these two compounds are 
almost superimposable, presenting both the typical excitation and emission profiles 
of RhodamineB (see Fig. 22). This proves that the luminescent properties of 
RhodamineB are (at least partially) preserved in both ISA23SH-ND-RodB and, more 
importantly, in the functionalized NPs. Indeed, while the RhodamineB emission 
maximum did not change after conjugation to SPION (580/581 nm), the quantum 
yield dropped of one order magnitude passing from the free polymer to the SPION@ 
ISA23SH-RodB nanosystem (2.5% vs. 0.3%, respectively), possibly due to the presence 
of the high local magnetic field. 
 
Figure 22. SPION@ISA23SH-RodB (grey) and ISA23SH-RodB (black). 
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2.5 Magnetic characterization of two-step synthesized-SPION@PAA 
The ability of the two-step synthesized-SPION@PAA to affect water nuclear 
relaxation times was measured by means of the 1H-NMR, to evaluate the capability of 
these systems to act as T2 MRI contrast agents. The 
1H-NMR longitudinal relaxation 
time values showed to be higher than the reference commercial contrast agent 
Endorem® for low applied external fields, while at ~ 0.5  and 1.5 Tesla (two of the 
most used magnetic fields in the clinical practice) the efficiency of two-step 
synthesized-SPION@PAA is similar to commercial product (green stars in Fig. 23). 
Figure 23. Longitudinal (left) and transverse (right) NMRD profiles of SPION@ISA23 (green circles) 
compared to commercial compound Endorem® (black squares). 
On the contrary, the 1H-NMR transverse relaxation time values of SPION@PAA 
showed a significant increase in relaxivity compared to Endorem®, highlighting the 
potentiality of these new nanocomposites to be used as effective T2 contrast agents in 
MRI. 
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3. Conclusions 
In this work, a new catechol functionalized poly(amidoamine) was synthesized and 
characterized. The implemented reaction conditions resulted in functionalization of 
less than 20% of the free –COOH groups, with the aim of avoiding any detrimental 
perturbation to the polymer biological properties that could be brought about by an 
extensive functionalization.  
Two different ligand exchange strategies were evaluated, in order to optimize the 
SPION-PAA interaction process. The two-step procedure was chosen due to the 
improved colloidal stability of the water-dispersed NPs. 
Judging from the DLS analysis it seems possible that magnetic clusters made of 
several NPs coated by ISA23-nitrodopamine were water-transferred, instead of single 
NPs. To confirm this, further investigation will be needed, for example with 
transmission electron microscopy. 
Moreover, a second catechol functionalized PAA was synthesized, bearing 
luminescent RhodamineB group, further successfully linked to the SPIONs. Even if the 
most of the luminescence was quenched by the closeness of the dye to both PAA 
amine groups and magnetic NP surface, this was not completely quenched. The 
efficacy of the optical contrast should be ascertained with future confocal microscopy 
studies. 
In future it will be taken into account the possibility to change the organic dye with 
an organometallic (triplet emitter) one, which could act as PDT agent, in order to 
obtain a multimodal theranostic agent. 
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4. Experimental Part 
Synthesis of superparamagnetic iron oxide nanoparticles (SPION)  
The synthesis of SPION was performed following a slightly modified literature 
procedure.16 Briefly, in a 250 mL three-necked round bottom flask 60 mmol of oleic 
acid (19 mL, d= 0.895 g/mL; 70% purity) and 10 mmol of Fe(CO)5 (1.348 mL, d= 1.49 
g/mL) were dissolved under inert atmosphere in 40 mL of 1-octadecene. This solution 
was then heated from room to 320 °C at a rate of 15 °C/min and refluxed for 3 h. 
During this time the reddish solution turned to black. The solution was then cooled to 
120°C at a rate of 5 °C/min and maintained at that temperature for 2 more hours in 
air to allow oxidation of Fe(0). The solution was cooled down to room temperature at 
a rate of 5 °C/min. The SPION were subsequently isolated by centrifugation of the 
reaction mixture after addition of ca 500 mL of acetone (4 centrifugation cycles for 5 
min at 5000 round centrifugal force, rcf) followed by removal of the yellow 
supernatant and addition of fresh acetone. The isolated particles were then re-
suspended in 30 mL of hexane and stored under nitrogen atmosphere at -25 °C for 
further uses. 
Synthesis of ISA23 copolymer 
2,2'-Bis(N-acrylamido)acetic acid (3.9637 g, 0.02 mol) and 2-Methyl piperazine 
(2.0034 g, 0.02mol) were dissolved in 1 M sodium hydroxide (20mL). The reaction 
mixture was then maintained at 25°C for 5 days. Morpholine (0.87 g, 0.01 mol) was 
then added in order to saturate any residual double bonds and the mixture was left to 
stand at 25°C for a further 5 h. After this time 20 mL of a 1 M HCL hydrochloric acid 
solution were added. The product was finally isolated by diluting with water and 
ultrafiltering through a membrane with nominal cut-off 1000 Da. The product 
retained by the membrane was finally recovered by lyophilisation, dried to constant 
weight at 25°C and 0.1 torr over potassium hydroxide, and stored at 4°C. Yield 5.13 g 
(85.79%). 
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Synthesis of nitrodopamine 
Dopamine·HCl (498 mg, 2.62 mmol), NaNO3 (633 mg, 9.16 mmol)were dissolved at 
0°C, under inert atmosphere (in a two-necked 50mL round bottom flask) in 15 mL 
water. Then H2SO4 (5 mL, 20%) was added dropwise, in the dark. The reaction mixture 
was then left overnight at room temperature under mechanical stirring. The yellow 
precipitate was then filtered and washed with ice cold water and cold methanol, and 
subsequently dried in vacuum, affording 338 mg of nitrodopamine·HSO4 (MW= 
296.25, 1.14mmol, 50.5% yield) 
Synthesis of ISA23-nitrodopamine copolymer (functionalization of ISA23 with 
nitrodopamine 
ISA23 copolymer (335 mg, 1mmol, Mn=30 kDa, Mw=44 kDa) was first dissolved 
under inert atmosphere in 20 mL degassed MES buffer (0.1 M). The solution pH was 
then carefully adjusted to 5.6 by addition of NaOH 1M. Then nitrodopamine (296 mg, 
1mmol) was added, after which pH was again adjusted to 5.6. Subsequently EDC (1-
ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride, 575.1mg, 3 mmol) was 
added. The previously turbid yellow suspension quickly became clearer/less opaque. 
The reaction was left in the dark for 4 hours under mechanical stirring and then 
filtered through a 3 kD cut-off centrifugal device in order to eliminate unreacted 
nitrodopamine, EDC and byproducts and further washed with water. The remaining 
yellow solution was then lyophilized, obtaining 146.7 mg of nitrodopamine- 
functionalized ISA23. Nitrodopamine 1H-NMR signals (D2O, 300 K, 9.4 T): δ 8.04 (1H, 
CH), 6.48 (1H,CH), 5.69 (1H, CH) (D2O) 
One-step ligand exchange via emulsion 
A water solution of ISA23-nitrodopamine (1.9 mg of Fe3O4 in 3 mL) was added to 
an hexane suspension of SPION@OA (150 µg in 3 mL hexane) in a 10 mL glass vial. The 
biphasic mixture was first vortexed for 10 min at 800 rpm amd then placed in an 
ultrasonicating bath but in no case the formation of an emulsion was observed. 
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One-step ligand exchange in THF 
A THF disperions of SPION@OA was prepared diluting 10 µL of an hexane 
suspension (= 0.23 mg of Fe3O4) with 1mL of THF. To this solution a five-fold amount 
by weight of isa23-nitrodopa (1.3 mg dissolved in 50 µL milliQ water) was added. An 
instantaneous clouding of the previously clear brown solutions was observed. 
Repetition of this experiment with either only SPION@OA and only isa23-nitrodopa 
showed that this turbidity is due to the polimer aggregation and precipitation, 
possibly because of the high content of organic solvent. 
One-step ligand exchange 
SPION@OA (320 μL hexane solution, 4.8 mg Fe3O4) were first washed with 1.5 mL 
EtOH, recovered with a magnet and subsequently redispersed in 8 mL hexane. To this 
suspension a solution of 14.4 mg of ISA23-nitrodopamine dissolved in 12 mL water, 
adjusted to pH 3-4 with 0.08 mL 1 M HCl. The mixture was subsequently vortexed 
until an emulsion was formed and then left shaking for 72h.  The organic phase, now 
colorless was then removed and the water phase was washed once with 10 mL 
hexane in order to remove eventual oleic acid left from the ligand exchange. After the 
organic phase was removed, leftover hexane was evaporated at the rotary 
evaporator. The water suspended SPIONs were then collected via centrifugation (10 
min at 5000 rcf) before discarding the supernatant and redispersing them in 5 mL 
water. This procedure was repeated twice in order to remove any remaining unbound 
polymer. 
Two-step ligand exchange with DMSA 
For the oleic acid/DMSA ligand exchange, see Chapter 3. 
In a schlenk flask, under inert atmosphere, 1.72 mL of Fe3O4@DMSA ([Fe3O4] 0.73 
mg/mL) were mixed with a solution of 12.6 mg of ISA23-Nitrodopamine dissolved in 1 
mL of milliQ water.  The initial pH of 3.9 was adjusted to 4.1 with NaOH (0.1M) and 
3.5 mL of milliQ water were added. The pH was adjusted to 4.3 and the solution was 
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sonicated for 4 h. The solution was purified by dialysis through a membrane with a 
nominal cut-off of 50000 Da for two days.  
Two-step ligand exchange with TMAOH 
A solution of SPION@OA in hexane (430 μL, 10 mg Fe3O4) was dried under N2 
stream in a glass vial. Subsequently a solution of TMAOH5H2O (450 mg dissolved in 
2.36 mL water) was added and the vial was placed in an ultrasonic bath in order to 
redisperse the SPIONs. After redispersion the suspension was diluted to 20 mL, 
affording a final concentration of Fe3O4 of 0.5 mg /mL.  
Ten mL of this solution were washed by centrifugation (5 min, 20800 rcf) and then 
redispersed in a vial with 10 ml of ISA23-nitrodopamine solution (15 mg, pH 3) and 
left shaking for 72h. After this time, the SPIONs were recovered with a magnet and 
redispersed in 10 mL milliQ water. The NPs suspension showed sign of aggregation: 
for this reason, pH was increased to 9-10 and the solution was left shaking for other 
24h.  
Synthesis of ISA23SH-nitrodopamine copolymer 
ISA23SH10% (30 mg, 0.092 mmol) was dissolved, under inert atmosphere, in 3 mL of 
0.1M MES buffer. To this solution nitrodopamine hydrogen sulphate (25.5 mg, 0.086 
mmol) was added, forming a yellow suspension. Subsequently EDC (47.9 mg, 0.25 
mmol) was added and the pH was adjusted to 5.4 with addition of 1M NaOH. The 
reaction proceeded for 4h at room temperature and was then filtered through a 3 kD 
cut-off centrifugal device in order to eliminate unreacted nitrodopamine, EDC and 
byproducts and further washed with water. The remaining yellow solution was then 
lyophilized, obtaining 15.2 mg of nitrodopamine- functionalized ISA23SH. 
Synthesis of ethylmaleimido-rhodamineB 
2-aminoethylmaleimide trifluoroacetate salt17 (2.4 mg, 9.3x10-3 mmol) was 
dissolved in an amber glass schlenk flask, under N2 atmosphere, in 0.5mL EtOH. To this 
solution, a solution of rhodamine B isothiocyanate (4.7 mg, 9.3x10-3 mmol) and 
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triethylamine (1.7 μL, 1.3 eq) in 0.7 mL EtOH was added. The reaction was carried out 
in 12 h, at room temperature and in the dark.  
Functionalization of ISA23SH-nitrodopamine copolymer with rhodamineB 
ISA23SH-nitrodopamine (15.2 mg, 0.0436 mmol) was dissolved in 3.33 mL water in 
a schlenk flask under inert atmosphere. To this solution 0.67 mL of ethanol solution of 
ethylmaleimido-rhodamineB (2.8 mg, 1 eq. with respect to –SH groups) was added. 
The reaction was left for 72h, at room temperature in the dark and was then filtered 
through a 3 kD cut-off centrifugal device in order to eliminate unreacted rhodamine 
and further washed with water. The solution was then lyophilized, recovering a purple 
polymer that was then dissolved in 2 mL milliQ water. The rhodamine concentration 
in this solution was determined spectrophotometrically, using it’s known 560= 86.000, 
and was found to be 0.2 mM. 
Two-step ligand exchange with ISA23SH-ND-RhodamineB  
A solution of SPION@OA in hexane (430 μL, 10 mg Fe3O4) was dried under N2 
stream in a glass vial. Subsequently a solution of TMAOH5H2O (450 mg dissolved in 
2.36 mL water) was added and the vial was placed in an ultrasonic bath in order to 
redisperse the SPIONs. After redispersion the suspension was diluted to 20 mL, 
affording a final concentration of 0.5 mg Fe3O4/mL.  
Six mL of this solution were washed by centrifugation (7.5 min, 20800 rcf) and then 
redispersed in a vial with 6 ml of ISA23SH-ND-RhodamineB solution (3 mg, pH 3) and 
left shaking for 72h. After this time, excess polymer was removed via centrifugation (5 
min x 20.000 rcf) and the isolated NPs washed twice with milliQ water (10 min x 
10.000 rcf). 
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Conclusion 
 
In conclusion, during this Ph.D work, several different new nanocomposites were 
synthesized and characterized, based on either poly(amidoamine)s (Chapter 1) or iron 
oxide nanoparticles (Chapter 2-5) or both (Chapter 6). 
These compounds were all designed for biomedical purposes taking into account 
different potential theranostic applications, and their efficacy was proven via different 
preliminary assays. 
In the future, more biologically-driven studies will be performed on these 
compounds in collaboration with biologists, to better ascertain their biological 
interactions and verify their medical applicability. 
Moreover, taking into account the results obtained in Chapter 6 and the 
poly(amidoamine)s chemical versatility (Chapter 1), we will also aim at the 
development of a new family of multifunctional nanocompounds. 
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